{
    "5e2dadcffbd6abf43b000011": [
        {
            "text": "pedal edema",
            "probability": 0.16796276746775488,
            "start_logit": 6.745097637176514,
            "end_logit": 6.346833229064941,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.14949535468269115,
            "start_logit": 6.628620624542236,
            "end_logit": 6.346833229064941,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination",
            "probability": 0.11693490503365106,
            "start_logit": 6.628620624542236,
            "end_logit": 6.101185321807861,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness",
            "probability": 0.09922688548092386,
            "start_logit": 6.628620624542236,
            "end_logit": 5.936976909637451,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension",
            "probability": 0.0970774218518961,
            "start_logit": 6.628620624542236,
            "end_logit": 5.915076732635498,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.09468191716286939,
            "start_logit": 6.171878337860107,
            "end_logit": 6.346833229064941,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "orthostatic hypotension and pedal edema",
            "probability": 0.08268982108168489,
            "start_logit": 6.036451816558838,
            "end_logit": 6.346833229064941,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness",
            "probability": 0.06284470692333913,
            "start_logit": 6.171878337860107,
            "end_logit": 5.936976909637451,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness, orthostatic hypotension",
            "probability": 0.06148335801921985,
            "start_logit": 6.171878337860107,
            "end_logit": 5.915076732635498,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "orthostatic hypotension",
            "probability": 0.05369608079824808,
            "start_logit": 6.036451816558838,
            "end_logit": 5.915076732635498,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness,",
            "probability": 0.00423762552969234,
            "start_logit": 6.628620624542236,
            "end_logit": 2.7835710048675537,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness,",
            "probability": 0.0026838727545829585,
            "start_logit": 6.171878337860107,
            "end_logit": 2.7835710048675537,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "pedal edema. This review discusses the safety and efficacy of amantadine ER in dyskinesia in PD patients.",
            "probability": 0.0020141582834743376,
            "start_logit": 6.745097637176514,
            "end_logit": 1.9232922792434692,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination,",
            "probability": 0.0017318713896917902,
            "start_logit": 6.628620624542236,
            "end_logit": 1.8887704610824585,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hypotension and pedal edema",
            "probability": 0.0012999767472021285,
            "start_logit": 1.8837016820907593,
            "end_logit": 6.346833229064941,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hypotension",
            "probability": 0.0008441626253448278,
            "start_logit": 1.8837016820907593,
            "end_logit": 5.915076732635498,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "pedal edema. This review discusses the safety and efficacy of amantadine ER in dyskinesia",
            "probability": 0.000315225816251972,
            "start_logit": 6.745097637176514,
            "end_logit": 0.06862487643957138,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness, orthostatic",
            "probability": 0.00029990955415487493,
            "start_logit": 6.628620624542236,
            "end_logit": 0.13529357314109802,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dyskinesia. The most common side effects are hallucination",
            "probability": 0.00025682136013429203,
            "start_logit": 0.5076286792755127,
            "end_logit": 6.101185321807861,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizzi",
            "probability": 0.0002231574371920939,
            "start_logit": 6.628620624542236,
            "end_logit": -0.16030985116958618,
            "question_text": "What are the most common side effects of amantadine ER?"
        }
    ],
    "5e2f93bbfbd6abf43b00002e": [
        {
            "text": "ruptured abdominal aortic aneurysms",
            "probability": 0.19370326719530523,
            "start_logit": -3.271584987640381,
            "end_logit": -4.297061443328857,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "ruptured abdominal aortic aneurysms (RAAAs",
            "probability": 0.16497351559452927,
            "start_logit": -3.271584987640381,
            "end_logit": -4.457603931427002,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "ruptured abdominal aortic aneurysms (RAAAs)",
            "probability": 0.1370846424784328,
            "start_logit": -3.271584987640381,
            "end_logit": -4.6427903175354,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "ruptured",
            "probability": 0.061799349625662775,
            "start_logit": -3.271584987640381,
            "end_logit": -5.439496040344238,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "abdominal aortic aneurysms",
            "probability": 0.04793641702579471,
            "start_logit": -4.668036937713623,
            "end_logit": -4.297061443328857,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "abdominal aortic aneurysms (RAAAs",
            "probability": 0.040826566099048604,
            "start_logit": -4.668036937713623,
            "end_logit": -4.457603931427002,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "abdominal aortic aneurysms (RAAAs)",
            "probability": 0.03392481027721867,
            "start_logit": -4.668036937713623,
            "end_logit": -4.6427903175354,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "computed tomography",
            "probability": 0.03386890150287006,
            "start_logit": -4.754742622375488,
            "end_logit": -4.55773401260376,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "computed tomography (PMCT) when autopsies cannot be performed.",
            "probability": 0.03144823486881369,
            "start_logit": -4.754742622375488,
            "end_logit": -4.631888389587402,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "ruptured abdominal",
            "probability": 0.029646477573042614,
            "start_logit": -3.271584987640381,
            "end_logit": -6.174045562744141,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "RAAAs",
            "probability": 0.029286209408687557,
            "start_logit": -5.000253200531006,
            "end_logit": -4.457603931427002,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "ruptured abdominal aortic",
            "probability": 0.028774374185333587,
            "start_logit": -3.271584987640381,
            "end_logit": -6.203903675079346,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "RAAAs) as the cause of death could be diagnosed without post-mortem computed tomography",
            "probability": 0.026495811274928453,
            "start_logit": -5.000253200531006,
            "end_logit": -4.55773401260376,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "r",
            "probability": 0.026184441157342298,
            "start_logit": -3.271584987640381,
            "end_logit": -6.298223495483398,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "RAAAs)",
            "probability": 0.024335357901966052,
            "start_logit": -5.000253200531006,
            "end_logit": -4.6427903175354,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "ruptured abdominal aortic aneurysms (RAAAs) as the cause of death",
            "probability": 0.021610922361125204,
            "start_logit": -3.271584987640381,
            "end_logit": -6.490190029144287,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "computed tomography (PMCT)",
            "probability": 0.02038252788902505,
            "start_logit": -4.754742622375488,
            "end_logit": -5.065553188323975,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "This study aimed to conduct a multicentre retrospective review of cases to clarify how many ruptured abdominal aortic aneurysms",
            "probability": 0.018359615549622756,
            "start_logit": -5.627758979797363,
            "end_logit": -4.297061443328857,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "RAAAs) as the cause of death could be diagnosed without post-mortem computed tomography (PMCT)",
            "probability": 0.015945353651573537,
            "start_logit": -5.000253200531006,
            "end_logit": -5.065553188323975,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "post-mortem computed tomography",
            "probability": 0.013413204379677307,
            "start_logit": -5.681000232696533,
            "end_logit": -4.55773401260376,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        }
    ],
    "5e2f9596fbd6abf43b00002f": [
        {
            "text": "achalasia",
            "probability": 0.26173016270859195,
            "start_logit": 4.032674789428711,
            "end_logit": 4.117980480194092,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia, ACTH-resistant adrenal insufficiency",
            "probability": 0.17344045613497847,
            "start_logit": 4.032674789428711,
            "end_logit": 3.706500768661499,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima, achalasia",
            "probability": 0.13952100557133315,
            "start_logit": 3.403575897216797,
            "end_logit": 4.117980480194092,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima, achalasia, ACTH-resistant adrenal insufficiency",
            "probability": 0.09245624041293778,
            "start_logit": 3.403575897216797,
            "end_logit": 3.706500768661499,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.07973485708539986,
            "start_logit": 3.255547285079956,
            "end_logit": 3.706500768661499,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima",
            "probability": 0.07971324533630593,
            "start_logit": 3.403575897216797,
            "end_logit": 3.5582010746002197,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia or adrenal insufficiency",
            "probability": 0.05757876885348958,
            "start_logit": 3.780785322189331,
            "end_logit": 2.8557097911834717,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia, ACTH-resistant adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.03626341047427251,
            "start_logit": 4.032674789428711,
            "end_logit": 2.1414756774902344,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima, achalasia or adrenal insufficiency",
            "probability": 0.026447752727941466,
            "start_logit": 3.002802610397339,
            "end_logit": 2.8557097911834717,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima, achalasia, ACTH-resistant adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.019331006569730858,
            "start_logit": 3.403575897216797,
            "end_logit": 2.1414756774902344,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.01667118454384749,
            "start_logit": 3.255547285079956,
            "end_logit": 2.1414756774902344,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia,",
            "probability": 0.004706778828850081,
            "start_logit": 4.032674789428711,
            "end_logit": 0.09967019408941269,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "autonomic/neurological abnormalities",
            "probability": 0.0033683803889298495,
            "start_logit": 1.6562975645065308,
            "end_logit": 2.1414756774902344,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima, achalasia,",
            "probability": 0.002509051721081849,
            "start_logit": 3.403575897216797,
            "end_logit": 0.09967019408941269,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima,",
            "probability": 0.002495613187762765,
            "start_logit": 3.403575897216797,
            "end_logit": 0.09429977834224701,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "ACTH-resistant adrenal insufficiency",
            "probability": 0.00214780446326481,
            "start_logit": -0.35871341824531555,
            "end_logit": 3.706500768661499,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "neurological abnormalities",
            "probability": 0.001024523005205873,
            "start_logit": 0.46609267592430115,
            "end_logit": 2.1414756774902344,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "ACTH-resistant adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.00044906890010270564,
            "start_logit": -0.35871341824531555,
            "end_logit": 2.1414756774902344,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "characterized by alacrima, achalasia",
            "probability": 0.00022980636856910415,
            "start_logit": -3.005157470703125,
            "end_logit": 4.117980480194092,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "insufficiency",
            "probability": 0.0001808827174037627,
            "start_logit": -2.833065986633301,
            "end_logit": 3.706500768661499,
            "question_text": "List symptoms of Allgrove syndrome."
        }
    ],
    "5e2b109cfbd6abf43b000002": [
        {
            "text": "Length of stay, Acute/emergent admission",
            "probability": 0.22375789908996727,
            "start_logit": 4.581131458282471,
            "end_logit": 4.457035541534424,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay",
            "probability": 0.1535622488608473,
            "start_logit": 4.581131458282471,
            "end_logit": 4.0805768966674805,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Charlson comorbidity index",
            "probability": 0.11815293061425451,
            "start_logit": 4.989025592803955,
            "end_logit": 3.4105565547943115,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acute/emergent admission",
            "probability": 0.08207663060597942,
            "start_logit": 3.5782201290130615,
            "end_logit": 4.457035541534424,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index",
            "probability": 0.07857752153605277,
            "start_logit": 4.581131458282471,
            "end_logit": 3.4105565547943115,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Charlson",
            "probability": 0.07445621096827905,
            "start_logit": 4.989025592803955,
            "end_logit": 2.9487879276275635,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson",
            "probability": 0.04951704955972539,
            "start_logit": 4.581131458282471,
            "end_logit": 2.9487879276275635,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Charlson comorbidity",
            "probability": 0.03566022356094476,
            "start_logit": 4.989025592803955,
            "end_logit": 2.2126126289367676,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acute/emergent admission, Charlson comorbidity index",
            "probability": 0.02882301914380626,
            "start_logit": 3.5782201290130615,
            "end_logit": 3.4105565547943115,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Charlson comorbidity index score",
            "probability": 0.026027355501305603,
            "start_logit": 4.989025592803955,
            "end_logit": 1.8977248668670654,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity",
            "probability": 0.023715806034374703,
            "start_logit": 4.581131458282471,
            "end_logit": 2.2126126289367676,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Charlson comorbidity index score, Emergency department visits",
            "probability": 0.019401874790520773,
            "start_logit": 4.989025592803955,
            "end_logit": 1.6039464473724365,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acute/emergent admission, Charlson",
            "probability": 0.01816334798432054,
            "start_logit": 3.5782201290130615,
            "end_logit": 2.9487879276275635,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score",
            "probability": 0.017309474058729818,
            "start_logit": 4.581131458282471,
            "end_logit": 1.8977248668670654,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "comorbidity index",
            "probability": 0.01313390089047311,
            "start_logit": 2.7922425270080566,
            "end_logit": 3.4105565547943115,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits",
            "probability": 0.012903202876696284,
            "start_logit": 4.581131458282471,
            "end_logit": 1.6039464473724365,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acute/emergent admission, Charlson comorbidity",
            "probability": 0.008699194349441882,
            "start_logit": 3.5782201290130615,
            "end_logit": 2.2126126289367676,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acute/emergent admission, Charlson comorbidity index score",
            "probability": 0.006349287842262597,
            "start_logit": 3.5782201290130615,
            "end_logit": 1.8977248668670654,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length",
            "probability": 0.004979798136194833,
            "start_logit": 4.581131458282471,
            "end_logit": 0.651860237121582,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acute/emergent admission, Charlson comorbidity index score, Emergency department visits",
            "probability": 0.0047330235958230665,
            "start_logit": 3.5782201290130615,
            "end_logit": 1.6039464473724365,
            "question_text": "What is included in the LACE Index?"
        }
    ],
    "5e2f906ffbd6abf43b00002c": [
        {
            "text": "viscous lidocaine",
            "probability": 0.49194514675602985,
            "start_logit": 3.965304374694824,
            "end_logit": 3.902827024459839,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lidocaine",
            "probability": 0.4618566142735451,
            "start_logit": 3.902191638946533,
            "end_logit": 3.902827024459839,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "antacid plus 15 mL of 2% viscous lidocaine",
            "probability": 0.027940617227403954,
            "start_logit": 1.0970185995101929,
            "end_logit": 3.902827024459839,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lidocaine, even though the specific etiology of the pain is frequently unknown. The efficacy of lidocaine",
            "probability": 0.007395771928401994,
            "start_logit": 2.589324951171875,
            "end_logit": 1.0813477039337158,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous lidocaine, even though the specific etiology of the pain is frequently unknown. The efficacy of lidocaine",
            "probability": 0.0040713281368425875,
            "start_logit": 1.992385745048523,
            "end_logit": 1.0813477039337158,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "2% viscous lidocaine",
            "probability": 0.0024158915178526578,
            "start_logit": -1.3509944677352905,
            "end_logit": 3.902827024459839,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous",
            "probability": 0.001054641419948448,
            "start_logit": 3.965304374694824,
            "end_logit": -2.2423393726348877,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "antacid",
            "probability": 0.0010250435249098857,
            "start_logit": 1.0970185995101929,
            "end_logit": 0.5974806547164917,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous lid",
            "probability": 0.0003432681598987853,
            "start_logit": 3.965304374694824,
            "end_logit": -3.364783525466919,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lid",
            "probability": 0.00032227306471911975,
            "start_logit": 3.902191638946533,
            "end_logit": -3.364783525466919,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "antacid and viscous lidocaine",
            "probability": 0.00029895347022361994,
            "start_logit": -1.951757550239563,
            "end_logit": 2.4140543937683105,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "antacid in combination with viscous lidocaine",
            "probability": 0.00023572942346301252,
            "start_logit": -2.1223526000976562,
            "end_logit": 2.347046136856079,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "v",
            "probability": 0.00022448461143436443,
            "start_logit": 3.965304374694824,
            "end_logit": -3.7894883155822754,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous lidocaine (GI cocktail).",
            "probability": 0.0001552111146208957,
            "start_logit": 3.965304374694824,
            "end_logit": -4.158509254455566,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lidocaine (GI cocktail).",
            "probability": 0.00014571803455961497,
            "start_logit": 3.902191638946533,
            "end_logit": -4.158509254455566,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous lidoc",
            "probability": 0.00014089131164508862,
            "start_logit": 3.965304374694824,
            "end_logit": -4.255306720733643,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lidoc",
            "probability": 0.0001322740647124027,
            "start_logit": 3.902191638946533,
            "end_logit": -4.255306720733643,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "aine",
            "probability": 0.00010991800656533435,
            "start_logit": -4.4410834312438965,
            "end_logit": 3.902827024459839,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lidocaine provides a significantly greater degree of immediate pain relief than antacid",
            "probability": 9.8253126193771e-05,
            "start_logit": 2.5819497108459473,
            "end_logit": -3.232393741607666,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous lidocaine provides a significantly greater degree of immediate pain relief than antacid",
            "probability": 8.79708270290856e-05,
            "start_logit": 2.471407890319824,
            "end_logit": -3.232393741607666,
            "question_text": "Which drugs are included in GI cocktail?"
        }
    ],
    "5e307a05fbd6abf43b000036": [
        {
            "text": "MAGeCK",
            "probability": 0.8791773132388071,
            "start_logit": 2.4537744522094727,
            "end_logit": 1.851516842842102,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "(MAGeCK",
            "probability": 0.037847122799316534,
            "start_logit": -0.6916571855545044,
            "end_logit": 1.851516842842102,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.033810242208727456,
            "start_logit": -0.8044483661651611,
            "end_logit": 1.851516842842102,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGeCK) method",
            "probability": 0.013279702490658093,
            "start_logit": 2.4537744522094727,
            "end_logit": -2.341233015060425,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGe",
            "probability": 0.007698730665016085,
            "start_logit": 2.4537744522094727,
            "end_logit": -2.8864142894744873,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGeCK)",
            "probability": 0.005678389527990823,
            "start_logit": 2.4537744522094727,
            "end_logit": -3.1908020973205566,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "We propose the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.00472723779739519,
            "start_logit": -2.7718710899353027,
            "end_logit": 1.851516842842102,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.0032583072163812096,
            "start_logit": -3.1440043449401855,
            "end_logit": 1.851516842842102,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.0024703691471918156,
            "start_logit": -3.420844554901123,
            "end_logit": 1.851516842842102,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens.",
            "probability": 0.0024409071984096407,
            "start_logit": 2.4537744522094727,
            "end_logit": -4.035099983215332,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens",
            "probability": 0.0015943710415024241,
            "start_logit": 2.4537744522094727,
            "end_logit": -4.4609904289245605,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens. MAGeCK",
            "probability": 0.0015441893050946044,
            "start_logit": -3.96502685546875,
            "end_logit": 1.925830602645874,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "Model",
            "probability": 0.001201203827435262,
            "start_logit": -0.8044483661651611,
            "end_logit": -1.4859226942062378,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGeCK demonstrates better performance compared with existing methods",
            "probability": 0.0011461753841067288,
            "start_logit": 1.8060110807418823,
            "end_logit": -4.143275737762451,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens. MAGeCK",
            "probability": 0.0010886680784766836,
            "start_logit": -4.314570903778076,
            "end_logit": 1.925830602645874,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "propose the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.0010139380147942548,
            "start_logit": -4.311370372772217,
            "end_logit": 1.851516842842102,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "(MAGeCK) method",
            "probability": 0.0005716691312822899,
            "start_logit": -0.6916571855545044,
            "end_logit": -2.341233015060425,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.0005191619678310481,
            "start_logit": -4.9807515144348145,
            "end_logit": 1.851516842842102,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method",
            "probability": 0.0005106932935006641,
            "start_logit": -0.8044483661651611,
            "end_logit": -2.341233015060425,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens. MAGeCK",
            "probability": 0.0004216076660818686,
            "start_logit": -5.2632060050964355,
            "end_logit": 1.925830602645874,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        }
    ],
    "5e48136dd14c9f295d000008": [
        {
            "text": "stem cells",
            "probability": 0.22491799708083196,
            "start_logit": -2.9107251167297363,
            "end_logit": -3.3639161586761475,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.15372033563234574,
            "start_logit": -2.9107251167297363,
            "end_logit": -3.7445170879364014,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem",
            "probability": 0.09367991110371567,
            "start_logit": -2.816624402999878,
            "end_logit": -4.333868980407715,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.08526662029414249,
            "start_logit": -2.9107251167297363,
            "end_logit": -4.333868980407715,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "inactivation of stem cells",
            "probability": 0.05559189826330517,
            "start_logit": -4.3084235191345215,
            "end_logit": -3.3639161586761475,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells",
            "probability": 0.048534934826972874,
            "start_logit": -4.444177150726318,
            "end_logit": -3.3639161586761475,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "proliferation of stem cells",
            "probability": 0.0416677490287169,
            "start_logit": -4.216132640838623,
            "end_logit": -3.7445170879364014,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "inactivation of stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.03799431512989747,
            "start_logit": -4.3084235191345215,
            "end_logit": -3.7445170879364014,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.03317122937394379,
            "start_logit": -4.444177150726318,
            "end_logit": -3.7445170879364014,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells during cellular repopulation after inactivation.",
            "probability": 0.025270068028510142,
            "start_logit": -2.816624402999878,
            "end_logit": -5.644132137298584,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "proliferation of stem",
            "probability": 0.023112544741254362,
            "start_logit": -4.216132640838623,
            "end_logit": -4.333868980407715,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem cells during cellular repopulation after inactivation.",
            "probability": 0.023000590735068077,
            "start_logit": -2.9107251167297363,
            "end_logit": -5.644132137298584,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells at high radiation doses, and proliferation",
            "probability": 0.021166960845219393,
            "start_logit": -2.9107251167297363,
            "end_logit": -5.727210521697998,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "inactivation of stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.021074939943308814,
            "start_logit": -4.3084235191345215,
            "end_logit": -4.333868980407715,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells during cellular repopulation after inactivation",
            "probability": 0.02056220789899538,
            "start_logit": -2.816624402999878,
            "end_logit": -5.850297927856445,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "inactivation of stem",
            "probability": 0.02023220212558137,
            "start_logit": -4.3084235191345215,
            "end_logit": -4.374678134918213,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem cells during cellular repopulation after inactivation",
            "probability": 0.018715538397466685,
            "start_logit": -2.9107251167297363,
            "end_logit": -5.850297927856445,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.018399638590971313,
            "start_logit": -4.444177150726318,
            "end_logit": -4.333868980407715,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem",
            "probability": 0.017663879850266004,
            "start_logit": -4.444177150726318,
            "end_logit": -4.374678134918213,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells during cellular repopulation",
            "probability": 0.016256438109486578,
            "start_logit": -2.816624402999878,
            "end_logit": -6.085263729095459,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        }
    ],
    "5e482160d14c9f295d00000c": [
        {
            "text": "peroxiredoxin 1",
            "probability": 0.16198040415954468,
            "start_logit": 4.224939823150635,
            "end_logit": 3.392308235168457,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "phosphatase and tensin homolog (PTEN",
            "probability": 0.11643993315992571,
            "start_logit": 4.231133937835693,
            "end_logit": 3.0560142993927,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1",
            "probability": 0.11273269901421602,
            "start_logit": 3.8624839782714844,
            "end_logit": 3.392308235168457,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1",
            "probability": 0.08346318537325804,
            "start_logit": 3.8624839782714844,
            "end_logit": 3.0916943550109863,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1 (Prx1), GSH reductase",
            "probability": 0.07860321581384788,
            "start_logit": 4.224939823150635,
            "end_logit": 2.669245481491089,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "PTEN",
            "probability": 0.05058542259930391,
            "start_logit": 3.3974218368530273,
            "end_logit": 3.0560142993927,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin",
            "probability": 0.041764887250346605,
            "start_logit": 3.8624839782714844,
            "end_logit": 2.3993446826934814,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "GSR), and phosphatase and tensin homolog (PTEN",
            "probability": 0.0368649855936385,
            "start_logit": 3.0810205936431885,
            "end_logit": 3.0560142993927,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1 (Prx1)",
            "probability": 0.03368978966081089,
            "start_logit": 4.224939823150635,
            "end_logit": 1.8220276832580566,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "phosphatase and tensin homolog",
            "probability": 0.03272097904045473,
            "start_logit": 4.231133937835693,
            "end_logit": 1.7866551876068115,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "GSR)",
            "probability": 0.030364773672824464,
            "start_logit": 3.0810205936431885,
            "end_logit": 2.8620352745056152,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "phosphatase and tensin homolog (PTEN)",
            "probability": 0.029907014491353374,
            "start_logit": 4.231133937835693,
            "end_logit": 1.6967318058013916,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "tensin homolog (PTEN",
            "probability": 0.028939267027615193,
            "start_logit": 2.8389577865600586,
            "end_logit": 3.0560142993927,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin",
            "probability": 0.02713020175594838,
            "start_logit": 4.224939823150635,
            "end_logit": 1.605480432510376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1 (Prx1",
            "probability": 0.027009139468852444,
            "start_logit": 4.224939823150635,
            "end_logit": 1.6010081768035889,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "GSH reductase",
            "probability": 0.026805598444808364,
            "start_logit": 3.1491379737854004,
            "end_logit": 2.669245481491089,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1)",
            "probability": 0.023446915924123825,
            "start_logit": 3.8624839782714844,
            "end_logit": 1.8220276832580566,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1 (Prx1), GSH reductase (GSR)",
            "probability": 0.019872498582834876,
            "start_logit": 4.224939823150635,
            "end_logit": 1.2941696643829346,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin",
            "probability": 0.018881672043093642,
            "start_logit": 3.8624839782714844,
            "end_logit": 1.605480432510376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1",
            "probability": 0.018797416923198296,
            "start_logit": 3.8624839782714844,
            "end_logit": 1.6010081768035889,
            "question_text": "List five proteins with antioxidant properties?"
        }
    ],
    "5c72c9207c78d6947100007b": [
        {
            "text": "Markov models",
            "probability": 0.36953035997629274,
            "start_logit": 4.209102630615234,
            "end_logit": 4.10750150680542,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov models for segmentation of symbolic sequences, extending a segmentation procedure based on the Jensen-Shannon divergence",
            "probability": 0.2242776911827447,
            "start_logit": 4.209102630615234,
            "end_logit": 3.6081535816192627,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Jensen-Shannon divergence",
            "probability": 0.17226209442172852,
            "start_logit": 3.945234775543213,
            "end_logit": 3.6081535816192627,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Jensen-Shannon divergence that has been introduced earlier. Higher-order Markov models",
            "probability": 0.13067101596860603,
            "start_logit": 3.945234775543213,
            "end_logit": 3.3318192958831787,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov-model",
            "probability": 0.039952080461741396,
            "start_logit": 3.3476173877716064,
            "end_logit": 2.7444345951080322,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov-model-based",
            "probability": 0.01039313799362966,
            "start_logit": 3.3476173877716064,
            "end_logit": 1.3978996276855469,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov models for segmentation of symbolic sequences, extending a segmentation procedure based on the Jensen-Shannon",
            "probability": 0.009855247329345493,
            "start_logit": 4.209102630615234,
            "end_logit": 0.48327264189720154,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Jensen-Shannon",
            "probability": 0.007569569389823539,
            "start_logit": 3.945234775543213,
            "end_logit": 0.48327264189720154,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov",
            "probability": 0.005366992618395732,
            "start_logit": 4.209102630615234,
            "end_logit": -0.12446367740631104,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "the Jensen-Shannon divergence",
            "probability": 0.004402277935856178,
            "start_logit": 0.27833977341651917,
            "end_logit": 3.6081535816192627,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Jensen-Shannon divergence that has been introduced earlier. Higher-order Markov",
            "probability": 0.0036796749487202694,
            "start_logit": 3.945234775543213,
            "end_logit": -0.23803912103176117,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "We introduce Markov models",
            "probability": 0.0033984597977201143,
            "start_logit": -0.47980794310569763,
            "end_logit": 4.10750150680542,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "the Jensen-Shannon divergence that has been introduced earlier. Higher-order Markov models",
            "probability": 0.003339388925843366,
            "start_logit": 0.27833977341651917,
            "end_logit": 3.3318192958831787,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov models for segmentation of symbolic sequences,",
            "probability": 0.0032415953168511203,
            "start_logit": 4.209102630615234,
            "end_logit": -0.6286658048629761,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "divergence",
            "probability": 0.002581253683850073,
            "start_logit": -0.25550714135169983,
            "end_logit": 3.6081535816192627,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov models for segmentation",
            "probability": 0.0021577425194574573,
            "start_logit": 4.209102630615234,
            "end_logit": -1.0356688499450684,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "We introduce Markov models for segmentation of symbolic sequences, extending a segmentation procedure based on the Jensen-Shannon divergence",
            "probability": 0.002062614603733625,
            "start_logit": -0.47980794310569763,
            "end_logit": 3.6081535816192627,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "divergence that has been introduced earlier. Higher-order Markov models",
            "probability": 0.0019580340206223038,
            "start_logit": -0.25550714135169983,
            "end_logit": 3.3318192958831787,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "higher-order Markov-model",
            "probability": 0.0018288028334072402,
            "start_logit": 0.2635982036590576,
            "end_logit": 2.7444345951080322,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segmentation procedure based on the Jensen-Shannon divergence",
            "probability": 0.0014719660716301071,
            "start_logit": -0.8171833753585815,
            "end_logit": 3.6081535816192627,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        }
    ],
    "5e2f972bfbd6abf43b000030": [
        {
            "text": "homogentisic aciduria",
            "probability": 0.4178104701413051,
            "start_logit": 4.4627766609191895,
            "end_logit": 4.557804584503174,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis",
            "probability": 0.20615704719892375,
            "start_logit": 4.4627766609191895,
            "end_logit": 3.851414918899536,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "arthritis",
            "probability": 0.11435630014792156,
            "start_logit": 3.873457431793213,
            "end_logit": 3.851414918899536,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.09723261161045316,
            "start_logit": 4.4627766609191895,
            "end_logit": 3.0998828411102295,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "ochronosis",
            "probability": 0.05883675840303037,
            "start_logit": 3.960437297821045,
            "end_logit": 3.0998828411102295,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "arthritis and ochronosis",
            "probability": 0.053935394732163744,
            "start_logit": 3.873457431793213,
            "end_logit": 3.0998828411102295,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria (dark urine)",
            "probability": 0.01232895621450377,
            "start_logit": 4.4627766609191895,
            "end_logit": 1.0347273349761963,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria (dark urine),",
            "probability": 0.00858946869560743,
            "start_logit": 4.4627766609191895,
            "end_logit": 0.673313558101654,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "relentlessly progressive arthritis",
            "probability": 0.007416164705930472,
            "start_logit": 1.1378004550933838,
            "end_logit": 3.851414918899536,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria (dark urine",
            "probability": 0.0052278992465933215,
            "start_logit": 4.4627766609191895,
            "end_logit": 0.17678619921207428,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "dark urine), relentlessly progressive arthritis",
            "probability": 0.005000207815780179,
            "start_logit": 0.7436178922653198,
            "end_logit": 3.851414918899536,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "relentlessly progressive arthritis and ochronosis",
            "probability": 0.00349778517052146,
            "start_logit": 1.1378004550933838,
            "end_logit": 3.0998828411102295,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.0023583150376333324,
            "start_logit": 0.7436178922653198,
            "end_logit": 3.0998828411102295,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "aciduria",
            "probability": 0.0015963845523464053,
            "start_logit": -1.1045098304748535,
            "end_logit": 4.557804584503174,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "(dark urine), relentlessly progressive arthritis",
            "probability": 0.001533072036117662,
            "start_logit": -0.4385879933834076,
            "end_logit": 3.851414918899536,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "progressive arthritis",
            "probability": 0.001356082930445079,
            "start_logit": -0.5612612366676331,
            "end_logit": 3.851414918899536,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "aciduria (dark urine), relentlessly progressive arthritis",
            "probability": 0.0007876919058404777,
            "start_logit": -1.1045098304748535,
            "end_logit": 3.851414918899536,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "(dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.0007230633145169214,
            "start_logit": -0.4385879933834076,
            "end_logit": 3.0998828411102295,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "progressive arthritis and ochronosis",
            "probability": 0.0006395875701513244,
            "start_logit": -0.5612612366676331,
            "end_logit": 3.0998828411102295,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis.",
            "probability": 0.0006167385702142862,
            "start_logit": 4.4627766609191895,
            "end_logit": -1.9605333805084229,
            "question_text": "List Alkaptonuria Triad."
        }
    ],
    "5e369ecfb5b409ea53000002": [
        {
            "text": "uc.38",
            "probability": 0.9486533436435582,
            "start_logit": 3.5746092796325684,
            "end_logit": 3.738454580307007,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38",
            "probability": 0.043347541142208,
            "start_logit": 0.4888158142566681,
            "end_logit": 3.738454580307007,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38,",
            "probability": 0.004164446296575825,
            "start_logit": 3.5746092796325684,
            "end_logit": -1.6900055408477783,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38, a T-UCR,",
            "probability": 0.0013565332854544427,
            "start_logit": 3.5746092796325684,
            "end_logit": -2.8116564750671387,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38, a T-UCR, was down-regulated in both breast cancer tissues and breast cancer cell lines. However, uc.38",
            "probability": 0.0010544536719087172,
            "start_logit": 0.4888158142566681,
            "end_logit": 0.022227386012673378,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "expression of uc.38",
            "probability": 0.0004076701567681341,
            "start_logit": -4.177731037139893,
            "end_logit": 3.738454580307007,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38, a T-UCR, was down-regulated in both breast cancer tissues and breast cancer cell lines.",
            "probability": 0.00039117107581219783,
            "start_logit": 3.5746092796325684,
            "end_logit": -4.055199146270752,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "u",
            "probability": 0.0003224935608656759,
            "start_logit": 3.5746092796325684,
            "end_logit": -4.248260974884033,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38,",
            "probability": 0.00019028922249091163,
            "start_logit": 0.4888158142566681,
            "end_logit": -1.6900055408477783,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38, a T-UCR,",
            "probability": 6.198511057386324e-05,
            "start_logit": 0.4888158142566681,
            "end_logit": -2.8116564750671387,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38, a T-UCR, was down-regulated in both breast cancer tissues and breast cancer cell lines.",
            "probability": 1.7874078467151934e-05,
            "start_logit": 0.4888158142566681,
            "end_logit": -4.055199146270752,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "down-regulated in both breast cancer tissues and breast cancer cell lines. However, uc.38",
            "probability": 8.976738504069042e-06,
            "start_logit": -4.277325630187988,
            "end_logit": 0.022227386012673378,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38 suppressed breast cancer. Additional experiments revealed that uc.38",
            "probability": 8.693943919588439e-06,
            "start_logit": -1.7755355834960938,
            "end_logit": -2.5115725994110107,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38 expression inhibited cell proliferation and induced cell apoptosis. Thus, uc.38",
            "probability": 6.072153139888347e-06,
            "start_logit": -2.623605728149414,
            "end_logit": -2.02241587638855,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38 expression inhibited cell proliferation and induced cell apoptosis. Thus, uc.38",
            "probability": 2.8102960906116404e-06,
            "start_logit": -3.394029140472412,
            "end_logit": -2.02241587638855,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 1.8128428623371205e-06,
            "start_logit": -2.998480796813965,
            "end_logit": -2.8563578128814697,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "expression of uc.38,",
            "probability": 1.7896110164509518e-06,
            "start_logit": -4.177731037139893,
            "end_logit": -1.6900055408477783,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38 suppressed breast cancer. Additional experiments revealed that uc.38",
            "probability": 9.804716287368365e-07,
            "start_logit": -3.957883834838867,
            "end_logit": -2.5115725994110107,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "expression of uc.38, a T-UCR,",
            "probability": 5.82950706754893e-07,
            "start_logit": -4.177731037139893,
            "end_logit": -2.8116564750671387,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs) are a type of lncRNA",
            "probability": 4.797474484411099e-07,
            "start_logit": -2.998480796813965,
            "end_logit": -4.185749530792236,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        }
    ],
    "5e36ad01b5b409ea53000006": [
        {
            "text": "Uc.160+",
            "probability": 0.8882647916161226,
            "start_logit": 3.674772262573242,
            "end_logit": 1.7706830501556396,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.160",
            "probability": 0.05635752508408546,
            "start_logit": 3.674772262573242,
            "end_logit": -0.986871063709259,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.160+,",
            "probability": 0.046349989340604004,
            "start_logit": 3.674772262573242,
            "end_logit": -1.1823657751083374,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160+",
            "probability": 0.0028160065612462004,
            "start_logit": -2.0791778564453125,
            "end_logit": 1.7706830501556396,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "U",
            "probability": 0.0021670775905355613,
            "start_logit": 3.674772262573242,
            "end_logit": -4.2452073097229,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.",
            "probability": 0.0014616736719424421,
            "start_logit": 3.674772262573242,
            "end_logit": -4.639004707336426,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc",
            "probability": 0.0012890303113640674,
            "start_logit": 3.674772262573242,
            "end_logit": -4.7646965980529785,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "gastric cancer (GC), indicating that T-UCRs could play an important role in GC biology. Uc.160+",
            "probability": 0.0002999896857930315,
            "start_logit": -4.318504810333252,
            "end_logit": 1.7706830501556396,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "+",
            "probability": 0.00029351086977047453,
            "start_logit": -4.340338230133057,
            "end_logit": 1.7706830501556396,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160",
            "probability": 0.00017866649889796375,
            "start_logit": -2.0791778564453125,
            "end_logit": -0.986871063709259,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "cancer (GC), indicating that T-UCRs could play an important role in GC biology. Uc.160+",
            "probability": 0.00016757847045910303,
            "start_logit": -4.900801181793213,
            "end_logit": 1.7706830501556396,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160+,",
            "probability": 0.00014694027651299655,
            "start_logit": -2.0791778564453125,
            "end_logit": -1.1823657751083374,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "indicating that T-UCRs could play an important role in GC biology. Uc.160+",
            "probability": 0.00011794880383118486,
            "start_logit": -5.252002239227295,
            "end_logit": 1.7706830501556396,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "gastric cancer (GC), indicating that T-UCRs could play an important role in GC biology. Uc.160",
            "probability": 1.903337428390854e-05,
            "start_logit": -4.318504810333252,
            "end_logit": -0.986871063709259,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 1.5883102293139674e-05,
            "start_logit": -2.5308005809783936,
            "end_logit": -2.9555134773254395,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "+,",
            "probability": 1.5315507057823567e-05,
            "start_logit": -4.340338230133057,
            "end_logit": -1.1823657751083374,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "downregulation of T-UCR expression",
            "probability": 1.2179146780991724e-05,
            "start_logit": -3.003176212310791,
            "end_logit": -2.7486684322357178,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "cancer (GC), indicating that T-UCRs could play an important role in GC biology. Uc.160",
            "probability": 1.063231138011049e-05,
            "start_logit": -4.900801181793213,
            "end_logit": -0.986871063709259,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "cancer (GC), indicating that T-UCRs could play an important role in GC biology. Uc.160+,",
            "probability": 8.74430732007544e-06,
            "start_logit": -4.900801181793213,
            "end_logit": -1.1823657751083374,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "indicating that T-UCRs could play an important role in GC biology. Uc.160",
            "probability": 7.483469719045908e-06,
            "start_logit": -5.252002239227295,
            "end_logit": -0.986871063709259,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        }
    ],
    "5e46e8c13f5415952900000c": [
        {
            "text": "cyclobutane pyrimidine dimer",
            "probability": 0.6725712785474225,
            "start_logit": 3.6907241344451904,
            "end_logit": 2.9947240352630615,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD) and a (6-4) photoproduct",
            "probability": 0.16219787749106968,
            "start_logit": 3.6907241344451904,
            "end_logit": 1.5724329948425293,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD)",
            "probability": 0.05282019713105337,
            "start_logit": 3.6907241344451904,
            "end_logit": 0.45050957798957825,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "a cyclobutane pyrimidine dimer",
            "probability": 0.02868266744294801,
            "start_logit": 0.5359090566635132,
            "end_logit": 2.9947240352630615,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD",
            "probability": 0.017671836234106928,
            "start_logit": 3.6907241344451904,
            "end_logit": -0.6444118618965149,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "CPD) and a (6-4) photoproduct",
            "probability": 0.013044786049833206,
            "start_logit": 1.1702955961227417,
            "end_logit": 1.5724329948425293,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "photoproduct",
            "probability": 0.007548254506624714,
            "start_logit": 0.6232234239578247,
            "end_logit": 1.5724329948425293,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "a (6-4) photoproduct",
            "probability": 0.007443641337522757,
            "start_logit": 0.6092672348022461,
            "end_logit": 1.5724329948425293,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "deoxyribonucleic acid (DNA) lesions such as a cyclobutane pyrimidine dimer",
            "probability": 0.0056940378430472855,
            "start_logit": -1.0809643268585205,
            "end_logit": 2.9947240352630615,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "CPD) and a (6-4) photoproduct ((6-4)pp)",
            "probability": 0.005029676491822957,
            "start_logit": 1.1702955961227417,
            "end_logit": 0.619400143623352,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine dimer",
            "probability": 0.00461297132190085,
            "start_logit": -1.2915117740631104,
            "end_logit": 2.9947240352630615,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "CPD)",
            "probability": 0.00424807143806516,
            "start_logit": 1.1702955961227417,
            "end_logit": 0.45050957798957825,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "photoproduct ((6-4)pp)",
            "probability": 0.002910379526443245,
            "start_logit": 0.6232234239578247,
            "end_logit": 0.619400143623352,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "a (6-4) photoproduct ((6-4)pp)",
            "probability": 0.002870043840188434,
            "start_logit": 0.6092672348022461,
            "end_logit": 0.619400143623352,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane",
            "probability": 0.0027516218916623096,
            "start_logit": 3.6907241344451904,
            "end_logit": -2.5041935443878174,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "c",
            "probability": 0.002372312157261154,
            "start_logit": 3.6907241344451904,
            "end_logit": -2.6525189876556396,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "a cyclobutane pyrimidine dimer (CPD)",
            "probability": 0.0022525852603355514,
            "start_logit": 0.5359090566635132,
            "end_logit": 0.45050957798957825,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "dimer",
            "probability": 0.0020578691220808523,
            "start_logit": -2.098712921142578,
            "end_logit": 2.9947240352630615,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine",
            "probability": 0.0017004882827688984,
            "start_logit": 3.6907241344451904,
            "end_logit": -2.985468626022339,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "(CPD) and a (6-4) photoproduct",
            "probability": 0.0015194040838420549,
            "start_logit": -0.9797747135162354,
            "end_logit": 1.5724329948425293,
            "question_text": "List types of DNA lesions caused by UV light."
        }
    ],
    "5cd96eb2a49efeb44c000003": [
        {
            "text": "Linkage disequilibrium",
            "probability": 0.3072391777733558,
            "start_logit": -4.289087295532227,
            "end_logit": -4.319632530212402,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "detecting such patterns could accurately reveal targets of positive selection",
            "probability": 0.09344315094003115,
            "start_logit": -4.892561435699463,
            "end_logit": -4.906431674957275,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "linkage disequilibrium",
            "probability": 0.06064582315883781,
            "start_logit": -4.5382466316223145,
            "end_logit": -5.69304895401001,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "detecting such patterns could accurately reveal targets of positive selection along a recombining chromosome or a genome.",
            "probability": 0.05529239808571609,
            "start_logit": -4.892561435699463,
            "end_logit": -5.431149482727051,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "linkage disequilibria",
            "probability": 0.051749075419566415,
            "start_logit": -4.810401439666748,
            "end_logit": -5.579538345336914,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "linkage disequilibrium occurs more frequently when positive selection has acted on the population rather than under various neutral models.",
            "probability": 0.04882816489354801,
            "start_logit": -4.5382466316223145,
            "end_logit": -5.909792423248291,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "detecting such patterns could accurately reveal targets of positive selection along a recombining chromosome or a genome. Calculating linkage disequilibria",
            "probability": 0.04766734487629447,
            "start_logit": -4.892561435699463,
            "end_logit": -5.579538345336914,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "detecting such patterns could accurately reveal targets of positive selection along a recombining chromosome or a genome",
            "probability": 0.04239777083144618,
            "start_logit": -4.892561435699463,
            "end_logit": -5.696689128875732,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "detecting such patterns",
            "probability": 0.03305511431565005,
            "start_logit": -4.892561435699463,
            "end_logit": -5.945608615875244,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "linkage disequilibrium occurs more frequently when positive selection has acted on the population rather than under various neutral models. Thus, detect",
            "probability": 0.031453158393943234,
            "start_logit": -4.5382466316223145,
            "end_logit": -6.349600315093994,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "positive selection",
            "probability": 0.030095244562561185,
            "start_logit": -6.025547504425049,
            "end_logit": -4.906431674957275,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "linkage disequilibria in whole genomes",
            "probability": 0.028739192585215134,
            "start_logit": -4.810401439666748,
            "end_logit": -6.167683124542236,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "reveal targets of positive selection",
            "probability": 0.02576729704710378,
            "start_logit": -6.1808085441589355,
            "end_logit": -4.906431674957275,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "detecting such patterns could accurately reveal targets",
            "probability": 0.0253906844753132,
            "start_logit": -4.892561435699463,
            "end_logit": -6.209402561187744,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "targets of positive selection",
            "probability": 0.02401959427868161,
            "start_logit": -6.251044750213623,
            "end_logit": -4.906431674957275,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "detect",
            "probability": 0.02206923594185576,
            "start_logit": -4.892561435699463,
            "end_logit": -6.349600315093994,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "patterns could accurately reveal targets of positive selection",
            "probability": 0.02159473227008087,
            "start_logit": -6.3574652671813965,
            "end_logit": -4.906431674957275,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "positive selection along a recombining chromosome or a genome.",
            "probability": 0.017808027941053083,
            "start_logit": -6.025547504425049,
            "end_logit": -5.431149482727051,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "linkage disequilibrium are observed on the same side of a beneficial allele",
            "probability": 0.01739258588530787,
            "start_logit": -5.1686482429504395,
            "end_logit": -6.311654090881348,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "positive selection along a recombining chromosome or a genome. Calculating linkage disequilibria",
            "probability": 0.015352226324438533,
            "start_logit": -6.025547504425049,
            "end_logit": -5.579538345336914,
            "question_text": "Which software are used for the detection of selective sweeps?"
        }
    ],
    "5c70273c7c78d69471000061": [
        {
            "text": "end",
            "probability": 0.32986700096478666,
            "start_logit": -0.06585216522216797,
            "end_logit": -1.5676538944244385,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage",
            "probability": 0.32942369396983123,
            "start_logit": -0.06585216522216797,
            "end_logit": -1.5689986944198608,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ",
            "probability": 0.17945858332319214,
            "start_logit": -0.06585216522216797,
            "end_logit": -2.176398992538452,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status",
            "probability": 0.03709559216347646,
            "start_logit": -0.06585216522216797,
            "end_logit": -3.752845287322998,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status in patients with SS and to compare with patients with SLE (with or without SS).",
            "probability": 0.02606723565999056,
            "start_logit": -0.06585216522216797,
            "end_logit": -4.105664253234863,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "damage",
            "probability": 0.013195501912208826,
            "start_logit": -3.283320903778076,
            "end_logit": -1.5689986944198608,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health",
            "probability": 0.010788259310703272,
            "start_logit": -0.06585216522216797,
            "end_logit": -4.987884998321533,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status in patients with SS and to compare",
            "probability": 0.010118156402147603,
            "start_logit": -0.06585216522216797,
            "end_logit": -5.052011966705322,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "determine the accumulated end",
            "probability": 0.007870566817129596,
            "start_logit": -3.8014116287231445,
            "end_logit": -1.5676538944244385,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "determine the accumulated end organ damage",
            "probability": 0.007859989592629742,
            "start_logit": -3.8014116287231445,
            "end_logit": -1.5689986944198608,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status in patients with SS",
            "probability": 0.006870720135597617,
            "start_logit": -0.06585216522216797,
            "end_logit": -5.439074516296387,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "accumulated end",
            "probability": 0.0057305780744459035,
            "start_logit": -4.118725299835205,
            "end_logit": -1.5676538944244385,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "accumulated end organ damage",
            "probability": 0.005722876772593611,
            "start_logit": -4.118725299835205,
            "end_logit": -1.5689986944198608,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "organ damage",
            "probability": 0.005600103374373012,
            "start_logit": -4.140411853790283,
            "end_logit": -1.5689986944198608,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status in patients with SS and to",
            "probability": 0.005425919204997224,
            "start_logit": -0.06585216522216797,
            "end_logit": -5.675156116485596,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "determine the accumulated end organ",
            "probability": 0.004281849250823913,
            "start_logit": -3.8014116287231445,
            "end_logit": -2.176398992538452,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status in patients",
            "probability": 0.004050496295714713,
            "start_logit": -0.06585216522216797,
            "end_logit": -5.967504024505615,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status in patients with SS and",
            "probability": 0.003853093832026305,
            "start_logit": -0.06585216522216797,
            "end_logit": -6.017467021942139,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status in patients with SS and to compare with patients with SLE (with or without SS",
            "probability": 0.003490051510410998,
            "start_logit": -0.06585216522216797,
            "end_logit": -6.116426944732666,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "end organ damage and health status in patients with SS and to compare with patients with SLE (with or without SS)",
            "probability": 0.003229731432920761,
            "start_logit": -0.06585216522216797,
            "end_logit": -6.193944454193115,
            "question_text": "Which organs are primarily damaged in SLE?"
        }
    ],
    "5c7a4ed5d774d04240000008": [
        {
            "text": "improve patient care",
            "probability": 0.8248783259843865,
            "start_logit": 2.955115795135498,
            "end_logit": 4.174326419830322,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "significant potential to improve patient care",
            "probability": 0.05590431781508849,
            "start_logit": 0.2635215222835541,
            "end_logit": 4.174326419830322,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "patient care",
            "probability": 0.038778821470540126,
            "start_logit": -0.10224583745002747,
            "end_logit": 4.174326419830322,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "to improve patient care",
            "probability": 0.028815448235236994,
            "start_logit": -0.3992084562778473,
            "end_logit": 4.174326419830322,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "potential to improve patient care",
            "probability": 0.01668700301158406,
            "start_logit": -0.9454899430274963,
            "end_logit": 4.174326419830322,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "improve",
            "probability": 0.010373955024796959,
            "start_logit": 2.955115795135498,
            "end_logit": -0.20161113142967224,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "improve clinical outcomes",
            "probability": 0.009902269872296329,
            "start_logit": 1.3553379774093628,
            "end_logit": 1.3516323566436768,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "fidelity of the molecular analysis",
            "probability": 0.002765067222888789,
            "start_logit": 0.20658273994922638,
            "end_logit": 1.2246885299682617,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "analysis of circulating cell-free tumor DNA in plasma is a powerful tool with considerable potential to improve clinical outcomes",
            "probability": 0.0026779837959584915,
            "start_logit": 0.04763816297054291,
            "end_logit": 1.3516323566436768,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "molecular analysis",
            "probability": 0.002575265017180478,
            "start_logit": 0.13547024130821228,
            "end_logit": 1.2246885299682617,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "clinical outcomes",
            "probability": 0.00250744226297209,
            "start_logit": -0.018162818625569344,
            "end_logit": 1.3516323566436768,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "improve not only the fidelity of the molecular analysis",
            "probability": 0.0009556941451479542,
            "start_logit": -0.8557995557785034,
            "end_logit": 1.2246885299682617,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "The isolation and analysis of circulating cell-free tumor DNA in plasma is a powerful tool with considerable potential to improve clinical outcomes",
            "probability": 0.0008558486245854384,
            "start_logit": -1.0930877923965454,
            "end_logit": 1.3516323566436768,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "significant potential to improve",
            "probability": 0.0007030720294579068,
            "start_logit": 0.2635215222835541,
            "end_logit": -0.20161113142967224,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "to improve",
            "probability": 0.00036239303979163063,
            "start_logit": -0.3992084562778473,
            "end_logit": -0.20161113142967224,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "isolation and analysis of circulating cell-free tumor DNA in plasma is a powerful tool with considerable potential to improve clinical outcomes",
            "probability": 0.0003604369866583861,
            "start_logit": -1.9578641653060913,
            "end_logit": 1.3516323566436768,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "fidelity",
            "probability": 0.00027854774458988197,
            "start_logit": 0.20658273994922638,
            "end_logit": -1.0705422163009644,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "analysis of circulating cell-free tumor DNA in plasma is a powerful tool with considerable potential to improve",
            "probability": 0.000214415751274731,
            "start_logit": 0.04763816297054291,
            "end_logit": -1.1732702255249023,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "potential to improve",
            "probability": 0.00020986151931466935,
            "start_logit": -0.9454899430274963,
            "end_logit": -0.20161113142967224,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "fidelity of the molecular analysis but also the number of tests performed on a single specimen. Circulating tumor DNA assays",
            "probability": 0.00019383044625006745,
            "start_logit": 0.20658273994922638,
            "end_logit": -1.43314790725708,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        }
    ],
    "5e2b0d167d50947c2f000002": [
        {
            "text": "Acromelic frontonasal dysostosis",
            "probability": 0.32446259380512177,
            "start_logit": 3.253067970275879,
            "end_logit": 3.1943981647491455,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis",
            "probability": 0.2503728198864952,
            "start_logit": 2.9938488006591797,
            "end_logit": 3.1943981647491455,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "Acromelic frontonasal dysostosis (AFND)",
            "probability": 0.21619135536276943,
            "start_logit": 3.253067970275879,
            "end_logit": 2.7883918285369873,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis (AFND)",
            "probability": 0.16682489849591256,
            "start_logit": 2.9938488006591797,
            "end_logit": 2.7883918285369873,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "AFND)",
            "probability": 0.031108875537471367,
            "start_logit": 1.3143972158432007,
            "end_logit": 2.7883918285369873,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "dysostosis",
            "probability": 0.0038067193421559855,
            "start_logit": -1.192334532737732,
            "end_logit": 3.1943981647491455,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "dysostosis (AFND)",
            "probability": 0.0025364397307403312,
            "start_logit": -1.192334532737732,
            "end_logit": 2.7883918285369873,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "Acromelic frontonasal dysostosis (AFND",
            "probability": 0.0013124355903373962,
            "start_logit": 3.253067970275879,
            "end_logit": -2.315887451171875,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis (AFND",
            "probability": 0.0010127460174023419,
            "start_logit": 2.9938488006591797,
            "end_logit": -2.315887451171875,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "(AFND)",
            "probability": 0.00048098333019371513,
            "start_logit": -2.8550186157226562,
            "end_logit": 2.7883918285369873,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "Acromelic frontonasal dysostosis (AFND) is a distinctive and rare frontonasal malformation",
            "probability": 0.000307525987837231,
            "start_logit": 3.253067970275879,
            "end_logit": -3.7669677734375,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis (AFND) is a distinctive and rare frontonasal malformation",
            "probability": 0.00023730362215322994,
            "start_logit": 2.9938488006591797,
            "end_logit": -3.7669677734375,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "cromelic frontonasal dysostosis",
            "probability": 0.000191668936399689,
            "start_logit": -4.181087970733643,
            "end_logit": 3.1943981647491455,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "osis",
            "probability": 0.00019048602214723347,
            "start_logit": -4.187278747558594,
            "end_logit": 3.1943981647491455,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "Acromelic front",
            "probability": 0.0001888768412430169,
            "start_logit": 3.253067970275879,
            "end_logit": -4.254432201385498,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "AFND",
            "probability": 0.0001888530434634803,
            "start_logit": 1.3143972158432007,
            "end_logit": -2.315887451171875,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "A",
            "probability": 0.00018503877949626043,
            "start_logit": 3.253067970275879,
            "end_logit": -4.274961948394775,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "front",
            "probability": 0.00014574754765620546,
            "start_logit": 2.9938488006591797,
            "end_logit": -4.254432201385498,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "cromelic frontonasal dysostosis (AFND)",
            "probability": 0.00012771015190144583,
            "start_logit": -4.181087970733643,
            "end_logit": 2.7883918285369873,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "osis (AFND)",
            "probability": 0.00012692196910195217,
            "start_logit": -4.187278747558594,
            "end_logit": 2.7883918285369873,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        }
    ],
    "5e2f9ceefbd6abf43b000033": [
        {
            "text": "atorvastatin",
            "probability": 0.1751012191151072,
            "start_logit": 6.288207054138184,
            "end_logit": 5.854247570037842,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "atorvastatin and hydrochlorthiazide",
            "probability": 0.17081092198239045,
            "start_logit": 6.288207054138184,
            "end_logit": 5.829440593719482,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan, atorvastatin",
            "probability": 0.1530993925133605,
            "start_logit": 6.153930187225342,
            "end_logit": 5.854247570037842,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.14934817999730737,
            "start_logit": 6.153930187225342,
            "end_logit": 5.829440593719482,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan",
            "probability": 0.12709755023752842,
            "start_logit": 6.153930187225342,
            "end_logit": 5.668115139007568,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "hydrochlorthiazide",
            "probability": 0.08938737587342739,
            "start_logit": 5.640629291534424,
            "end_logit": 5.829440593719482,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "aspirin, valsartan, atorvastatin",
            "probability": 0.03808536351741295,
            "start_logit": 4.7626729011535645,
            "end_logit": 5.854247570037842,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "aspirin, valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.03715220310469293,
            "start_logit": 4.7626729011535645,
            "end_logit": 5.829440593719482,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "aspirin, valsartan",
            "probability": 0.0316170843234829,
            "start_logit": 4.7626729011535645,
            "end_logit": 5.668115139007568,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "aspirin",
            "probability": 0.02490556231589764,
            "start_logit": 4.7626729011535645,
            "end_logit": 5.429508686065674,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan,",
            "probability": 0.0007602627903360871,
            "start_logit": 6.153930187225342,
            "end_logit": 0.5490691065788269,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "atorvastatin and hydrochlorthiazide (PolyPill)",
            "probability": 0.0005186735304687243,
            "start_logit": 6.288207054138184,
            "end_logit": 0.03240273892879486,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan, atorvastatin and hydrochlorthiazide (PolyPill)",
            "probability": 0.00045350113967693395,
            "start_logit": 6.153930187225342,
            "end_logit": 0.03240273892879486,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "atorvas",
            "probability": 0.000282589833925789,
            "start_logit": 6.288207054138184,
            "end_logit": -0.5748754143714905,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "hydrochlorthiazide (PolyPill)",
            "probability": 0.00027142799351194397,
            "start_logit": 5.640629291534424,
            "end_logit": 0.03240273892879486,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "ator",
            "probability": 0.0002488972183092064,
            "start_logit": 6.288207054138184,
            "end_logit": -0.7018318772315979,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan, atorvas",
            "probability": 0.0002470818428514128,
            "start_logit": 6.153930187225342,
            "end_logit": -0.5748754143714905,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan, ator",
            "probability": 0.0002176227733534786,
            "start_logit": 6.153930187225342,
            "end_logit": -0.7018318772315979,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "atorvastat",
            "probability": 0.00020596514431695572,
            "start_logit": 6.288207054138184,
            "end_logit": -0.8911649584770203,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "aspirin, valsartan,",
            "probability": 0.00018912475264188774,
            "start_logit": 4.7626729011535645,
            "end_logit": 0.5490691065788269,
            "question_text": "Which drugs are included in PolyIran?"
        }
    ],
    "5e2a120c76af173751000001": [
        {
            "text": "vasodilation",
            "probability": 0.19347711701556627,
            "start_logit": 5.772552967071533,
            "end_logit": 6.015341281890869,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.16112187509318684,
            "start_logit": 5.772552967071533,
            "end_logit": 5.832343101501465,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow upregulation, and neovessel formation",
            "probability": 0.15787663681252284,
            "start_logit": 5.752205848693848,
            "end_logit": 5.832343101501465,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation",
            "probability": 0.1390128170716741,
            "start_logit": 5.772552967071533,
            "end_logit": 5.68474817276001,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "neovessel formation",
            "probability": 0.13641067913498856,
            "start_logit": 5.606061935424805,
            "end_logit": 5.832343101501465,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow upregulation",
            "probability": 0.1362128886621827,
            "start_logit": 5.752205848693848,
            "end_logit": 5.68474817276001,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow",
            "probability": 0.012234014253750834,
            "start_logit": 5.772552967071533,
            "end_logit": 3.2544021606445312,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow",
            "probability": 0.011987602701256806,
            "start_logit": 5.752205848693848,
            "end_logit": 3.2544021606445312,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation",
            "probability": 0.007140424790216632,
            "start_logit": 2.473165988922119,
            "end_logit": 6.015341281890869,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.0059463292037218885,
            "start_logit": 2.473165988922119,
            "end_logit": 5.832343101501465,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation",
            "probability": 0.005130377072429556,
            "start_logit": 2.473165988922119,
            "end_logit": 5.68474817276001,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel formation,",
            "probability": 0.004931983060161819,
            "start_logit": 5.772552967071533,
            "end_logit": 2.3459231853485107,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow upregulation, and neovessel formation,",
            "probability": 0.0048326454611103764,
            "start_logit": 5.752205848693848,
            "end_logit": 2.3459231853485107,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "neovessel formation,",
            "probability": 0.004175566839262669,
            "start_logit": 5.606061935424805,
            "end_logit": 2.3459231853485107,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "sustained and dose-dependent vasodilation",
            "probability": 0.004146868636224523,
            "start_logit": 1.929747223854065,
            "end_logit": 6.015341281890869,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.0034533864300855042,
            "start_logit": 1.929747223854065,
            "end_logit": 5.832343101501465,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation,",
            "probability": 0.003368482270648964,
            "start_logit": 5.772552967071533,
            "end_logit": 1.9646443128585815,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow upregulation,",
            "probability": 0.003300635942482006,
            "start_logit": 5.752205848693848,
            "end_logit": 1.9646443128585815,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "sustained and dose-dependent vasodilation, blood flow upregulation",
            "probability": 0.002979514580534929,
            "start_logit": 1.929747223854065,
            "end_logit": 5.68474817276001,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel",
            "probability": 0.0022601549679924157,
            "start_logit": 5.772552967071533,
            "end_logit": 1.5656154155731201,
            "question_text": "What are the in vivo effects of AZD8601?"
        }
    ],
    "5c7006037c78d6947100005d": [
        {
            "text": "Disease Activity Index 2000",
            "probability": 0.4936530946800571,
            "start_logit": 1.669435739517212,
            "end_logit": 1.1149814128875732,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Systemic Lupus Erythematosus Disease Activity Index 2000",
            "probability": 0.09907937546830835,
            "start_logit": 0.06352400779724121,
            "end_logit": 1.1149814128875732,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "2000",
            "probability": 0.09896100665161563,
            "start_logit": 0.062328606843948364,
            "end_logit": 1.1149814128875732,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Disease Activity",
            "probability": 0.09858355549701912,
            "start_logit": 1.669435739517212,
            "end_logit": -0.4959471523761749,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Disease Activity Index",
            "probability": 0.06595301763425275,
            "start_logit": 1.669435739517212,
            "end_logit": -0.8979089856147766,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Disease",
            "probability": 0.028760930096463164,
            "start_logit": 1.669435739517212,
            "end_logit": -1.7278337478637695,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Activity Index 2000",
            "probability": 0.023445039489968032,
            "start_logit": -1.377738356590271,
            "end_logit": 1.1149814128875732,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Systemic Lupus Erythematosus Disease Activity",
            "probability": 0.019786358508337674,
            "start_logit": 0.06352400779724121,
            "end_logit": -0.4959471523761749,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Systemic Lupus Erythematosus Disease Activity Index",
            "probability": 0.013237198080743803,
            "start_logit": 0.06352400779724121,
            "end_logit": -0.8979089856147766,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "2000 (SLEDAI-2K) and the time to partial recovery identified by the SLEDAI-2K Responder Index 50",
            "probability": 0.013015579753719511,
            "start_logit": 0.062328606843948364,
            "end_logit": -0.9135974049568176,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Disease Activity Index 2000 (SLEDAI-2K) and the time to partial recovery",
            "probability": 0.008535431052690898,
            "start_logit": 1.669435739517212,
            "end_logit": -2.9426257610321045,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Systemic Lupus Erythematosus Disease",
            "probability": 0.005772505069966421,
            "start_logit": 0.06352400779724121,
            "end_logit": -1.7278337478637695,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Responder Index 50",
            "probability": 0.005750210986262625,
            "start_logit": -0.7545819282531738,
            "end_logit": -0.9135974049568176,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Systemic Lupus Erythematosus",
            "probability": 0.005313429929542561,
            "start_logit": 0.06352400779724121,
            "end_logit": -1.8107023239135742,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Activity",
            "probability": 0.004682023422109911,
            "start_logit": -1.377738356590271,
            "end_logit": -0.4959471523761749,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Disease Activity Index 2000 (SLEDAI-2K",
            "probability": 0.00357829145513506,
            "start_logit": 1.669435739517212,
            "end_logit": -3.8119661808013916,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Disease Activity Index 2000 (SLEDAI-2K) and the time to partial recovery identified by the SLEDAI-2K Responder Index",
            "probability": 0.0031807443582354366,
            "start_logit": 1.669435739517212,
            "end_logit": -3.929736375808716,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Activity Index",
            "probability": 0.0031323030678451877,
            "start_logit": -1.377738356590271,
            "end_logit": -0.8979089856147766,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "Activity Index 2000 (SLEDAI-2K) and the time to partial recovery identified by the SLEDAI-2K Responder Index 50",
            "probability": 0.003083545647277432,
            "start_logit": -1.377738356590271,
            "end_logit": -0.9135974049568176,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "time to complete recovery identified by Systemic Lupus Erythematosus Disease Activity Index 2000",
            "probability": 0.0024963591504492733,
            "start_logit": -3.6175639629364014,
            "end_logit": 1.1149814128875732,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        }
    ],
    "5e2f992cfbd6abf43b000031": [
        {
            "text": "aspirin",
            "probability": 0.12193955094464633,
            "start_logit": 6.400436878204346,
            "end_logit": 6.2607502937316895,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril",
            "probability": 0.10102310800386995,
            "start_logit": 6.413748264312744,
            "end_logit": 6.059262752532959,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril",
            "probability": 0.0996872611193589,
            "start_logit": 6.400436878204346,
            "end_logit": 6.059262752532959,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril, simvastatin",
            "probability": 0.08152225376138696,
            "start_logit": 6.413748264312744,
            "end_logit": 5.844789505004883,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin",
            "probability": 0.08044427021032359,
            "start_logit": 6.400436878204346,
            "end_logit": 5.844789505004883,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril, simvastatin, atenolol, and hydrochlorothiazide",
            "probability": 0.07317646474855856,
            "start_logit": 6.413748264312744,
            "end_logit": 5.73678731918335,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril, simvastatin, atenolol",
            "probability": 0.06542624331793302,
            "start_logit": 6.413748264312744,
            "end_logit": 5.6248369216918945,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol",
            "probability": 0.06456110023306401,
            "start_logit": 6.400436878204346,
            "end_logit": 5.6248369216918945,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "simvastatin",
            "probability": 0.05715505136382941,
            "start_logit": 6.058640003204346,
            "end_logit": 5.844789505004883,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "simvastatin, atenolol, and hydrochlorothiazide",
            "probability": 0.05130383923841314,
            "start_logit": 6.058640003204346,
            "end_logit": 5.73678731918335,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "hydrochlorothiazide",
            "probability": 0.0488853480074167,
            "start_logit": 6.01035213470459,
            "end_logit": 5.73678731918335,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "atenolol, and hydrochlorothiazide",
            "probability": 0.04825602178019371,
            "start_logit": 5.997395038604736,
            "end_logit": 5.73678731918335,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "simvastatin, atenolol",
            "probability": 0.045870178078296096,
            "start_logit": 6.058640003204346,
            "end_logit": 5.6248369216918945,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "atenolol",
            "probability": 0.04314515921744662,
            "start_logit": 5.997395038604736,
            "end_logit": 5.6248369216918945,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "acetylsalicylic acid], ramipril",
            "probability": 0.005572814743359074,
            "start_logit": 3.516299247741699,
            "end_logit": 6.059262752532959,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "acetylsalicylic acid], ramipril, simvastatin",
            "probability": 0.004497074250140012,
            "start_logit": 3.516299247741699,
            "end_logit": 5.844789505004883,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "acetylsalicylic acid], ramipril, simvastatin, atenolol",
            "probability": 0.003609157751816624,
            "start_logit": 3.516299247741699,
            "end_logit": 5.6248369216918945,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "aspirin [acetylsalicylic acid",
            "probability": 0.0015932469634565873,
            "start_logit": 6.400436878204346,
            "end_logit": 1.9229989051818848,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril,",
            "probability": 0.0011736880784399418,
            "start_logit": 6.413748264312744,
            "end_logit": 1.6040644645690918,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril,",
            "probability": 0.0011581681880509854,
            "start_logit": 6.400436878204346,
            "end_logit": 1.6040644645690918,
            "question_text": "Which medication are included in the Polycap polypill?"
        }
    ],
    "5c74305d7c78d694710000a4": [
        {
            "text": "cytoplasmic mRNA",
            "probability": 0.2214343414873412,
            "start_logit": -1.0749406814575195,
            "end_logit": -2.214573621749878,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "mRNA",
            "probability": 0.18969126422942564,
            "start_logit": -1.2296689748764038,
            "end_logit": -2.214573621749878,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic",
            "probability": 0.16934145803620138,
            "start_logit": -1.0749406814575195,
            "end_logit": -2.4827826023101807,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 0.08226440193984291,
            "start_logit": -1.0749406814575195,
            "end_logit": -3.204761266708374,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 0.07047162739180861,
            "start_logit": -1.2296689748764038,
            "end_logit": -3.204761266708374,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "mRNA is sequestered to insoluble ribonucleoprotein (RNP) granules",
            "probability": 0.04541678490968635,
            "start_logit": -1.2296689748764038,
            "end_logit": -3.644089698791504,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "mRNA is sequestered to insoluble ribonucleoprotein (RNP) granules,",
            "probability": 0.026827776573802996,
            "start_logit": -1.2296689748764038,
            "end_logit": -4.170533657073975,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "ribonucleoprotein",
            "probability": 0.023429175513006082,
            "start_logit": -2.330897092819214,
            "end_logit": -3.204761266708374,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP)",
            "probability": 0.017294283773776706,
            "start_logit": -1.0749406814575195,
            "end_logit": -4.764323711395264,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic mRNA is",
            "probability": 0.016332601455851695,
            "start_logit": -1.0749406814575195,
            "end_logit": -4.821536540985107,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "ribonucleoprotein (RNP) granules",
            "probability": 0.015099379200787017,
            "start_logit": -2.330897092819214,
            "end_logit": -3.644089698791504,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "c",
            "probability": 0.014898406603655111,
            "start_logit": -1.0749406814575195,
            "end_logit": -4.913445472717285,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "mRNA is sequestered to insoluble ribonucleoprotein (RNP)",
            "probability": 0.01481511192417138,
            "start_logit": -1.2296689748764038,
            "end_logit": -4.764323711395264,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble",
            "probability": 0.014760581786579583,
            "start_logit": -1.0749406814575195,
            "end_logit": -4.922739505767822,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "stress, cytoplasmic mRNA",
            "probability": 0.01435539827409311,
            "start_logit": -3.810940742492676,
            "end_logit": -2.214573621749878,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "mRNA is",
            "probability": 0.01399128878342016,
            "start_logit": -1.2296689748764038,
            "end_logit": -4.821536540985107,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic mRNA is sequestered",
            "probability": 0.013430277437905772,
            "start_logit": -1.0749406814575195,
            "end_logit": -5.01718807220459,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "mRNA is sequestered to insoluble",
            "probability": 0.012644621430674434,
            "start_logit": -1.2296689748764038,
            "end_logit": -4.922739505767822,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic m",
            "probability": 0.0119962002475909,
            "start_logit": -1.0749406814575195,
            "end_logit": -5.130109786987305,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "mRNA is sequestered",
            "probability": 0.011505019000379023,
            "start_logit": -1.2296689748764038,
            "end_logit": -5.01718807220459,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        }
    ],
    "5c7a4a31d774d04240000006": [
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms, and tumor heterogenity",
            "probability": 0.4320523591841493,
            "start_logit": 4.267502307891846,
            "end_logit": 2.4396636486053467,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogeneity",
            "probability": 0.3825412468173238,
            "start_logit": 4.267502307891846,
            "end_logit": 2.31795334815979,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms",
            "probability": 0.03883149187036055,
            "start_logit": 4.267502307891846,
            "end_logit": 0.030348429456353188,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "tumor heterogenity",
            "probability": 0.038240477074243294,
            "start_logit": 1.8428500890731812,
            "end_logit": 2.4396636486053467,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogeneity in methodologies",
            "probability": 0.030269239133354248,
            "start_logit": 4.267502307891846,
            "end_logit": -0.21875114738941193,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms, and tumor",
            "probability": 0.010845155703146007,
            "start_logit": 4.267502307891846,
            "end_logit": -1.2451646327972412,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms,",
            "probability": 0.010367432786284521,
            "start_logit": 4.267502307891846,
            "end_logit": -1.290213704109192,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues to be considered",
            "probability": 0.010163171394299555,
            "start_logit": 1.8428500890731812,
            "end_logit": 1.114539623260498,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "tumor heterogenity for PD-L1 expression",
            "probability": 0.00946234788914063,
            "start_logit": 1.8428500890731812,
            "end_logit": 1.0430896282196045,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "imperfect predictive biomarker for patient selection",
            "probability": 0.007693230543022653,
            "start_logit": 1.3392809629440308,
            "end_logit": 1.3396790027618408,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues",
            "probability": 0.005982475963231308,
            "start_logit": 1.8428500890731812,
            "end_logit": 0.5846036076545715,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "he",
            "probability": 0.005891034095484861,
            "start_logit": 4.267502307891846,
            "end_logit": -1.8554515838623047,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies",
            "probability": 0.005564065846982085,
            "start_logit": 4.267502307891846,
            "end_logit": -1.9125540256500244,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogenity",
            "probability": 0.004264495647891592,
            "start_logit": -0.3507205545902252,
            "end_logit": 2.4396636486053467,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "scoring algorithms, and tumor heterogenity",
            "probability": 0.0016071116454535028,
            "start_logit": -1.3266059160232544,
            "end_logit": 2.4396636486053467,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "imperfect",
            "probability": 0.001582005767507572,
            "start_logit": 1.3392809629440308,
            "end_logit": -0.2419682741165161,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "patient selection",
            "probability": 0.0013613909664805844,
            "start_logit": -0.3925528824329376,
            "end_logit": 1.3396790027618408,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogenity for PD-L1 expression are important issues to be considered",
            "probability": 0.001133374986290607,
            "start_logit": -0.3507205545902252,
            "end_logit": 1.114539623260498,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "imperfect predictive biomarker for patient selection and association with other markers of the tumor immune microenvironment",
            "probability": 0.001092672027051284,
            "start_logit": 1.3392809629440308,
            "end_logit": -0.6120356917381287,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "heterogenity for PD-L1 expression",
            "probability": 0.001055220658302284,
            "start_logit": -0.3507205545902252,
            "end_logit": 1.0430896282196045,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        }
    ],
    "5e360f3d158f994d3a000009": [
        {
            "text": "congenital sensorineural deafness",
            "probability": 0.20741202774401996,
            "start_logit": 5.561133861541748,
            "end_logit": 5.64048433303833,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.10878132393935261,
            "start_logit": 4.91576623916626,
            "end_logit": 5.64048433303833,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hyperplasia of the medial portion of the eyebrows, and congenital sensorineural deafness",
            "probability": 0.10526623759239723,
            "start_logit": 4.8829193115234375,
            "end_logit": 5.64048433303833,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "heterochromia iridis, hyperplasia of the medial portion of the eyebrows, and congenital sensorineural deafness",
            "probability": 0.10170107919330666,
            "start_logit": 4.848464488983154,
            "end_logit": 5.64048433303833,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "poliosis",
            "probability": 0.09170230927735881,
            "start_logit": 5.126523494720459,
            "end_logit": 5.25893497467041,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "poliosis, heterochromia iridis, hyperplasia of the medial portion of the eyebrows",
            "probability": 0.06563122283927526,
            "start_logit": 5.126523494720459,
            "end_logit": 4.924438953399658,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "poliosis, heterochromia iridis",
            "probability": 0.06222568453936485,
            "start_logit": 5.126523494720459,
            "end_logit": 4.871155261993408,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hyperplasia of the medial portion of the eyebrows",
            "probability": 0.051441608940142255,
            "start_logit": 4.8829193115234375,
            "end_logit": 4.924438953399658,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "heterochromia iridis, hyperplasia of the medial portion of the eyebrows",
            "probability": 0.04969938381297644,
            "start_logit": 4.848464488983154,
            "end_logit": 4.924438953399658,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "heterochromia iridis",
            "probability": 0.04712053265441242,
            "start_logit": 4.848464488983154,
            "end_logit": 4.871155261993408,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "lacrimal puncta, a broad nasal root, poliosis",
            "probability": 0.02976710824967792,
            "start_logit": 4.00137996673584,
            "end_logit": 5.25893497467041,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "lacrimal puncta, a broad nasal root, poliosis, heterochromia iridis",
            "probability": 0.02019882271439056,
            "start_logit": 4.00137996673584,
            "end_logit": 4.871155261993408,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "nasal root, poliosis",
            "probability": 0.010654415990745155,
            "start_logit": 2.9739503860473633,
            "end_logit": 5.25893497467041,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "lateral displacement of the medial canthi and lacrimal puncta, a broad nasal root, poliosis",
            "probability": 0.010537526367475892,
            "start_logit": 2.962918758392334,
            "end_logit": 5.25893497467041,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "deafness",
            "probability": 0.0081439963051514,
            "start_logit": 2.3237075805664062,
            "end_logit": 5.64048433303833,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "nasal root, poliosis, heterochromia iridis, hyperplasia of the medial portion of the eyebrows",
            "probability": 0.007625351592793313,
            "start_logit": 2.9739503860473633,
            "end_logit": 4.924438953399658,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "nasal root, poliosis, heterochromia iridis",
            "probability": 0.007229679749787512,
            "start_logit": 2.9739503860473633,
            "end_logit": 4.871155261993408,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "lacrimal puncta, a broad nasal root",
            "probability": 0.00584106340795026,
            "start_logit": 4.00137996673584,
            "end_logit": 3.630443811416626,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "lacrimal puncta",
            "probability": 0.0050452073227808,
            "start_logit": 4.00137996673584,
            "end_logit": 3.4839696884155273,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "a broad nasal root, poliosis",
            "probability": 0.003975417766640952,
            "start_logit": 1.9881057739257812,
            "end_logit": 5.25893497467041,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        }
    ],
    "5e493bc06d0a277941000003": [
        {
            "text": "breast cancer",
            "probability": 0.6108135764669995,
            "start_logit": 1.6368969678878784,
            "end_logit": 2.254340648651123,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "Breast cancer",
            "probability": 0.36026679400910255,
            "start_logit": 1.5653623342514038,
            "end_logit": 1.7979283332824707,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "Breast",
            "probability": 0.008823395434978117,
            "start_logit": 1.5653623342514038,
            "end_logit": -1.9115097522735596,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "breast",
            "probability": 0.008686467786511332,
            "start_logit": 1.6368969678878784,
            "end_logit": -1.9986847639083862,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancer",
            "probability": 0.004998299809052108,
            "start_logit": -3.168797016143799,
            "end_logit": 2.254340648651123,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "breast cancer have been discovered by genome-wide association studies and may expand the genetic features.",
            "probability": 0.001329725653923787,
            "start_logit": 1.6368969678878784,
            "end_logit": -3.875478506088257,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "numerous susceptibility loci of breast cancer",
            "probability": 0.0012194324850052834,
            "start_logit": -4.579509258270264,
            "end_logit": 2.254340648651123,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "breast cancer have been discovered by genome-wide association studies",
            "probability": 0.0011951611702824554,
            "start_logit": 1.6368969678878784,
            "end_logit": -3.9821701049804688,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "susceptibility loci of breast cancer",
            "probability": 0.0008791841042369937,
            "start_logit": -4.906655788421631,
            "end_logit": 2.254340648651123,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": ", numerous susceptibility loci of breast cancer",
            "probability": 0.000619987713338711,
            "start_logit": -5.255950450897217,
            "end_logit": 2.254340648651123,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "breast cancer have been discovered by genome-wide association",
            "probability": 0.00039496591246410004,
            "start_logit": 1.6368969678878784,
            "end_logit": -5.089406967163086,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "Breast cancer is a heterogeneous and polygenic disease that can be divided into different molecular subtypes",
            "probability": 0.00036973767098055055,
            "start_logit": 1.5653623342514038,
            "end_logit": -5.083878040313721,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "breast cancer have been discovered by genome-wide association studies and may expand the genetic features",
            "probability": 0.00033515686663634025,
            "start_logit": 1.6368969678878784,
            "end_logit": -5.253607749938965,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "numerous susceptibility loci of breast",
            "probability": 1.7341724884525617e-05,
            "start_logit": -4.579509258270264,
            "end_logit": -1.9986847639083862,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "susceptibility loci of breast",
            "probability": 1.2503003689015206e-05,
            "start_logit": -4.906655788421631,
            "end_logit": -1.9986847639083862,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancer have been discovered by genome-wide association studies and may expand the genetic features.",
            "probability": 1.088117183076077e-05,
            "start_logit": -3.168797016143799,
            "end_logit": -3.875478506088257,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancer have been discovered by genome-wide association studies",
            "probability": 9.78002794856351e-06,
            "start_logit": -3.168797016143799,
            "end_logit": -3.9821701049804688,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": ", numerous susceptibility loci of breast",
            "probability": 8.816934507415124e-06,
            "start_logit": -5.255950450897217,
            "end_logit": -1.9986847639083862,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "genome-wide association studies and may expand the genetic features.",
            "probability": 4.630314178052389e-06,
            "start_logit": -4.0232062339782715,
            "end_logit": -3.875478506088257,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "genome-wide association studies",
            "probability": 4.161739450154067e-06,
            "start_logit": -4.0232062339782715,
            "end_logit": -3.9821701049804688,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        }
    ],
    "5e2f43bafbd6abf43b000029": [
        {
            "text": "Middle East respiratory syndrome",
            "probability": 0.9224974368170037,
            "start_logit": 4.8438825607299805,
            "end_logit": 5.4855122566223145,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory syndrome",
            "probability": 0.059053556850596774,
            "start_logit": 2.095242738723755,
            "end_logit": 5.4855122566223145,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel human coronavirus that can cause human respiratory",
            "probability": 0.00348998994400277,
            "start_logit": 4.8438825607299805,
            "end_logit": -0.09167348593473434,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory",
            "probability": 0.003230435683562443,
            "start_logit": 4.8438825607299805,
            "end_logit": -0.16895532608032227,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "East respiratory syndrome",
            "probability": 0.0031627163379167,
            "start_logit": -0.8317707777023315,
            "end_logit": 5.4855122566223145,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel human coronavirus that can cause human respiratory disease",
            "probability": 0.002782439172328213,
            "start_logit": 4.8438825607299805,
            "end_logit": -0.31824439764022827,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "syndrome",
            "probability": 0.001796342944818571,
            "start_logit": -1.3974491357803345,
            "end_logit": 5.4855122566223145,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome coronavirus",
            "probability": 0.001295153394781367,
            "start_logit": 4.8438825607299805,
            "end_logit": -1.0829432010650635,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome coronavirus (MERS-CoV)",
            "probability": 0.0005959070530500092,
            "start_logit": 4.8438825607299805,
            "end_logit": -1.8592429161071777,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome coronavirus (MERS-CoV",
            "probability": 0.00048656093919686446,
            "start_logit": 4.8438825607299805,
            "end_logit": -2.0619654655456543,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle",
            "probability": 0.0004828976672156851,
            "start_logit": 4.8438825607299805,
            "end_logit": -2.0695228576660156,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory syndrome coronavirus (MERS-CoV) is a novel human coronavirus that can cause human respiratory",
            "probability": 0.00022341126526843896,
            "start_logit": 2.095242738723755,
            "end_logit": -0.09167348593473434,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory",
            "probability": 0.00020679593208375934,
            "start_logit": 2.095242738723755,
            "end_logit": -0.16895532608032227,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel human coronavirus that can cause human respiratory disease.",
            "probability": 0.00019206405016896985,
            "start_logit": 4.8438825607299805,
            "end_logit": -2.9914987087249756,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory syndrome coronavirus (MERS-CoV) is a novel human coronavirus that can cause human respiratory disease",
            "probability": 0.00017811749202616633,
            "start_logit": 2.095242738723755,
            "end_logit": -0.31824439764022827,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East",
            "probability": 0.00014429411663786993,
            "start_logit": 4.8438825607299805,
            "end_logit": -3.2774739265441895,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory syndrome coronavirus",
            "probability": 8.290908091068973e-05,
            "start_logit": 2.095242738723755,
            "end_logit": -1.0829432010650635,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory syndrome coronavirus (MERS-CoV)",
            "probability": 3.814691470187904e-05,
            "start_logit": 2.095242738723755,
            "end_logit": -1.8592429161071777,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory syndrome coronavirus (MERS-CoV",
            "probability": 3.114713704060036e-05,
            "start_logit": 2.095242738723755,
            "end_logit": -2.0619654655456543,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory disease",
            "probability": 2.9677206688524637e-05,
            "start_logit": 0.3031786382198334,
            "end_logit": -0.31824439764022827,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        }
    ],
    "5e2f9e0dfbd6abf43b000034": [
        {
            "text": "urinary urgency",
            "probability": 0.35715471836754564,
            "start_logit": 5.192162990570068,
            "end_logit": 5.858534336090088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance, and urinary urgency",
            "probability": 0.21251055035257316,
            "start_logit": 4.672985553741455,
            "end_logit": 5.858534336090088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance",
            "probability": 0.1043195769726406,
            "start_logit": 4.672985553741455,
            "end_logit": 5.14700174331665,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "cognitive disorder, gait disturbance, and urinary urgency",
            "probability": 0.07370427198097765,
            "start_logit": 3.6140546798706055,
            "end_logit": 5.858534336090088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "normal pressure hydrocephalus (cognitive disorder, gait disturbance, and urinary urgency",
            "probability": 0.043517818900536506,
            "start_logit": 3.0871644020080566,
            "end_logit": 5.858534336090088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "cognitive disorder, gait disturbance",
            "probability": 0.036180784725161466,
            "start_logit": 3.6140546798706055,
            "end_logit": 5.14700174331665,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "hydrocephalus (cognitive disorder, gait disturbance, and urinary urgency",
            "probability": 0.03330457052886242,
            "start_logit": 2.819688558578491,
            "end_logit": 5.858534336090088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "normal pressure hydrocephalus (cognitive disorder, gait disturbance",
            "probability": 0.02136251800649004,
            "start_logit": 3.0871644020080566,
            "end_logit": 5.14700174331665,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "idiopathic normal pressure hydrocephalus (cognitive disorder, gait disturbance, and urinary urgency",
            "probability": 0.01957102307844597,
            "start_logit": 2.288043975830078,
            "end_logit": 5.858534336090088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "hydrocephalus (cognitive disorder, gait disturbance",
            "probability": 0.016348923397272324,
            "start_logit": 2.819688558578491,
            "end_logit": 5.14700174331665,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "cognitive disorder",
            "probability": 0.0126810311050863,
            "start_logit": 3.6140546798706055,
            "end_logit": 4.098580837249756,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "normal pressure hydrocephalus",
            "probability": 0.010476477969200556,
            "start_logit": 3.0871644020080566,
            "end_logit": 4.4344964027404785,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "idiopathic normal pressure hydrocephalus (cognitive disorder, gait disturbance",
            "probability": 0.009607244652456142,
            "start_logit": 2.288043975830078,
            "end_logit": 5.14700174331665,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait",
            "probability": 0.008055284059326949,
            "start_logit": 4.672985553741455,
            "end_logit": 2.5858709812164307,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "hydrocephalus",
            "probability": 0.008017740967597336,
            "start_logit": 2.819688558578491,
            "end_logit": 4.4344964027404785,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "urgency",
            "probability": 0.007874194526520365,
            "start_logit": 1.3775848150253296,
            "end_logit": 5.858534336090088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "normal pressure hydrocephalus (cognitive disorder",
            "probability": 0.007487365389697402,
            "start_logit": 3.0871644020080566,
            "end_logit": 4.098580837249756,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance,",
            "probability": 0.006137319293378348,
            "start_logit": 4.672985553741455,
            "end_logit": 2.3139307498931885,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "rinary urgency",
            "probability": 0.0059584389726337,
            "start_logit": 1.0988024473190308,
            "end_logit": 5.858534336090088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "hydrocephalus (cognitive disorder",
            "probability": 0.005730146753597208,
            "start_logit": 2.819688558578491,
            "end_logit": 4.098580837249756,
            "question_text": "List symptoms of the Hakim Triad?"
        }
    ],
    "5e36e093b5b409ea5300000f": [
        {
            "text": "Aip1, Ede1",
            "probability": 0.3086908914931373,
            "start_logit": 2.2054896354675293,
            "end_logit": 1.7831504344940186,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede1",
            "probability": 0.2811694716981839,
            "start_logit": 2.1121068000793457,
            "end_logit": 1.7831504344940186,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1",
            "probability": 0.1989797786376179,
            "start_logit": 2.2054896354675293,
            "end_logit": 1.3440132141113281,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1, Ede1 and Inn1",
            "probability": 0.07623232106424052,
            "start_logit": 2.2054896354675293,
            "end_logit": 0.3845955431461334,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede1 and Inn1",
            "probability": 0.06943580789274878,
            "start_logit": 2.1121068000793457,
            "end_logit": 0.3845955431461334,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Inn1",
            "probability": 0.033554663154479955,
            "start_logit": 1.3848799467086792,
            "end_logit": 0.3845955431461334,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip",
            "probability": 0.006545437845643775,
            "start_logit": 2.2054896354675293,
            "end_logit": -2.0704216957092285,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1, Ede1 and Inn",
            "probability": 0.005975431999838754,
            "start_logit": 2.2054896354675293,
            "end_logit": -2.1615335941314697,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede1 and Inn",
            "probability": 0.005442690746190795,
            "start_logit": 2.1121068000793457,
            "end_logit": -2.1615335941314697,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1, Ede",
            "probability": 0.0033562654087960792,
            "start_logit": 2.2054896354675293,
            "end_logit": -2.738361120223999,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede",
            "probability": 0.0030570366598946515,
            "start_logit": 2.1121068000793457,
            "end_logit": -2.738361120223999,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Inn",
            "probability": 0.0026301653308985146,
            "start_logit": 1.3848799467086792,
            "end_logit": -2.1615335941314697,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1, Ede1 and Inn1 as cytokinetic regulators. Our results suggest that cytokinesis",
            "probability": 0.0010521354600899898,
            "start_logit": 2.2054896354675293,
            "end_logit": -3.8983681201934814,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede1 and Inn1 as cytokinetic regulators. Our results suggest that cytokinesis",
            "probability": 0.0009583320390099843,
            "start_logit": 2.1121068000793457,
            "end_logit": -3.8983681201934814,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Cdc14",
            "probability": 0.0007502674981548675,
            "start_logit": -0.5909025073051453,
            "end_logit": -1.4401233196258545,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "A",
            "probability": 0.0005558957152657836,
            "start_logit": 2.2054896354675293,
            "end_logit": -4.536364555358887,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Inn1 as cytokinetic regulators. Our results suggest that cytokinesis",
            "probability": 0.00046311132159353885,
            "start_logit": 1.3848799467086792,
            "end_logit": -3.8983681201934814,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "1",
            "probability": 0.000451039148316688,
            "start_logit": -4.323051929473877,
            "end_logit": 1.7831504344940186,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "ip1, Ede1",
            "probability": 0.00035713325361338776,
            "start_logit": -4.556497097015381,
            "end_logit": 1.7831504344940186,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "1, Ede1",
            "probability": 0.0003421236322847227,
            "start_logit": -4.599433898925781,
            "end_logit": 1.7831504344940186,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        }
    ],
    "5d2f3a5db3a6380763000001": [
        {
            "text": "cyclophosphamide",
            "probability": 0.5496568589551937,
            "start_logit": 4.992555618286133,
            "end_logit": 4.951283931732178,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "cyclophosphamide and glucocorticosteroids",
            "probability": 0.31964055506640354,
            "start_logit": 4.992555618286133,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "glucocorticosteroids",
            "probability": 0.1233251139670965,
            "start_logit": 4.040182590484619,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "mide",
            "probability": 0.001668508236707506,
            "start_logit": -0.8048086166381836,
            "end_logit": 4.951283931732178,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "yclophosphamide",
            "probability": 0.0010916818913533851,
            "start_logit": -1.229019045829773,
            "end_logit": 4.951283931732178,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "mide and glucocorticosteroids",
            "probability": 0.0009702833508305739,
            "start_logit": -0.8048086166381836,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "yclophosphamide and glucocorticosteroids",
            "probability": 0.0006348429934476306,
            "start_logit": -1.229019045829773,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "lophosphamide",
            "probability": 0.0005016279263725092,
            "start_logit": -2.0066351890563965,
            "end_logit": 4.951283931732178,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "de",
            "probability": 0.0003620059185622453,
            "start_logit": -2.3328332901000977,
            "end_logit": 4.951283931732178,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "lucocorticosteroids",
            "probability": 0.0003544855018922452,
            "start_logit": -1.8117293119430542,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "clophosphamide",
            "probability": 0.0003073542492529222,
            "start_logit": -2.496492862701416,
            "end_logit": 4.951283931732178,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "lophosphamide and glucocorticosteroids",
            "probability": 0.00029171041206926574,
            "start_logit": -2.0066351890563965,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "de and glucocorticosteroids",
            "probability": 0.00021051638101361674,
            "start_logit": -2.3328332901000977,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "c",
            "probability": 0.00020825585575806664,
            "start_logit": 4.992555618286133,
            "end_logit": -2.9269981384277344,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "cyclophosphamide and g",
            "probability": 0.00020551542700479833,
            "start_logit": 4.992555618286133,
            "end_logit": -2.940244436264038,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "clophosphamide and glucocorticosteroids",
            "probability": 0.0001787349347736062,
            "start_logit": -2.496492862701416,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "hosphamide",
            "probability": 0.00012693688925438233,
            "start_logit": -3.3808038234710693,
            "end_logit": 4.951283931732178,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "intravenous immunosuppression with large doses of cyclophosphamide",
            "probability": 9.39392844309292e-05,
            "start_logit": -3.681845188140869,
            "end_logit": 4.951283931732178,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "ids",
            "probability": 9.177989960178022e-05,
            "start_logit": -3.163003444671631,
            "end_logit": 4.409186840057373,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "g",
            "probability": 7.929285898060691e-05,
            "start_logit": 4.040182590484619,
            "end_logit": -2.940244436264038,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        }
    ],
    "5e49c88c6d0a277941000013": [
        {
            "text": "ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.26450851094459427,
            "start_logit": 1.8060437440872192,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "RNA, and two microRNAs",
            "probability": 0.13898525592078312,
            "start_logit": 1.1625381708145142,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "ncRNA, a circular RNA",
            "probability": 0.13258972186438914,
            "start_logit": 1.8060437440872192,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "ncRNA",
            "probability": 0.08168079751453201,
            "start_logit": 1.8060437440872192,
            "end_logit": 0.9721828103065491,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "RNA",
            "probability": 0.06966889783613665,
            "start_logit": 1.1625381708145142,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "microRNAs",
            "probability": 0.06171374071655084,
            "start_logit": 0.35067692399024963,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "two microRNAs",
            "probability": 0.05523729272964704,
            "start_logit": 0.23980863392353058,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.046926173803098783,
            "start_logit": 0.0767459124326706,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a circular RNA, and two microRNAs",
            "probability": 0.04002280152277346,
            "start_logit": -0.08238035440444946,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a long ncRNA, a circular RNA",
            "probability": 0.02352260163763176,
            "start_logit": 0.0767459124326706,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a circular RNA",
            "probability": 0.020062160204930953,
            "start_logit": -0.08238035440444946,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "circular RNA, and two microRNAs",
            "probability": 0.017463331305369763,
            "start_logit": -0.9117263555526733,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a long ncRNA",
            "probability": 0.014490903475486,
            "start_logit": 0.0767459124326706,
            "end_logit": 0.9721828103065491,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "circular RNA",
            "probability": 0.008753813751912382,
            "start_logit": -0.9117263555526733,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.007675044404447668,
            "start_logit": -1.7338556051254272,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "ncRNAs-a long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.004142580275019241,
            "start_logit": -2.350510835647583,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "centered on four ncRNAs-a long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.003952552584484399,
            "start_logit": -2.397468090057373,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "long ncRNA, a circular RNA",
            "probability": 0.0038472561780657126,
            "start_logit": -1.7338556051254272,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "four ncRNAs-a long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.0023864930980930566,
            "start_logit": -2.9020047187805176,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "long ncRNA",
            "probability": 0.002370070232054073,
            "start_logit": -1.7338556051254272,
            "end_logit": 0.9721828103065491,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        }
    ],
    "5e5cbf4e1af46fc130000004": [
        {
            "text": "amifostine",
            "probability": 0.3799514422658851,
            "start_logit": 3.5830094814300537,
            "end_logit": 3.320560932159424,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin",
            "probability": 0.333951120592026,
            "start_logit": 3.5830094814300537,
            "end_logit": 3.191512107849121,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin",
            "probability": 0.2677622834335581,
            "start_logit": 3.362114429473877,
            "end_logit": 3.191512107849121,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin,",
            "probability": 0.007454044480895309,
            "start_logit": 3.5830094814300537,
            "end_logit": -0.6107257604598999,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin,",
            "probability": 0.005976659001717084,
            "start_logit": 3.362114429473877,
            "end_logit": -0.6107257604598999,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA approval for use in radiation therapy.",
            "probability": 0.0005653335151681362,
            "start_logit": 3.5830094814300537,
            "end_logit": -3.18982195854187,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "Only two radioprotective compounds, amifostine",
            "probability": 0.0005395144645449511,
            "start_logit": -2.9741196632385254,
            "end_logit": 3.320560932159424,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA approval for use in radiation therapy",
            "probability": 0.00048797381983587405,
            "start_logit": 3.5830094814300537,
            "end_logit": -3.3369760513305664,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "Only two radioprotective compounds, amifostine and palifermin",
            "probability": 0.0004741960155116654,
            "start_logit": -2.9741196632385254,
            "end_logit": 3.191512107849121,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin, currently have the US FDA approval for use in radiation therapy.",
            "probability": 0.0004532848779024422,
            "start_logit": 3.362114429473877,
            "end_logit": -3.18982195854187,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin, currently have the US FDA approval for use in radiation therapy",
            "probability": 0.00039125781049458545,
            "start_logit": 3.362114429473877,
            "end_logit": -3.3369760513305664,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "ostine",
            "probability": 0.0003212681326996064,
            "start_logit": -3.4925131797790527,
            "end_logit": 3.320560932159424,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA approval",
            "probability": 0.0002951564745037342,
            "start_logit": 3.5830094814300537,
            "end_logit": -3.8397321701049805,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "ostine and palifermin",
            "probability": 0.0002823725376214327,
            "start_logit": -3.4925131797790527,
            "end_logit": 3.191512107849121,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "am",
            "probability": 0.0002668072025140505,
            "start_logit": 3.5830094814300537,
            "end_logit": -3.940711498260498,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin, currently have the US FDA approval",
            "probability": 0.0002366567042602274,
            "start_logit": 3.362114429473877,
            "end_logit": -3.8397321701049805,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and p",
            "probability": 0.00016206915088125243,
            "start_logit": 3.5830094814300537,
            "end_logit": -4.439214706420898,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "ine",
            "probability": 0.0001487483676717846,
            "start_logit": -4.262533187866211,
            "end_logit": 3.320560932159424,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA approval for use in radiation",
            "probability": 0.00014262690624966293,
            "start_logit": 3.5830094814300537,
            "end_logit": -4.567005634307861,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "two radioprotective compounds, amifostine",
            "probability": 0.00013718424605877605,
            "start_logit": -4.343464374542236,
            "end_logit": 3.320560932159424,
            "question_text": "List approved radioprotective compounds"
        }
    ],
    "5e48100bd14c9f295d000007": [
        {
            "text": "leukaemia",
            "probability": 0.19180055792974096,
            "start_logit": 4.758993148803711,
            "end_logit": 4.9688720703125,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukaemia, increases in solid cancer such as cancers of the lung, breast",
            "probability": 0.11233803447471552,
            "start_logit": 4.758993148803711,
            "end_logit": 4.433928489685059,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukaemia, increases in solid cancer such as cancers of the lung, breast, stomach and thyroid",
            "probability": 0.08916203422295679,
            "start_logit": 4.758993148803711,
            "end_logit": 4.202871322631836,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukaemia, increases in solid cancer such as cancers of the lung",
            "probability": 0.08741905781150912,
            "start_logit": 4.758993148803711,
            "end_logit": 4.18312931060791,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.07221673762412041,
            "start_logit": 4.523604393005371,
            "end_logit": 4.227476596832275,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid",
            "probability": 0.07046150750551523,
            "start_logit": 4.523604393005371,
            "end_logit": 4.202871322631836,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukaemia, increases in solid cancer such as cancers of the lung, breast, stomach",
            "probability": 0.0660902280604354,
            "start_logit": 4.758993148803711,
            "end_logit": 3.9034368991851807,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukaemia, increases in solid cancer",
            "probability": 0.033838637824908174,
            "start_logit": 4.758993148803711,
            "end_logit": 3.2340192794799805,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast",
            "probability": 0.030685614625414533,
            "start_logit": 3.4612746238708496,
            "end_logit": 4.433928489685059,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "cancers of the lung, breast",
            "probability": 0.030035848154964642,
            "start_logit": 3.4398722648620605,
            "end_logit": 4.433928489685059,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast, stomach and thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.024961685591859614,
            "start_logit": 3.4612746238708496,
            "end_logit": 4.227476596832275,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "cancers of the lung, breast, stomach and thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.024433123053957263,
            "start_logit": 3.4398722648620605,
            "end_logit": 4.227476596832275,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast, stomach and thyroid",
            "probability": 0.024354991024873922,
            "start_logit": 3.4612746238708496,
            "end_logit": 4.202871322631836,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "cancers of the lung, breast, stomach and thyroid",
            "probability": 0.023839275216367205,
            "start_logit": 3.4398722648620605,
            "end_logit": 4.202871322631836,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "cancers of the lung",
            "probability": 0.0233732551807068,
            "start_logit": 3.4398722648620605,
            "end_logit": 4.18312931060791,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, breast",
            "probability": 0.022726410354224586,
            "start_logit": 3.161008358001709,
            "end_logit": 4.433928489685059,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, breast, stomach and thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.018487148353349088,
            "start_logit": 3.161008358001709,
            "end_logit": 4.227476596832275,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast, stomach",
            "probability": 0.018052828485482664,
            "start_logit": 3.4612746238708496,
            "end_logit": 3.9034368991851807,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, breast, stomach and thyroid",
            "probability": 0.01803781762110506,
            "start_logit": 3.161008358001709,
            "end_logit": 4.202871322631836,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung",
            "probability": 0.017685206883793214,
            "start_logit": 3.161008358001709,
            "end_logit": 4.18312931060791,
            "question_text": "List the most common cancers after a radiation exposure?"
        }
    ],
    "5cf0f567a49efeb44c00000b": [
        {
            "text": "MBF",
            "probability": 0.20073871989762793,
            "start_logit": 5.086180686950684,
            "end_logit": 4.102355480194092,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF in Saccharomyces cerevisiae or MBF",
            "probability": 0.15229339243154788,
            "start_logit": 5.086180686950684,
            "end_logit": 3.826160192489624,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF and MBF",
            "probability": 0.13133260234693916,
            "start_logit": 4.661909580230713,
            "end_logit": 4.102355480194092,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF",
            "probability": 0.11461906662442947,
            "start_logit": 4.661909580230713,
            "end_logit": 3.9662365913391113,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF and MBF in Saccharomyces cerevisiae or MBF",
            "probability": 0.09963741702885683,
            "start_logit": 4.661909580230713,
            "end_logit": 3.826160192489624,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1p, the closest orthologues of SBF",
            "probability": 0.03985834860303357,
            "start_logit": 4.37925910949707,
            "end_logit": 3.1926047801971436,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (Swi6p and Swi4p) and MBF",
            "probability": 0.026787403094665405,
            "start_logit": 3.849170207977295,
            "end_logit": 3.32529354095459,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6p, Swi4p and Mbp1p, the closest orthologues of SBF",
            "probability": 0.026106571562630326,
            "start_logit": 3.9561142921447754,
            "end_logit": 3.1926047801971436,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4p and Mbp1p, the closest orthologues of SBF",
            "probability": 0.025434449914400862,
            "start_logit": 3.9300317764282227,
            "end_logit": 3.1926047801971436,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6p",
            "probability": 0.02395739357014506,
            "start_logit": 3.9561142921447754,
            "end_logit": 3.1066946983337402,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6p, Swi4p",
            "probability": 0.022040659234268577,
            "start_logit": 3.9561142921447754,
            "end_logit": 3.0233066082000732,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4p",
            "probability": 0.02147321573916768,
            "start_logit": 3.9300317764282227,
            "end_logit": 3.0233066082000732,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4p) and MBF",
            "probability": 0.0197335245010803,
            "start_logit": 3.5435574054718018,
            "end_logit": 3.32529354095459,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4p and Swi6p",
            "probability": 0.018575696410553903,
            "start_logit": 3.659817695617676,
            "end_logit": 3.1485683917999268,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1",
            "probability": 0.0178916334088914,
            "start_logit": 4.37925910949707,
            "end_logit": 2.391606092453003,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1p",
            "probability": 0.013662363032854374,
            "start_logit": 4.37925910949707,
            "end_logit": 2.121917724609375,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6p and Swi4p) and MBF",
            "probability": 0.011944485805867223,
            "start_logit": 3.041508197784424,
            "end_logit": 3.32529354095459,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6p, Swi4p and Mbp1",
            "probability": 0.011718729559358144,
            "start_logit": 3.9561142921447754,
            "end_logit": 2.391606092453003,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4p and Mbp1",
            "probability": 0.011417027292260549,
            "start_logit": 3.9300317764282227,
            "end_logit": 2.391606092453003,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1p, the closest orthologues of SBF (Swi6",
            "probability": 0.010777299941421426,
            "start_logit": 4.37925910949707,
            "end_logit": 1.884714961051941,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        }
    ],
    "5e5b626fb761aafe0900000c": [
        {
            "text": "phosphatidylcholine",
            "probability": 0.9739130346777768,
            "start_logit": 5.189540863037109,
            "end_logit": 4.785592555999756,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "phosphatidylcholine across the canalicular membrane of the hepatocyte into bile",
            "probability": 0.009751802673152293,
            "start_logit": 5.189540863037109,
            "end_logit": 0.1817227005958557,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "phosphatidylcholine across the canalicular membrane",
            "probability": 0.004779196565988325,
            "start_logit": 5.189540863037109,
            "end_logit": -0.5314570069313049,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "choline",
            "probability": 0.003191641375257172,
            "start_logit": -0.5312458276748657,
            "end_logit": 4.785592555999756,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "hosphatidylcholine",
            "probability": 0.001840134142217774,
            "start_logit": -1.0819426774978638,
            "end_logit": 4.785592555999756,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "line",
            "probability": 0.0013503748804619545,
            "start_logit": -1.3913989067077637,
            "end_logit": 4.785592555999756,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "phosphatidylcholine across the canalicular membrane of the hepatocyte",
            "probability": 0.0012613359069430295,
            "start_logit": 5.189540863037109,
            "end_logit": -1.863558053970337,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "p",
            "probability": 0.001112789231006589,
            "start_logit": 5.189540863037109,
            "end_logit": -1.98885977268219,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P-glycoprotein 3 (MDR3) is a phospholipid",
            "probability": 0.0004931693589982988,
            "start_logit": 2.928494691848755,
            "end_logit": -0.5415859222412109,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "lcholine",
            "probability": 0.00042855735348055574,
            "start_logit": -2.539111852645874,
            "end_logit": 4.785592555999756,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "dylcholine",
            "probability": 0.0004164481210717854,
            "start_logit": -2.567774534225464,
            "end_logit": 4.785592555999756,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "phosphatidylcholine across the canalicular membrane of the hepatocyte into bile.",
            "probability": 0.00029571619863093506,
            "start_logit": 5.189540863037109,
            "end_logit": -3.314084529876709,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P-glycoprotein",
            "probability": 0.00025023163719189583,
            "start_logit": 2.928494691848755,
            "end_logit": -1.2200515270233154,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "tidylcholine",
            "probability": 0.00024873396116848286,
            "start_logit": -3.0831525325775146,
            "end_logit": 4.785592555999756,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P-glycoprotein 3",
            "probability": 0.00021323774015407962,
            "start_logit": 2.928494691848755,
            "end_logit": -1.380030870437622,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P",
            "probability": 0.00017554255615205856,
            "start_logit": 2.928494691848755,
            "end_logit": -1.5745570659637451,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "Multidrug-resistant P-glycoprotein 3 (MDR3) is a phospholipid",
            "probability": 0.00012111799287209198,
            "start_logit": 1.5244072675704956,
            "end_logit": -0.5415859222412109,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "Multidrug-resistant P-glycoprotein",
            "probability": 6.145465669509386e-05,
            "start_logit": 1.5244072675704956,
            "end_logit": -1.2200515270233154,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "Multidrug-resistant P-glycoprotein 3",
            "probability": 5.236928576524137e-05,
            "start_logit": 1.5244072675704956,
            "end_logit": -1.380030870437622,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "Multidrug-resistant P",
            "probability": 4.311168501619578e-05,
            "start_logit": 1.5244072675704956,
            "end_logit": -1.5745570659637451,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        }
    ],
    "5e30ee25fbd6abf43b00003f": [
        {
            "text": "metabolic wasting",
            "probability": 0.25070755255115224,
            "start_logit": 4.534983158111572,
            "end_logit": 5.108867168426514,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple allergies and metabolic wasting",
            "probability": 0.15693591510475297,
            "start_logit": 4.06653356552124,
            "end_logit": 5.108867168426514,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple allergies",
            "probability": 0.12944688807646043,
            "start_logit": 4.06653356552124,
            "end_logit": 4.916300296783447,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple allergies and metabolic wasting",
            "probability": 0.09259263409020485,
            "start_logit": 3.538905620574951,
            "end_logit": 5.108867168426514,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis",
            "probability": 0.07770243408087406,
            "start_logit": 3.538905620574951,
            "end_logit": 4.933544158935547,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple allergies",
            "probability": 0.07637403034084962,
            "start_logit": 3.538905620574951,
            "end_logit": 4.916300296783447,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple allergies and metabolic wasting",
            "probability": 0.07063781635509257,
            "start_logit": 3.268261671066284,
            "end_logit": 5.108867168426514,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis",
            "probability": 0.05927826033765581,
            "start_logit": 3.268261671066284,
            "end_logit": 4.933544158935547,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple allergies",
            "probability": 0.05826483696596678,
            "start_logit": 3.268261671066284,
            "end_logit": 4.916300296783447,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "allergies and metabolic wasting",
            "probability": 0.013789807950065767,
            "start_logit": 1.634625792503357,
            "end_logit": 5.108867168426514,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "allergies",
            "probability": 0.011374373578645451,
            "start_logit": 1.634625792503357,
            "end_logit": 4.916300296783447,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "wasting",
            "probability": 0.0007632737008016005,
            "start_logit": -1.2594425678253174,
            "end_logit": 5.108867168426514,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis,",
            "probability": 0.0004777927992789934,
            "start_logit": 3.538905620574951,
            "end_logit": -0.15792053937911987,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "metabolic",
            "probability": 0.0004026537312695292,
            "start_logit": 4.534983158111572,
            "end_logit": -1.3250982761383057,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis,",
            "probability": 0.0003645024287609666,
            "start_logit": 3.268261671066284,
            "end_logit": -0.15792053937911987,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple allergies and metabolic",
            "probability": 0.0002520499727435771,
            "start_logit": 4.06653356552124,
            "end_logit": -1.3250982761383057,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "itis, multiple allergies and metabolic wasting",
            "probability": 0.00018260629136195836,
            "start_logit": -2.6897268295288086,
            "end_logit": 5.108867168426514,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "itis",
            "probability": 0.00015324062714840148,
            "start_logit": -2.6897268295288086,
            "end_logit": 4.933544158935547,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "itis, multiple allergies",
            "probability": 0.0001506208196142417,
            "start_logit": -2.6897268295288086,
            "end_logit": 4.916300296783447,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple allergies and metabolic",
            "probability": 0.00014871019730005274,
            "start_logit": 3.538905620574951,
            "end_logit": -1.3250982761383057,
            "question_text": "List features of the SAM syndrome."
        }
    ],
    "5e30f12afbd6abf43b000041": [
        {
            "text": "ipilimumab",
            "probability": 0.4259971176172887,
            "start_logit": 5.134748935699463,
            "end_logit": 4.950572490692139,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab plus nivolumab",
            "probability": 0.3442528762163658,
            "start_logit": 5.134748935699463,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "nivolumab",
            "probability": 0.22889207750915475,
            "start_logit": 4.726623058319092,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab plus",
            "probability": 0.00013564817033601733,
            "start_logit": 5.134748935699463,
            "end_logit": -3.101550817489624,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "b",
            "probability": 0.0001293034807323932,
            "start_logit": -2.9652767181396484,
            "end_logit": 4.950572490692139,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "b plus nivolumab",
            "probability": 0.00010449154068432899,
            "start_logit": -2.9652767181396484,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ab",
            "probability": 8.838381193015309e-05,
            "start_logit": -3.1326940059661865,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "i",
            "probability": 7.565883296011885e-05,
            "start_logit": 5.134748935699463,
            "end_logit": -3.6853811740875244,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "plus nivolumab",
            "probability": 6.699950981866333e-05,
            "start_logit": -3.4096975326538086,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "lumab",
            "probability": 3.811280171098732e-05,
            "start_logit": -3.973832607269287,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab plus ni",
            "probability": 3.531323114940995e-05,
            "start_logit": 5.134748935699463,
            "end_logit": -4.447357654571533,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "umab",
            "probability": 2.8365021866058708e-05,
            "start_logit": -4.4822821617126465,
            "end_logit": 4.950572490692139,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ni",
            "probability": 2.3479597121126907e-05,
            "start_logit": 4.726623058319092,
            "end_logit": -4.447357654571533,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "pilimumab",
            "probability": 2.3150326253954188e-05,
            "start_logit": -4.68543004989624,
            "end_logit": 4.950572490692139,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "umab plus nivolumab",
            "probability": 2.2922080825211963e-05,
            "start_logit": -4.4822821617126465,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "volumab",
            "probability": 1.984809931498178e-05,
            "start_logit": -4.626274585723877,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "pilimumab plus nivolumab",
            "probability": 1.8708028924812464e-05,
            "start_logit": -4.68543004989624,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab plus nivolumab for the treatment of non-small cell lung cancer",
            "probability": 1.8549550078721103e-05,
            "start_logit": 5.134748935699463,
            "end_logit": -5.091169834136963,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "The first data from the phase III CheckMate-227 trial of ipilimumab",
            "probability": 1.603583879198692e-05,
            "start_logit": -5.052612781524658,
            "end_logit": 4.950572490692139,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "The first data from the phase III CheckMate-227 trial of ipilimumab plus nivolumab",
            "probability": 1.2958734691822313e-05,
            "start_logit": -5.052612781524658,
            "end_logit": 4.737516403198242,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        }
    ],
    "5e46f9683f54159529000010": [
        {
            "text": "fibrosis",
            "probability": 0.6052217091656528,
            "start_logit": 4.402865886688232,
            "end_logit": 4.910343170166016,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced fibrosis",
            "probability": 0.37924470839028623,
            "start_logit": 3.935452699661255,
            "end_logit": 4.910343170166016,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fibrosis (RIF)",
            "probability": 0.006176198218719804,
            "start_logit": 4.402865886688232,
            "end_logit": 0.32545122504234314,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced fibrosis (RIF)",
            "probability": 0.0038701362772462916,
            "start_logit": 3.935452699661255,
            "end_logit": 0.32545122504234314,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "induced fibrosis",
            "probability": 0.00281907060764155,
            "start_logit": -0.9663217067718506,
            "end_logit": 4.910343170166016,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced",
            "probability": 0.0004535339499016042,
            "start_logit": 3.935452699661255,
            "end_logit": -1.818523645401001,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation",
            "probability": 0.0003873257678874027,
            "start_logit": 3.935452699661255,
            "end_logit": -1.976327657699585,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fi",
            "probability": 0.00033373077769175715,
            "start_logit": 4.402865886688232,
            "end_logit": -2.592672348022461,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "sis",
            "probability": 0.0002563630362881635,
            "start_logit": -3.363889694213867,
            "end_logit": 4.910343170166016,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced fi",
            "probability": 0.00020912275542966704,
            "start_logit": 3.935452699661255,
            "end_logit": -2.592672348022461,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fibrosis (",
            "probability": 0.00017166504663562404,
            "start_logit": 4.402865886688232,
            "end_logit": -3.2574617862701416,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "brosis",
            "probability": 0.00017151355662854012,
            "start_logit": -3.765821933746338,
            "end_logit": 4.910343170166016,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fibro",
            "probability": 0.000161093689734414,
            "start_logit": 4.402865886688232,
            "end_logit": -3.3210208415985107,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced fibrosis (",
            "probability": 0.00010756894467959843,
            "start_logit": 3.935452699661255,
            "end_logit": -3.2574617862701416,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced fibro",
            "probability": 0.00010094470912331618,
            "start_logit": 3.935452699661255,
            "end_logit": -3.3210208415985107,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fibrosis (RIF) is one of the severe long-term side effects",
            "probability": 8.194397899299263e-05,
            "start_logit": 4.402865886688232,
            "end_logit": -3.9969711303710938,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fibrosis (RIF) is one of the severe",
            "probability": 6.483779950197578e-05,
            "start_logit": 4.402865886688232,
            "end_logit": -4.231118202209473,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "-induced fibrosis",
            "probability": 5.9655580103411986e-05,
            "start_logit": -4.821896553039551,
            "end_logit": 4.910343170166016,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fibrosis (RIF) is",
            "probability": 5.752991953529365e-05,
            "start_logit": 4.402865886688232,
            "end_logit": -4.350701808929443,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced fibrosis (RIF) is one of the severe long-term side effects",
            "probability": 5.134782831960728e-05,
            "start_logit": 3.935452699661255,
            "end_logit": -3.9969711303710938,
            "question_text": "List side effects of radiation therapy?"
        }
    ],
    "5e4027f948dab47f2600000d": [
        {
            "text": "meningitis",
            "probability": 0.7157400952594439,
            "start_logit": 5.421733379364014,
            "end_logit": 5.911182880401611,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis and meningitis",
            "probability": 0.17274671324068555,
            "start_logit": 4.000242710113525,
            "end_logit": 5.911182880401611,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis",
            "probability": 0.10813754952534815,
            "start_logit": 4.000242710113525,
            "end_logit": 5.442760467529297,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "psis and meningitis",
            "probability": 0.0008317349333881458,
            "start_logit": -1.3358252048492432,
            "end_logit": 5.911182880401611,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "ingitis",
            "probability": 0.0006031676435824473,
            "start_logit": -1.6571438312530518,
            "end_logit": 5.911182880401611,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "psis",
            "probability": 0.0005206569541262887,
            "start_logit": -1.3358252048492432,
            "end_logit": 5.442760467529297,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis",
            "probability": 0.0003495816296366468,
            "start_logit": -2.202601909637451,
            "end_logit": 5.911182880401611,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis caused by serogroup B meningococcus are devastating diseases of infants and young adults,",
            "probability": 0.00024348843889824502,
            "start_logit": 5.421733379364014,
            "end_logit": -2.074820041656494,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis caused by serogroup B meningococcus",
            "probability": 0.00012811005958596238,
            "start_logit": 5.421733379364014,
            "end_logit": -2.7169997692108154,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis caused by serogroup B meningococcus are devastating diseases",
            "probability": 0.00012357673553690525,
            "start_logit": 5.421733379364014,
            "end_logit": -2.7530272006988525,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "men",
            "probability": 0.00011364002325179158,
            "start_logit": 5.421733379364014,
            "end_logit": -2.8368537425994873,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis caused by serogroup B meningococcus are devastating diseases of infants and young adults",
            "probability": 0.00010408775122400201,
            "start_logit": 5.421733379364014,
            "end_logit": -2.9246551990509033,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis caused",
            "probability": 8.52134999042085e-05,
            "start_logit": 5.421733379364014,
            "end_logit": -3.124729633331299,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis caused by serogroup B",
            "probability": 7.975571782843615e-05,
            "start_logit": 5.421733379364014,
            "end_logit": -3.1909210681915283,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis and meningitis caused by serogroup B meningococcus are devastating diseases of infants and young adults,",
            "probability": 5.87669012961061e-05,
            "start_logit": 4.000242710113525,
            "end_logit": -2.074820041656494,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis and meningitis caused by serogroup B meningococcus",
            "probability": 3.091987143534471e-05,
            "start_logit": 4.000242710113525,
            "end_logit": -2.7169997692108154,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis and meningitis caused by serogroup B meningococcus are devastating diseases",
            "probability": 2.9825735680318012e-05,
            "start_logit": 4.000242710113525,
            "end_logit": -2.7530272006988525,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis and men",
            "probability": 2.742747072486723e-05,
            "start_logit": 4.000242710113525,
            "end_logit": -2.8368537425994873,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis and meningitis caused by serogroup B meningococcus are devastating diseases of infants and young adults",
            "probability": 2.5121991951621407e-05,
            "start_logit": 4.000242710113525,
            "end_logit": -2.9246551990509033,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis and meningitis caused",
            "probability": 2.0566616471097107e-05,
            "start_logit": 4.000242710113525,
            "end_logit": -3.124729633331299,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        }
    ],
    "5e52c1fd6d0a27794100004c": [
        {
            "text": "ovarian cancer",
            "probability": 0.49084037549401544,
            "start_logit": 4.510928630828857,
            "end_logit": 4.753941059112549,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial ovarian cancer",
            "probability": 0.3251216370970619,
            "start_logit": 4.099009037017822,
            "end_logit": 4.753941059112549,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "ovarian cancer (EOC)",
            "probability": 0.06180168297701131,
            "start_logit": 4.510928630828857,
            "end_logit": 2.6817526817321777,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial ovarian cancer (EOC)",
            "probability": 0.04093604631570191,
            "start_logit": 4.099009037017822,
            "end_logit": 2.6817526817321777,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "ovarian",
            "probability": 0.03906002341368018,
            "start_logit": 4.510928630828857,
            "end_logit": 2.22292160987854,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial ovarian",
            "probability": 0.0258724819540851,
            "start_logit": 4.099009037017822,
            "end_logit": 2.22292160987854,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "ovarian cancer (EOC) is the most lethal gynecologic malignancy",
            "probability": 0.006889266736579274,
            "start_logit": 4.510928630828857,
            "end_logit": 0.48778674006462097,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy",
            "probability": 0.004563295506284803,
            "start_logit": 4.099009037017822,
            "end_logit": 0.48778674006462097,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "cancer",
            "probability": 0.0013368240609359068,
            "start_logit": -1.3948936462402344,
            "end_logit": 4.753941059112549,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial",
            "probability": 0.0011130282750997959,
            "start_logit": 4.099009037017822,
            "end_logit": -0.9231738448143005,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "varian cancer",
            "probability": 0.0006246558332309967,
            "start_logit": -2.155744791030884,
            "end_logit": 4.753941059112549,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "ovarian cancer (EOC) is the most lethal gynecologic",
            "probability": 0.00047494182304631214,
            "start_logit": 4.510928630828857,
            "end_logit": -2.1867408752441406,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial ovarian cancer (EOC) is the most lethal gynecologic",
            "probability": 0.00031459079314587223,
            "start_logit": 4.099009037017822,
            "end_logit": -2.1867408752441406,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "o",
            "probability": 0.00020486842690753106,
            "start_logit": 4.510928630828857,
            "end_logit": -3.0275652408599854,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "cancer (EOC)",
            "probability": 0.0001683194393428808,
            "start_logit": -1.3948936462402344,
            "end_logit": 2.6817526817321777,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "(EOC)",
            "probability": 0.00015171766707556368,
            "start_logit": -1.4987359046936035,
            "end_logit": 2.6817526817321777,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "ian cancer",
            "probability": 0.00015046863434442986,
            "start_logit": -3.579190969467163,
            "end_logit": 4.753941059112549,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "pithelial ovarian cancer",
            "probability": 0.00013941338904000037,
            "start_logit": -3.6555020809173584,
            "end_logit": 4.753941059112549,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial o",
            "probability": 0.0001357002432382182,
            "start_logit": 4.099009037017822,
            "end_logit": -3.0275652408599854,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "E",
            "probability": 0.00010066192017255637,
            "start_logit": 4.099009037017822,
            "end_logit": -3.3262460231781006,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        }
    ],
    "5e36e254b5b409ea53000010": [
        {
            "text": "congenital pontocerebellar hypoplasia",
            "probability": 0.13079129782442236,
            "start_logit": 3.459519624710083,
            "end_logit": 3.5331315994262695,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "pontocerebellar hypoplasia",
            "probability": 0.12079827673451173,
            "start_logit": 3.3800387382507324,
            "end_logit": 3.5331315994262695,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "optic atrophy",
            "probability": 0.10928717647331998,
            "start_logit": 3.245738983154297,
            "end_logit": 3.567288398742676,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome",
            "probability": 0.09073612695471091,
            "start_logit": 3.245738983154297,
            "end_logit": 3.3812649250030518,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia",
            "probability": 0.07550452311325569,
            "start_logit": 3.245738983154297,
            "end_logit": 3.1975018978118896,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia",
            "probability": 0.054548956270054204,
            "start_logit": 2.585015296936035,
            "end_logit": 3.5331315994262695,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia",
            "probability": 0.04805439343560447,
            "start_logit": 2.4582502841949463,
            "end_logit": 3.5331315994262695,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Leigh syndrome",
            "probability": 0.04686316180421951,
            "start_logit": 2.585015296936035,
            "end_logit": 3.3812649250030518,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "inherited optic atrophy",
            "probability": 0.04009216720680877,
            "start_logit": 2.242940902709961,
            "end_logit": 3.567288398742676,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Leigh syndrome, progressive myoclonic ataxia",
            "probability": 0.03899638217281462,
            "start_logit": 2.585015296936035,
            "end_logit": 3.1975018978118896,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "optic atrophy, Charcot-Marie-Tooth type 2",
            "probability": 0.03788570922778508,
            "start_logit": 3.245738983154297,
            "end_logit": 2.507883310317993,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "progressive myoclonic ataxia",
            "probability": 0.03435349857512066,
            "start_logit": 2.4582502841949463,
            "end_logit": 3.1975018978118896,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome",
            "probability": 0.03328668642523295,
            "start_logit": 2.242940902709961,
            "end_logit": 3.3812649250030518,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia",
            "probability": 0.027698949348060182,
            "start_logit": 2.242940902709961,
            "end_logit": 3.1975018978118896,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Charcot-Marie-Tooth type 2, Leigh syndrome",
            "probability": 0.024612521931649797,
            "start_logit": 1.941038727760315,
            "end_logit": 3.3812649250030518,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia",
            "probability": 0.02048089105667168,
            "start_logit": 1.941038727760315,
            "end_logit": 3.1975018978118896,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "myoclonic ataxia and lethal congenital pontocerebellar hypoplasia",
            "probability": 0.01943433627183441,
            "start_logit": 1.5529581308364868,
            "end_logit": 3.5331315994262695,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "lethal congenital pontocerebellar hypoplasia",
            "probability": 0.01878314553247319,
            "start_logit": 1.5188766717910767,
            "end_logit": 3.5331315994262695,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "inherited optic atrophy, Charcot-Marie-Tooth type 2",
            "probability": 0.013898430155524312,
            "start_logit": 2.242940902709961,
            "end_logit": 2.507883310317993,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "myoclonic ataxia",
            "probability": 0.013893369485925362,
            "start_logit": 1.5529581308364868,
            "end_logit": 3.1975018978118896,
            "question_text": "List SLC25A46-related pathologies"
        }
    ],
    "5e5015436d0a277941000037": [
        {
            "text": "MobiDB",
            "probability": 0.8317756880500516,
            "start_logit": 3.691145896911621,
            "end_logit": 3.2379605770111084,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mobidb",
            "probability": 0.07818532775145677,
            "start_logit": 3.691145896911621,
            "end_logit": 0.8734797835350037,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mobidb.bio.unipd.it)",
            "probability": 0.03240652279266254,
            "start_logit": 3.691145896911621,
            "end_logit": -0.007242498453706503,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "The MobiDB",
            "probability": 0.023189616006509328,
            "start_logit": 0.1112876906991005,
            "end_logit": 3.2379605770111084,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mobidb.bio.unipd.it) database",
            "probability": 0.013241646391638745,
            "start_logit": 3.691145896911621,
            "end_logit": -0.9022353291511536,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "mobidb",
            "probability": 0.006831208912081295,
            "start_logit": 1.2535655498504639,
            "end_logit": 0.8734797835350037,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (",
            "probability": 0.002916349341215116,
            "start_logit": 3.691145896911621,
            "end_logit": -2.415269613265991,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "mobidb.bio.unipd.it)",
            "probability": 0.0028314228983541898,
            "start_logit": 1.2535655498504639,
            "end_logit": -0.007242498453706503,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "The MobiDB (URL: mobidb",
            "probability": 0.002179779661689581,
            "start_logit": 0.1112876906991005,
            "end_logit": 0.8734797835350037,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mobidb.bio.unipd.it) database of protein disorder and mobility annotations",
            "probability": 0.001407862124193587,
            "start_logit": 3.691145896911621,
            "end_logit": -3.1435298919677734,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "mobidb.bio.unipd.it) database",
            "probability": 0.001156949205722378,
            "start_logit": 1.2535655498504639,
            "end_logit": -0.9022353291511536,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "Mob",
            "probability": 0.00112894181997749,
            "start_logit": 3.691145896911621,
            "end_logit": -3.36432147026062,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "The MobiDB (URL: mobidb.bio.unipd.it)",
            "probability": 0.0009034825500006871,
            "start_logit": 0.1112876906991005,
            "end_logit": -0.007242498453706503,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mob",
            "probability": 0.0005425186342903064,
            "start_logit": 3.691145896911621,
            "end_logit": -4.097135066986084,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "The MobiDB (URL: mobidb.bio.unipd.it) database",
            "probability": 0.00036917248186942026,
            "start_logit": 0.1112876906991005,
            "end_logit": -0.9022353291511536,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mobidb.bio.unipd.it) database of protein disorder and mobility",
            "probability": 0.0003361540307081625,
            "start_logit": 3.691145896911621,
            "end_logit": -4.5757880210876465,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "b",
            "probability": 0.00019357860093414825,
            "start_logit": -4.674488544464111,
            "end_logit": 3.2379605770111084,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": ")",
            "probability": 0.00018215680592319607,
            "start_logit": -1.4901012182235718,
            "end_logit": -0.007242498453706503,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "mobidb.bio.unipd.it) database of protein disorder and mobility annotations",
            "probability": 0.00012300773772216795,
            "start_logit": 1.2535655498504639,
            "end_logit": -3.1435298919677734,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "(URL: mobidb",
            "probability": 9.861420299909715e-05,
            "start_logit": -2.984476089477539,
            "end_logit": 0.8734797835350037,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        }
    ],
    "5e4f0a4f6d0a277941000031": [
        {
            "text": "kappa or lambda",
            "probability": 0.16083573544771593,
            "start_logit": 3.9599666595458984,
            "end_logit": 2.642097234725952,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "lambda",
            "probability": 0.11284886565781538,
            "start_logit": 3.6056325435638428,
            "end_logit": 2.642097234725952,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta or epsilon chain or only kappa or lambda",
            "probability": 0.09625717770319141,
            "start_logit": 3.4466066360473633,
            "end_logit": 2.642097234725952,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "kappa",
            "probability": 0.06751986177335127,
            "start_logit": 3.9599666595458984,
            "end_logit": 1.7741354703903198,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon chain or only kappa or lambda",
            "probability": 0.06626337950634875,
            "start_logit": 3.0732204914093018,
            "end_logit": 2.642097234725952,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta or epsilon",
            "probability": 0.06384965145989117,
            "start_logit": 3.4466066360473633,
            "end_logit": 2.231604814529419,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta",
            "probability": 0.06245783632460624,
            "start_logit": 3.4466066360473633,
            "end_logit": 2.2095654010772705,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon",
            "probability": 0.043954059187989135,
            "start_logit": 3.0732204914093018,
            "end_logit": 2.231604814529419,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta or epsilon chain or only kappa",
            "probability": 0.04040937367010182,
            "start_logit": 3.4466066360473633,
            "end_logit": 1.7741354703903198,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "delta or epsilon chain or only kappa or lambda",
            "probability": 0.0363363120476303,
            "start_logit": 2.472400665283203,
            "end_logit": 2.642097234725952,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gamma, alpha, mu, delta or epsilon chain or only kappa or lambda",
            "probability": 0.03602175006241371,
            "start_logit": 2.4637060165405273,
            "end_logit": 2.642097234725952,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "kappa or lambda light chains",
            "probability": 0.02854897405363639,
            "start_logit": 3.9599666595458984,
            "end_logit": 0.9133346676826477,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon chain or only kappa",
            "probability": 0.02781778696413032,
            "start_logit": 3.0732204914093018,
            "end_logit": 1.7741354703903198,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu",
            "probability": 0.02481473157627549,
            "start_logit": 3.4466066360473633,
            "end_logit": 1.2865111827850342,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "delta or epsilon",
            "probability": 0.024102730985245967,
            "start_logit": 2.472400665283203,
            "end_logit": 2.231604814529419,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gamma, alpha, mu, delta or epsilon",
            "probability": 0.023894074616984874,
            "start_logit": 2.4637060165405273,
            "end_logit": 2.231604814529419,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "delta",
            "probability": 0.023577331942025822,
            "start_logit": 2.472400665283203,
            "end_logit": 2.2095654010772705,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gamma, alpha, mu, delta",
            "probability": 0.02337322393205298,
            "start_logit": 2.4637060165405273,
            "end_logit": 2.2095654010772705,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "lambda light chains",
            "probability": 0.020031116397602935,
            "start_logit": 3.6056325435638428,
            "end_logit": 0.9133346676826477,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta or epsilon chain or only kappa or lambda light chains",
            "probability": 0.017086026690989988,
            "start_logit": 3.4466066360473633,
            "end_logit": 0.9133346676826477,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        }
    ],
    "5e55046fb761aafe09000004": [
        {
            "text": "SB222200",
            "probability": 0.9954002740226705,
            "start_logit": 5.196680545806885,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "SB",
            "probability": 0.0029071987609338556,
            "start_logit": 5.196680545806885,
            "end_logit": 0.13714809715747833,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "00",
            "probability": 0.0005857206892693384,
            "start_logit": -2.2413766384124756,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "kisspeptin-induced GnRH release was blocked in the presence of the NK3R antagonist SB222200",
            "probability": 0.0002615848958761853,
            "start_logit": -3.0474607944488525,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "antagonist SB222200",
            "probability": 0.00017453829854676718,
            "start_logit": -3.452075481414795,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "S",
            "probability": 0.00014682548561434358,
            "start_logit": 5.196680545806885,
            "end_logit": -2.8485524654388428,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "B222200",
            "probability": 0.00014222269907440276,
            "start_logit": -3.656825542449951,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "222200",
            "probability": 0.00012195217148642096,
            "start_logit": -3.8105907440185547,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "SB22",
            "probability": 0.00010353752136959403,
            "start_logit": 5.196680545806885,
            "end_logit": -3.1978631019592285,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "SB2222",
            "probability": 8.254486869044446e-05,
            "start_logit": 5.196680545806885,
            "end_logit": -3.424455165863037,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "GnRH release was blocked in the presence of the NK3R antagonist SB222200",
            "probability": 3.828207880939347e-05,
            "start_logit": -4.969237804412842,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "blocked in the presence of the NK3R antagonist SB222200",
            "probability": 1.1289703062280287e-05,
            "start_logit": -6.190328598022461,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "the NK3R antagonist SB222200",
            "probability": 1.1175655352024615e-05,
            "start_logit": -6.20048189163208,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "2200",
            "probability": 1.049065996567522e-05,
            "start_logit": -6.263734340667725,
            "end_logit": 5.973103046417236,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "kisspeptin-induced GnRH release was blocked in the presence of the NK3R antagonist SB",
            "probability": 7.639934456688099e-07,
            "start_logit": -3.0474607944488525,
            "end_logit": 0.13714809715747833,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "antagonist SB",
            "probability": 5.097622921280293e-07,
            "start_logit": -3.452075481414795,
            "end_logit": 0.13714809715747833,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "B",
            "probability": 4.15380290036323e-07,
            "start_logit": -3.656825542449951,
            "end_logit": 0.13714809715747833,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "senktide",
            "probability": 2.767528832353229e-07,
            "start_logit": -1.2169737815856934,
            "end_logit": -2.708773136138916,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "peptide 234",
            "probability": 2.541253485746927e-07,
            "start_logit": -1.9498286247253418,
            "end_logit": -2.06121563911438,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "peptide 234 in pubertal but not prepubertal monkeys; and (3) the kisspeptin",
            "probability": 1.424750189387704e-07,
            "start_logit": -1.9498286247253418,
            "end_logit": -2.6398766040802,
            "question_text": "List 3 NK3R antagonists."
        }
    ],
    "5e51c6036d0a27794100003c": [
        {
            "text": "macrocephaly/hemi/megalencephaly",
            "probability": 0.1939272109350447,
            "start_logit": 3.9944474697113037,
            "end_logit": 4.116749286651611,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly",
            "probability": 0.14380319583393045,
            "start_logit": 3.9944474697113037,
            "end_logit": 3.8177120685577393,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly/hemi/megalencephaly, and seizures",
            "probability": 0.11962940655249771,
            "start_logit": 3.9944474697113037,
            "end_logit": 3.633665084838867,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability, macrocephaly/hemi/megalencephaly",
            "probability": 0.11766792976869422,
            "start_logit": 3.494831085205078,
            "end_logit": 4.116749286651611,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability, macrocephaly",
            "probability": 0.08725451300162487,
            "start_logit": 3.494831085205078,
            "end_logit": 3.8177120685577393,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability, macrocephaly/hemi/megalencephaly, and seizures",
            "probability": 0.07258674293626985,
            "start_logit": 3.494831085205078,
            "end_logit": 3.633665084838867,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability",
            "probability": 0.07038688775692911,
            "start_logit": 3.494831085205078,
            "end_logit": 3.6028897762298584,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "seizures",
            "probability": 0.04523096926547497,
            "start_logit": 3.0218307971954346,
            "end_logit": 3.633665084838867,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "megalencephaly",
            "probability": 0.035064947755640216,
            "start_logit": 2.2841665744781494,
            "end_logit": 4.116749286651611,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "hemi/megalencephaly",
            "probability": 0.03347184531438363,
            "start_logit": 2.2376692295074463,
            "end_logit": 4.116749286651611,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "megalencephaly, and seizures",
            "probability": 0.021630790597027716,
            "start_logit": 2.2841665744781494,
            "end_logit": 3.633665084838867,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "hemi/megalencephaly, and seizures",
            "probability": 0.020648040942113657,
            "start_logit": 2.2376692295074463,
            "end_logit": 3.633665084838867,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "seizures. It is also associated with a pattern of facial dysmorphology",
            "probability": 0.008096128391823429,
            "start_logit": 3.0218307971954346,
            "end_logit": 1.91326904296875,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly/hemi/megalencephaly, and seizure",
            "probability": 0.006854173972494599,
            "start_logit": 3.9944474697113037,
            "end_logit": 0.7741242051124573,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "seizures. It is also associated with a pattern of facial dysmorphology and other non-neurological features",
            "probability": 0.004768284402236259,
            "start_logit": 3.0218307971954346,
            "end_logit": 1.3838696479797363,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability,",
            "probability": 0.004221594062757028,
            "start_logit": 3.494831085205078,
            "end_logit": 0.7890955805778503,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability, macrocephaly/hemi/megalencephaly, and seizure",
            "probability": 0.004158861759157906,
            "start_logit": 3.494831085205078,
            "end_logit": 0.7741242051124573,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "megalencephaly, and seizures. It is also associated with a pattern of facial dysmorphology",
            "probability": 0.0038718086464677574,
            "start_logit": 2.2841665744781494,
            "end_logit": 1.91326904296875,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "hemi/megalencephaly, and seizures. It is also associated with a pattern of facial dysmorphology",
            "probability": 0.0036959011319392635,
            "start_logit": 2.2376692295074463,
            "end_logit": 1.91326904296875,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly/hemi/megalencephaly,",
            "probability": 0.003030766973492474,
            "start_logit": 3.9944474697113037,
            "end_logit": -0.04191788658499718,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        }
    ],
    "5e494b0e6d0a277941000007": [
        {
            "text": "nivolumab",
            "probability": 0.9947666099069002,
            "start_logit": 4.726171016693115,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "nivolumab (OPDIVO",
            "probability": 0.001188573888749381,
            "start_logit": 4.726171016693115,
            "end_logit": -2.090463161468506,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "immune checkpoint inhibitors (ICI), such as nivolumab",
            "probability": 0.0007494486685266447,
            "start_logit": -2.464754581451416,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "inhibitors (ICI), such as nivolumab",
            "probability": 0.000401780590558256,
            "start_logit": -3.088186264038086,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "ab",
            "probability": 0.0003564184061636182,
            "start_logit": -3.207987070083618,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "lumab",
            "probability": 0.0003407049349691004,
            "start_logit": -3.25307559967041,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "(ICI), such as nivolumab",
            "probability": 0.0003124592199756075,
            "start_logit": -3.339618444442749,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "checkpoint inhibitors (ICI), such as nivolumab",
            "probability": 0.0002663701331900987,
            "start_logit": -3.4992055892944336,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "ni",
            "probability": 0.00025979588398758593,
            "start_logit": 4.726171016693115,
            "end_logit": -3.6110763549804688,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "such as nivolumab",
            "probability": 0.000244911860220475,
            "start_logit": -3.5831940174102783,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "nivolumab (",
            "probability": 0.00021139850765792084,
            "start_logit": 4.726171016693115,
            "end_logit": -3.817227602005005,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "PD1 immune checkpoint inhibitors (ICI), such as nivolumab",
            "probability": 0.00018814338225024642,
            "start_logit": -3.8468880653381348,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "volumab",
            "probability": 0.00017944400965915356,
            "start_logit": -3.8942291736602783,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "), such as nivolumab",
            "probability": 0.00012692710429344005,
            "start_logit": -4.240479469299316,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": ", such as nivolumab",
            "probability": 0.00010643724908335949,
            "start_logit": -4.416536808013916,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "s (ICI), such as nivolumab",
            "probability": 7.74610774042479e-05,
            "start_logit": -4.734316825866699,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "as nivolumab",
            "probability": 6.083559548396562e-05,
            "start_logit": -4.975917339324951,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "emerged recently, among which PD1 immune checkpoint inhibitors (ICI), such as nivolumab",
            "probability": 5.8578659981693564e-05,
            "start_logit": -5.013721942901611,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "new therapies have emerged recently, among which PD1 immune checkpoint inhibitors (ICI), such as nivolumab",
            "probability": 5.619800970810946e-05,
            "start_logit": -5.055211067199707,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "among which PD1 immune checkpoint inhibitors (ICI), such as nivolumab",
            "probability": 4.750291123644218e-05,
            "start_logit": -5.223301410675049,
            "end_logit": 4.639290809631348,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        }
    ],
    "5e4be9496d0a27794100002a": [
        {
            "text": "erlotinib and gefitinib, or EGFR-neutralizing antibodies, cetuximab",
            "probability": 0.12758633737140151,
            "start_logit": 6.131990909576416,
            "end_logit": 6.551632404327393,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "gefitinib, or EGFR-neutralizing antibodies, cetuximab",
            "probability": 0.11809117315115349,
            "start_logit": 6.054654598236084,
            "end_logit": 6.551632404327393,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "cetuximab",
            "probability": 0.11399720052122586,
            "start_logit": 6.019371509552002,
            "end_logit": 6.551632404327393,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "erlotinib",
            "probability": 0.10337943571201434,
            "start_logit": 6.131990909576416,
            "end_logit": 6.341245174407959,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "erlotinib and gefitinib",
            "probability": 0.10136012659426036,
            "start_logit": 6.131990909576416,
            "end_logit": 6.321518898010254,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "gefitinib",
            "probability": 0.09381675582881535,
            "start_logit": 6.054654598236084,
            "end_logit": 6.321518898010254,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "bevacizumab",
            "probability": 0.08643447480961289,
            "start_logit": 6.124026775360107,
            "end_logit": 6.17018985748291,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "gefitinib, or EGFR-neutralizing antibodies, cetuximab and bevacizumab",
            "probability": 0.08064158288020583,
            "start_logit": 6.054654598236084,
            "end_logit": 6.17018985748291,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "cetuximab and bevacizumab",
            "probability": 0.07784590878928095,
            "start_logit": 6.019371509552002,
            "end_logit": 6.17018985748291,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "bevacizumab. A major advantage with erlotinib and gefitinib",
            "probability": 0.021084898348602645,
            "start_logit": 6.124026775360107,
            "end_logit": 4.759360313415527,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "cetuximab and bevacizumab. A major advantage with erlotinib and gefitinib",
            "probability": 0.018989796343322436,
            "start_logit": 6.019371509552002,
            "end_logit": 4.759360313415527,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "bevacizumab. A major advantage with erlotinib",
            "probability": 0.01782425522405138,
            "start_logit": 6.124026775360107,
            "end_logit": 4.591363430023193,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "cetuximab and bevacizumab. A major advantage with erlotinib",
            "probability": 0.016053147189991963,
            "start_logit": 6.019371509552002,
            "end_logit": 4.591363430023193,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "afatinib",
            "probability": 0.011190989462448401,
            "start_logit": 5.019110202789307,
            "end_logit": 5.230828762054443,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "gefitinib. Alternatively, another second-generation EGFR-tyrosine kinase-inhibitor, afatinib",
            "probability": 0.0061224736368136225,
            "start_logit": 4.4159674644470215,
            "end_logit": 5.230828762054443,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "erlotinib and gefitinib,",
            "probability": 0.0024739878430093537,
            "start_logit": 6.131990909576416,
            "end_logit": 2.608670473098755,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "gefitinib,",
            "probability": 0.002289870003025521,
            "start_logit": 6.054654598236084,
            "end_logit": 2.608670473098755,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "erlotinib and gefitinib, or EGFR-neutralizing antibodies",
            "probability": 0.00040054377086577,
            "start_logit": 6.131990909576416,
            "end_logit": 0.7879068851470947,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "gefitinib, or EGFR-neutralizing antibodies",
            "probability": 0.00037073471011425115,
            "start_logit": 6.054654598236084,
            "end_logit": 0.7879068851470947,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "erlotinib and gefitinib, or EGFR-neutralizing antibodies,",
            "probability": 4.6307809784170236e-05,
            "start_logit": 6.131990909576416,
            "end_logit": -1.369605541229248,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        }
    ],
    "5d36a9507bc3fee31f000005": [
        {
            "text": "T cells",
            "probability": 0.5671322942665332,
            "start_logit": 0.4692360758781433,
            "end_logit": -0.29208657145500183,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T",
            "probability": 0.2660171793656842,
            "start_logit": 0.4692360758781433,
            "end_logit": -1.0491182804107666,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells (defined by low or negative TCR expression) and fewer mature T cells",
            "probability": 0.03835964791117369,
            "start_logit": -2.2243504524230957,
            "end_logit": -0.29208657145500183,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells (intermediate or high expression of TCR)",
            "probability": 0.029646523811837928,
            "start_logit": 0.4692360758781433,
            "end_logit": -3.2433342933654785,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells (intermediate or high expression of TCR",
            "probability": 0.019009236963093302,
            "start_logit": 0.4692360758781433,
            "end_logit": -3.6877541542053223,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells (defined by low or negative TCR expression) and fewer mature T",
            "probability": 0.017992848303566178,
            "start_logit": -2.2243504524230957,
            "end_logit": -1.0491182804107666,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "mature T cells",
            "probability": 0.01126081296649613,
            "start_logit": -3.4500277042388916,
            "end_logit": -0.29208657145500183,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "immature T cells (defined by low or negative TCR expression) and fewer mature T cells",
            "probability": 0.007921235672742749,
            "start_logit": -3.801809310913086,
            "end_logit": -0.29208657145500183,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells (intermediate or high expression of TCR) were produced.",
            "probability": 0.007766229990565414,
            "start_logit": 0.4692360758781433,
            "end_logit": -4.582894325256348,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "immature T cells",
            "probability": 0.007174973455587163,
            "start_logit": -3.801809310913086,
            "end_logit": -0.39103472232818604,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "mature T",
            "probability": 0.005281959311779212,
            "start_logit": -3.4500277042388916,
            "end_logit": -1.0491182804107666,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells (",
            "probability": 0.005213699333581637,
            "start_logit": 0.4692360758781433,
            "end_logit": -4.98138952255249,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "immature T cells (defined by low or negative TCR expression) and fewer mature T",
            "probability": 0.0037155083426858387,
            "start_logit": -3.801809310913086,
            "end_logit": -1.0491182804107666,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "TCR)",
            "probability": 0.0027364906724869184,
            "start_logit": -1.9134324789047241,
            "end_logit": -3.2433342933654785,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "fewer mature T cells",
            "probability": 0.0021202459887258085,
            "start_logit": -5.119824409484863,
            "end_logit": -0.29208657145500183,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells (defined by low or negative TCR expression) and fewer mature T cells (intermediate or high expression of TCR)",
            "probability": 0.0020052291620654378,
            "start_logit": -2.2243504524230957,
            "end_logit": -3.2433342933654785,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "thymocytes",
            "probability": 0.001840043366054028,
            "start_logit": -2.586150646209717,
            "end_logit": -2.967503309249878,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "TCR expression) and fewer mature T cells",
            "probability": 0.0017654686076000352,
            "start_logit": -5.302940368652344,
            "end_logit": -0.29208657145500183,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "TCR",
            "probability": 0.0017546272868533483,
            "start_logit": -1.9134324789047241,
            "end_logit": -3.6877541542053223,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells (defined by low or negative TCR expression) and fewer mature T cells (intermediate or high expression of TCR",
            "probability": 0.001285745220887798,
            "start_logit": -2.2243504524230957,
            "end_logit": -3.6877541542053223,
            "question_text": "Which cells mature in the human thymus?"
        }
    ],
    "5e30f8abfbd6abf43b000047": [
        {
            "text": "FLT3",
            "probability": 0.9576638229098043,
            "start_logit": 3.0512375831604004,
            "end_logit": 2.0587832927703857,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors have been reported in acute myeloid leukemia",
            "probability": 0.016969601798905446,
            "start_logit": 3.0512375831604004,
            "end_logit": -1.974289894104004,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitor",
            "probability": 0.006953209525822281,
            "start_logit": 3.0512375831604004,
            "end_logit": -2.8665101528167725,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors",
            "probability": 0.004773387991210279,
            "start_logit": 3.0512375831604004,
            "end_logit": -3.24265718460083,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FL",
            "probability": 0.004590514707708775,
            "start_logit": 3.0512375831604004,
            "end_logit": -3.281721353530884,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "3",
            "probability": 0.0027660080014834773,
            "start_logit": -2.795854091644287,
            "end_logit": 2.0587832927703857,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors have been reported in acute myeloid leukemia (AML)",
            "probability": 0.0012709438031233188,
            "start_logit": 3.0512375831604004,
            "end_logit": -4.565953731536865,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors have been reported",
            "probability": 0.0011507771048423219,
            "start_logit": 3.0512375831604004,
            "end_logit": -4.665276050567627,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT",
            "probability": 0.0006448930559155205,
            "start_logit": 3.0512375831604004,
            "end_logit": -5.244384288787842,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "effects of FLT3",
            "probability": 0.0004900963525515552,
            "start_logit": -4.526412487030029,
            "end_logit": 2.0587832927703857,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors have been",
            "probability": 0.00041669402775788714,
            "start_logit": 3.0512375831604004,
            "end_logit": -5.681116580963135,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors have been reported in acute myeloid leukemia (AML) with constitutively activating",
            "probability": 0.00039288190489370097,
            "start_logit": 3.0512375831604004,
            "end_logit": -5.739959716796875,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors have been reported in acute myeloid",
            "probability": 0.00035689517760322225,
            "start_logit": 3.0512375831604004,
            "end_logit": -5.836026668548584,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "T3",
            "probability": 0.00033914409380129913,
            "start_logit": -4.894589424133301,
            "end_logit": 2.0587832927703857,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "of FLT3",
            "probability": 0.0002936478176418869,
            "start_logit": -5.038633346557617,
            "end_logit": 2.0587832927703857,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors have been reported in acute myeloid leukemia (AML",
            "probability": 0.00025115669547027403,
            "start_logit": 3.0512375831604004,
            "end_logit": -6.187391757965088,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors have been reported in acute myeloid leukemia (AML) with constitutively",
            "probability": 0.00024483239405019314,
            "start_logit": 3.0512375831604004,
            "end_logit": -6.212894916534424,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "Therapeutic effects of FLT3",
            "probability": 0.00021379546677992973,
            "start_logit": -5.355994701385498,
            "end_logit": 2.0587832927703857,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "acute myeloid leukemia",
            "probability": 0.00016868408980711617,
            "start_logit": -1.5599136352539062,
            "end_logit": -1.974289894104004,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "3 inhibitors have been reported in acute myeloid leukemia",
            "probability": 4.9013080827406013e-05,
            "start_logit": -2.795854091644287,
            "end_logit": -1.974289894104004,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        }
    ],
    "5e4163b848dab47f2600000f": [
        {
            "text": "Mumps",
            "probability": 0.5590970456034262,
            "start_logit": 4.702183246612549,
            "end_logit": 5.092565059661865,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mumps is a Paramyxoviridae virus. This disease was rampant prior to introduction of the measles, mumps",
            "probability": 0.1231303633796119,
            "start_logit": 4.702183246612549,
            "end_logit": 3.5794856548309326,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mumps is a Paramyxoviridae virus. This disease was rampant prior to introduction of the measles",
            "probability": 0.10806664398405016,
            "start_logit": 4.702183246612549,
            "end_logit": 3.4489901065826416,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles, mumps, and rubella",
            "probability": 0.03999045754744786,
            "start_logit": 3.572610378265381,
            "end_logit": 3.584455728530884,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles, mumps",
            "probability": 0.03979219512368824,
            "start_logit": 3.572610378265381,
            "end_logit": 3.5794856548309326,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "rubella",
            "probability": 0.03503810183754685,
            "start_logit": 3.4404056072235107,
            "end_logit": 3.584455728530884,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles",
            "probability": 0.03492403389176962,
            "start_logit": 3.572610378265381,
            "end_logit": 3.4489901065826416,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "mumps, and rubella",
            "probability": 0.02971808701221377,
            "start_logit": 3.2757253646850586,
            "end_logit": 3.584455728530884,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "mumps",
            "probability": 0.02957075236485321,
            "start_logit": 3.2757253646850586,
            "end_logit": 3.5794856548309326,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "ps",
            "probability": 0.00013044312172789566,
            "start_logit": -3.6609578132629395,
            "end_logit": 5.092565059661865,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mum",
            "probability": 0.00012140308723509664,
            "start_logit": 4.702183246612549,
            "end_logit": -3.3423969745635986,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mumps is a Paramyxoviridae virus. This disease was rampant prior to introduction of the measles, mumps,",
            "probability": 8.443328187128823e-05,
            "start_logit": 4.702183246612549,
            "end_logit": -3.7055516242980957,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mumps is a Paramyxoviridae virus. This disease was rampant prior to introduction of the me",
            "probability": 5.2864971130499964e-05,
            "start_logit": 4.702183246612549,
            "end_logit": -4.17377233505249,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles, mumps, and rubella vaccine, resulting in decreased incidence. This disease has demonstrated several outbreaks.",
            "probability": 5.1806526650334906e-05,
            "start_logit": 3.572610378265381,
            "end_logit": -3.0644242763519287,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mumps is a Paramyxoviridae virus.",
            "probability": 4.73834703778919e-05,
            "start_logit": 4.702183246612549,
            "end_logit": -4.283239841461182,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "rubella vaccine, resulting in decreased incidence. This disease has demonstrated several outbreaks.",
            "probability": 4.539088742533939e-05,
            "start_logit": 3.4404056072235107,
            "end_logit": -3.0644242763519287,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mumps is",
            "probability": 4.408095562037342e-05,
            "start_logit": 4.702183246612549,
            "end_logit": -4.355485439300537,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "mumps, and rubella vaccine, resulting in decreased incidence. This disease has demonstrated several outbreaks.",
            "probability": 3.849895603141153e-05,
            "start_logit": 3.2757253646850586,
            "end_logit": -3.0644242763519287,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "ps is a Paramyxoviridae virus. This disease was rampant prior to introduction of the measles, mumps",
            "probability": 2.872758692793979e-05,
            "start_logit": -3.6609578132629395,
            "end_logit": 3.5794856548309326,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles, mumps,",
            "probability": 2.728641039413994e-05,
            "start_logit": 3.572610378265381,
            "end_logit": -3.7055516242980957,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        }
    ],
    "5e342175fbd6abf43b000064": [
        {
            "text": "sacral anomalies, anorectal malformations and a presacral mass",
            "probability": 0.22271977596317796,
            "start_logit": 4.909509658813477,
            "end_logit": 4.871092319488525,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral anomalies, anorectal malformations",
            "probability": 0.19704207595821355,
            "start_logit": 4.909509658813477,
            "end_logit": 4.748595237731934,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral anomalies",
            "probability": 0.18933942527518072,
            "start_logit": 4.909509658813477,
            "end_logit": 4.708719253540039,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformations and a presacral mass",
            "probability": 0.14359635468714754,
            "start_logit": 4.470601558685303,
            "end_logit": 4.871092319488525,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformations",
            "probability": 0.12704091365584622,
            "start_logit": 4.470601558685303,
            "end_logit": 4.748595237731934,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "presacral mass",
            "probability": 0.08035556285065842,
            "start_logit": 3.890056610107422,
            "end_logit": 4.871092319488525,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "a presacral mass",
            "probability": 0.026264785098219424,
            "start_logit": 2.771824359893799,
            "end_logit": 4.871092319488525,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral anomalies,",
            "probability": 0.005062749336986016,
            "start_logit": 4.909509658813477,
            "end_logit": 1.087087631225586,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral",
            "probability": 0.0020720418244918105,
            "start_logit": 4.909509658813477,
            "end_logit": 0.19371245801448822,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "malformations and a presacral mass",
            "probability": 0.0009754770868494771,
            "start_logit": -0.521233320236206,
            "end_logit": 4.871092319488525,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anomalies, anorectal malformations and a presacral mass",
            "probability": 0.0009065573773920193,
            "start_logit": -0.5945056676864624,
            "end_logit": 4.871092319488525,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "malformations",
            "probability": 0.0008630128573507072,
            "start_logit": -0.521233320236206,
            "end_logit": 4.748595237731934,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anomalies, anorectal malformations",
            "probability": 0.0008020390054904234,
            "start_logit": -0.5945056676864624,
            "end_logit": 4.748595237731934,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anomalies",
            "probability": 0.0007706861776062413,
            "start_logit": -0.5945056676864624,
            "end_logit": 4.708719253540039,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral anomalies, anorectal",
            "probability": 0.0004241717998056243,
            "start_logit": 4.909509658813477,
            "end_logit": -1.3924387693405151,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "mass",
            "probability": 0.0004205705476295187,
            "start_logit": -1.362547755241394,
            "end_logit": 4.871092319488525,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "triad of sacral anomalies, anorectal malformations and a presacral mass",
            "probability": 0.0003913658213420155,
            "start_logit": -1.43451726436615,
            "end_logit": 4.871092319488525,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "triad of sacral anomalies, anorectal malformations",
            "probability": 0.00034624466355907027,
            "start_logit": -1.43451726436615,
            "end_logit": 4.748595237731934,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "triad of sacral anomalies",
            "probability": 0.00033270947478636706,
            "start_logit": -1.43451726436615,
            "end_logit": 4.708719253540039,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal",
            "probability": 0.00027348053826726316,
            "start_logit": 4.470601558685303,
            "end_logit": -1.3924387693405151,
            "question_text": "List features of the Currarino triad."
        }
    ],
    "5e36a901b5b409ea53000005": [
        {
            "text": "uc.339",
            "probability": 0.9583529899864128,
            "start_logit": 2.36409330368042,
            "end_logit": 2.006507158279419,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "339",
            "probability": 0.03511022093999259,
            "start_logit": -0.9426305890083313,
            "end_logit": 2.006507158279419,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.339 that we call \"entrapping\". Our results support a key role for uc.339",
            "probability": 0.002667966909768671,
            "start_logit": -3.519806146621704,
            "end_logit": 2.006507158279419,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "key role for uc.339",
            "probability": 0.0009000415641767654,
            "start_logit": -4.6064372062683105,
            "end_logit": 2.006507158279419,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "support a key role for uc.339",
            "probability": 0.0006793027924845259,
            "start_logit": -4.887811183929443,
            "end_logit": 2.006507158279419,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "role for uc.339",
            "probability": 0.0006535112256802444,
            "start_logit": -4.926518440246582,
            "end_logit": 2.006507158279419,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "a key role for uc.339",
            "probability": 0.0006332353823338476,
            "start_logit": -4.958035945892334,
            "end_logit": 2.006507158279419,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "results support a key role for uc.339",
            "probability": 0.0006130712583650236,
            "start_logit": -4.990396976470947,
            "end_logit": 2.006507158279419,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved regions",
            "probability": 0.00017869896409951163,
            "start_logit": -2.174622058868408,
            "end_logit": -2.042046308517456,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs) encode long non-coding RNAs implicated in human carcinogenesis",
            "probability": 5.4228821245996605e-05,
            "start_logit": -2.174622058868408,
            "end_logit": -3.2345364093780518,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "The transcribed ultraconserved regions",
            "probability": 3.305740318050898e-05,
            "start_logit": -3.86207914352417,
            "end_logit": -2.042046308517456,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs)",
            "probability": 1.962293309995975e-05,
            "start_logit": -2.174622058868408,
            "end_logit": -4.251049995422363,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.339. We find that transcribed uc.339",
            "probability": 1.6409789704042158e-05,
            "start_logit": -3.3959240913391113,
            "end_logit": -3.208568811416626,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs) encode long non-coding RNAs implicated in human carcinogenesis.",
            "probability": 1.5910462254920392e-05,
            "start_logit": -2.174622058868408,
            "end_logit": -4.4607720375061035,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "ultraconserved regions",
            "probability": 1.5783804619650406e-05,
            "start_logit": -4.601340293884277,
            "end_logit": -2.042046308517456,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved",
            "probability": 1.3982632380432802e-05,
            "start_logit": -2.174622058868408,
            "end_logit": -4.589932918548584,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs) encode long non-coding RNAs implicated",
            "probability": 1.315621599586685e-05,
            "start_logit": -2.174622058868408,
            "end_logit": -4.650854587554932,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed",
            "probability": 1.0907739111604964e-05,
            "start_logit": -2.174622058868408,
            "end_logit": -4.838276386260986,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "The transcribed ultraconserved regions (T-UCRs) encode long non-coding RNAs implicated in human carcinogenesis",
            "probability": 1.00317537763363e-05,
            "start_logit": -3.86207914352417,
            "end_logit": -3.2345364093780518,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.339 that we call \"entrapping\". Our results support a key role",
            "probability": 7.869421317124055e-06,
            "start_logit": -3.519806146621704,
            "end_logit": -3.819580316543579,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        }
    ],
    "5e3a6a4eb5b409ea53000016": [
        {
            "text": "internuclear ophthalmoplegia",
            "probability": 0.2599084563133997,
            "start_logit": 4.49495792388916,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "horizontal conjugate gaze palsy with internuclear ophthalmoplegia",
            "probability": 0.17417730903833303,
            "start_logit": 4.094702243804932,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "conjugate gaze palsy with internuclear ophthalmoplegia",
            "probability": 0.11510021209300553,
            "start_logit": 3.680431604385376,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "extraocular movements characterized by horizontal conjugate gaze palsy with internuclear ophthalmoplegia",
            "probability": 0.09976658540623115,
            "start_logit": 3.537461757659912,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "horizontal conjugate gaze palsy",
            "probability": 0.08112517022975778,
            "start_logit": 4.094702243804932,
            "end_logit": 4.524835109710693,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "gaze palsy with internuclear ophthalmoplegia",
            "probability": 0.060707860168933016,
            "start_logit": 3.0407016277313232,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "ophthalmoplegia",
            "probability": 0.059989735468092345,
            "start_logit": 3.028801918029785,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "conjugate gaze palsy",
            "probability": 0.05360930393907562,
            "start_logit": 3.680431604385376,
            "end_logit": 4.524835109710693,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "extraocular movements characterized by horizontal conjugate gaze palsy",
            "probability": 0.04646748344550972,
            "start_logit": 3.537461757659912,
            "end_logit": 4.524835109710693,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "gaze palsy",
            "probability": 0.028275413816418193,
            "start_logit": 3.0407016277313232,
            "end_logit": 4.524835109710693,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "extraocular movements",
            "probability": 0.008700694381580654,
            "start_logit": 3.537461757659912,
            "end_logit": 2.849485158920288,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "horizontal conjugate gaze",
            "probability": 0.002576256210030237,
            "start_logit": 4.094702243804932,
            "end_logit": 1.075179100036621,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "palsy with internuclear ophthalmoplegia",
            "probability": 0.0020931320620560553,
            "start_logit": -0.3267100155353546,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "conjugate gaze",
            "probability": 0.0017024469939143614,
            "start_logit": 3.680431604385376,
            "end_logit": 1.075179100036621,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "extraocular movements characterized by horizontal conjugate gaze",
            "probability": 0.0014756473539831124,
            "start_logit": 3.537461757659912,
            "end_logit": 1.075179100036621,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "characterized by horizontal conjugate gaze palsy with internuclear ophthalmoplegia",
            "probability": 0.0010920102959032778,
            "start_logit": -0.9773512482643127,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "palsy",
            "probability": 0.000974901356469404,
            "start_logit": -0.3267100155353546,
            "end_logit": 4.524835109710693,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "gaze",
            "probability": 0.0008979298315111789,
            "start_logit": 3.0407016277313232,
            "end_logit": 1.075179100036621,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "with internuclear ophthalmoplegia",
            "probability": 0.0007785455457780661,
            "start_logit": -1.3156993389129639,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "hthalmoplegia",
            "probability": 0.0005809060500176368,
            "start_logit": -1.6085377931594849,
            "end_logit": 5.288915634155273,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        }
    ],
    "5e639b111af46fc130000012": [
        {
            "text": "adrenal cortical carcinoma",
            "probability": 0.12371602351674695,
            "start_logit": 5.845504283905029,
            "end_logit": 5.603851318359375,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "laryngeal and lung cancer, and adrenal cortical carcinoma",
            "probability": 0.10056238342665899,
            "start_logit": 5.638293743133545,
            "end_logit": 5.603851318359375,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "laryngeal and lung cancer",
            "probability": 0.0752193682935288,
            "start_logit": 5.638293743133545,
            "end_logit": 5.31348180770874,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "leukaemia, laryngeal and lung cancer, and adrenal cortical carcinoma",
            "probability": 0.07063770037535752,
            "start_logit": 5.285079479217529,
            "end_logit": 5.603851318359375,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "leukaemia",
            "probability": 0.06095977175415057,
            "start_logit": 5.285079479217529,
            "end_logit": 5.456501483917236,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcoma",
            "probability": 0.06089408468360948,
            "start_logit": 5.225105285644531,
            "end_logit": 5.515397548675537,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcoma, breast and brain tumour, leukaemia",
            "probability": 0.0574112325731154,
            "start_logit": 5.225105285644531,
            "end_logit": 5.456501483917236,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "leukaemia, laryngeal and lung cancer",
            "probability": 0.05283609058268798,
            "start_logit": 5.285079479217529,
            "end_logit": 5.31348180770874,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcoma, breast and brain tumour, leukaemia, laryngeal and lung cancer",
            "probability": 0.04976044032662176,
            "start_logit": 5.225105285644531,
            "end_logit": 5.31348180770874,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "lung cancer, and adrenal cortical carcinoma",
            "probability": 0.04937977043536035,
            "start_logit": 4.927056312561035,
            "end_logit": 5.603851318359375,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "breast and brain tumour, leukaemia, laryngeal and lung cancer, and adrenal cortical carcinoma",
            "probability": 0.04434509631897038,
            "start_logit": 4.819517612457275,
            "end_logit": 5.603851318359375,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "breast and brain tumour, leukaemia",
            "probability": 0.03826946426137212,
            "start_logit": 4.819517612457275,
            "end_logit": 5.456501483917236,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "lung cancer",
            "probability": 0.03693543263457113,
            "start_logit": 4.927056312561035,
            "end_logit": 5.31348180770874,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "breast and brain tumour, leukaemia, laryngeal and lung cancer",
            "probability": 0.03316956120537189,
            "start_logit": 4.819517612457275,
            "end_logit": 5.31348180770874,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcoma, breast and brain tumour",
            "probability": 0.03266744709428386,
            "start_logit": 5.225105285644531,
            "end_logit": 4.892640590667725,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "brain tumour, leukaemia, laryngeal and lung cancer, and adrenal cortical carcinoma",
            "probability": 0.029484095580974073,
            "start_logit": 4.4113664627075195,
            "end_logit": 5.603851318359375,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "brain tumour, leukaemia",
            "probability": 0.025444539211256025,
            "start_logit": 4.4113664627075195,
            "end_logit": 5.456501483917236,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "brain tumour, leukaemia, laryngeal and lung cancer",
            "probability": 0.022053723954587212,
            "start_logit": 4.4113664627075195,
            "end_logit": 5.31348180770874,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "breast and brain tumour",
            "probability": 0.02177562896760363,
            "start_logit": 4.819517612457275,
            "end_logit": 4.892640590667725,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "brain tumour",
            "probability": 0.014478144803171784,
            "start_logit": 4.4113664627075195,
            "end_logit": 4.892640590667725,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        }
    ],
    "5e475d3035b8f0833c000002": [
        {
            "text": "clinical prediction rules (CPRs) for appendicitis",
            "probability": 0.3391668044325248,
            "start_logit": -2.404235363006592,
            "end_logit": -2.0567188262939453,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "appendicitis",
            "probability": 0.11424686170676036,
            "start_logit": -3.492365837097168,
            "end_logit": -2.0567188262939453,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical prediction rules",
            "probability": 0.10639352705170152,
            "start_logit": -2.404235363006592,
            "end_logit": -3.2160661220550537,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical",
            "probability": 0.07768050716611753,
            "start_logit": -2.404235363006592,
            "end_logit": -3.530606508255005,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical prediction rules (CPRs)",
            "probability": 0.04150688708388179,
            "start_logit": -2.404235363006592,
            "end_logit": -4.157351493835449,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "many clinical prediction rules (CPRs) for appendicitis",
            "probability": 0.040946122227719615,
            "start_logit": -4.518470287322998,
            "end_logit": -2.0567188262939453,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "right iliac fossa (RIF) pain. The aim of this study was to derive and validate an appendicitis",
            "probability": 0.030353659924620077,
            "start_logit": -3.6473793983459473,
            "end_logit": -3.227149724960327,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Although many clinical prediction rules (CPRs) for appendicitis",
            "probability": 0.02904407984120762,
            "start_logit": -4.861912727355957,
            "end_logit": -2.0567188262939453,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical prediction rules (CPRs) for appendicitis exist, none have been developed",
            "probability": 0.028342135560389316,
            "start_logit": -2.404235363006592,
            "end_logit": -4.538861274719238,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical prediction rules (CPRs) for appendicitis exist, none",
            "probability": 0.027416278002310352,
            "start_logit": -2.404235363006592,
            "end_logit": -4.572073936462402,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "validate an appendicitis",
            "probability": 0.02390269957321059,
            "start_logit": -3.886305093765259,
            "end_logit": -3.227149724960327,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "prediction rules (CPRs) for appendicitis",
            "probability": 0.0220281906992024,
            "start_logit": -5.138404369354248,
            "end_logit": -2.0567188262939453,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "appendicitis exist, none have been developed for a New Zealand population presenting with right iliac fossa",
            "probability": 0.019640932805140714,
            "start_logit": -3.492365837097168,
            "end_logit": -3.817464590072632,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical prediction rules (CPRs) for appendicitis exist",
            "probability": 0.017963212082149963,
            "start_logit": -2.404235363006592,
            "end_logit": -4.994884967803955,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "right iliac fossa",
            "probability": 0.016820564844847122,
            "start_logit": -3.6473793983459473,
            "end_logit": -3.817464590072632,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "derive and validate an appendicitis",
            "probability": 0.01508205623846541,
            "start_logit": -4.346790790557861,
            "end_logit": -3.227149724960327,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "(CPRs) for appendicitis",
            "probability": 0.013077828105944378,
            "start_logit": -5.659809112548828,
            "end_logit": -2.0567188262939453,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "many clinical prediction rules",
            "probability": 0.012844424353928317,
            "start_logit": -4.518470287322998,
            "end_logit": -3.2160661220550537,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "none have been developed for a New Zealand population presenting with right iliac fossa",
            "probability": 0.011911578291837102,
            "start_logit": -3.9924707412719727,
            "end_logit": -3.817464590072632,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "CPRs) for appendicitis",
            "probability": 0.011631650008041278,
            "start_logit": -5.7769975662231445,
            "end_logit": -2.0567188262939453,
            "question_text": "Which factors are included in the the APPEND score?"
        }
    ],
    "5e493a3e6d0a277941000002": [
        {
            "text": "adipogenesis",
            "probability": 0.7626952190312676,
            "start_logit": -1.3833247423171997,
            "end_logit": -1.681937575340271,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "adipogenesis.",
            "probability": 0.049083931350049986,
            "start_logit": -1.3833247423171997,
            "end_logit": -4.425264358520508,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "9",
            "probability": 0.04809481939013291,
            "start_logit": -2.8301801681518555,
            "end_logit": -2.9987661838531494,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "required for adipogenesis",
            "probability": 0.03035007650088306,
            "start_logit": -4.607384204864502,
            "end_logit": -1.681937575340271,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "neurogenesis. Of the lncRNAs,",
            "probability": 0.022581124154296042,
            "start_logit": -3.9650659561157227,
            "end_logit": -2.6199405193328857,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "fat cell differentiation, while upregulated genes were mostly associated with GO terms linked to neurogenesis. Of the lncRNAs,",
            "probability": 0.013574217421539579,
            "start_logit": -4.474008083343506,
            "end_logit": -2.6199405193328857,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "RNA binding protein Sam68 is required for adipogenesis",
            "probability": 0.009520484895419068,
            "start_logit": -5.766737461090088,
            "end_logit": -1.681937575340271,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "KH-type RNA binding protein Sam68 is required for adipogenesis",
            "probability": 0.009420966851111679,
            "start_logit": -5.77724552154541,
            "end_logit": -1.681937575340271,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "652 protein-coding genes and 9",
            "probability": 0.008001848779203673,
            "start_logit": -4.623682022094727,
            "end_logit": -2.9987661838531494,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "We identified 652 protein-coding genes and 9",
            "probability": 0.0077270460423686065,
            "start_logit": -4.658627986907959,
            "end_logit": -2.9987661838531494,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "lncRNAs,",
            "probability": 0.007678896018696021,
            "start_logit": -5.043704509735107,
            "end_logit": -2.6199405193328857,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": ",",
            "probability": 0.006822079818432813,
            "start_logit": -5.162015914916992,
            "end_logit": -2.6199405193328857,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "neurogenesis. Of the lncRNAs",
            "probability": 0.006082139587529563,
            "start_logit": -3.9650659561157227,
            "end_logit": -3.9316983222961426,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "fat cell differentiation, while upregulated genes were mostly associated with GO terms linked to neurogenesis. Of the lncRNAs",
            "probability": 0.003656163642923521,
            "start_logit": -4.474008083343506,
            "end_logit": -3.9316983222961426,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "neurogenesis",
            "probability": 0.0030150912748482567,
            "start_logit": -3.9650659561157227,
            "end_logit": -4.633424758911133,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "neurogenesis. Of the lncRNAs, we",
            "probability": 0.002897625035560732,
            "start_logit": -3.9650659561157227,
            "end_logit": -4.673163414001465,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "we",
            "probability": 0.002413565183246193,
            "start_logit": -4.147852420806885,
            "end_logit": -4.673163414001465,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "neurogenesis.",
            "probability": 0.002363217440390061,
            "start_logit": -3.9650659561157227,
            "end_logit": -4.877030849456787,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "lncRNAs",
            "probability": 0.0020682813284540924,
            "start_logit": -5.043704509735107,
            "end_logit": -3.9316983222961426,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "required for adipogenesis.",
            "probability": 0.001953206253646435,
            "start_logit": -4.607384204864502,
            "end_logit": -4.425264358520508,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        }
    ],
    "5e6e4a6c51b80c9423000002": [
        {
            "text": "KMT2C",
            "probability": 0.5889783093209039,
            "start_logit": 3.8967103958129883,
            "end_logit": 2.587218999862671,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3",
            "probability": 0.1273981493774889,
            "start_logit": 3.8967103958129883,
            "end_logit": 1.0561468601226807,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL3",
            "probability": 0.040097490117354376,
            "start_logit": 2.7407069206237793,
            "end_logit": 1.0561468601226807,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3)",
            "probability": 0.036275167953732784,
            "start_logit": 3.8967103958129883,
            "end_logit": -0.2000369280576706,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3), a subunit of the COMPASS complex,",
            "probability": 0.029513923147158404,
            "start_logit": 3.8967103958129883,
            "end_logit": -0.40630823373794556,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3), a subunit of the COMPASS",
            "probability": 0.02519212345998089,
            "start_logit": 3.8967103958129883,
            "end_logit": -0.5646389722824097,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3), a subunit of the COMPASS complex",
            "probability": 0.02431434056250262,
            "start_logit": 3.8967103958129883,
            "end_logit": -0.600104033946991,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3),",
            "probability": 0.023081451329589133,
            "start_logit": 3.8967103958129883,
            "end_logit": -0.6521410346031189,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "lysine methyltransferase KMT2C",
            "probability": 0.023073029077637537,
            "start_logit": 0.6569854021072388,
            "end_logit": 2.587218999862671,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "The lysine methyltransferase KMT2C",
            "probability": 0.01872205964447942,
            "start_logit": 0.4480235278606415,
            "end_logit": 2.587218999862671,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL3)",
            "probability": 0.01141730233631782,
            "start_logit": 2.7407069206237793,
            "end_logit": -0.2000369280576706,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL3), a subunit of the COMPASS complex,",
            "probability": 0.009289257712927596,
            "start_logit": 2.7407069206237793,
            "end_logit": -0.40630823373794556,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL3), a subunit of the COMPASS",
            "probability": 0.007929007810613032,
            "start_logit": 2.7407069206237793,
            "end_logit": -0.5646389722824097,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL3), a subunit of the COMPASS complex",
            "probability": 0.0076527330669939,
            "start_logit": 2.7407069206237793,
            "end_logit": -0.600104033946991,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL3),",
            "probability": 0.00726469160741147,
            "start_logit": 2.7407069206237793,
            "end_logit": -0.6521410346031189,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2",
            "probability": 0.0067679189999539134,
            "start_logit": 3.8967103958129883,
            "end_logit": -1.8789767026901245,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "lysine methyltransferase KMT2C (also known as MLL3",
            "probability": 0.004990780065251012,
            "start_logit": 0.6569854021072388,
            "end_logit": 1.0561468601226807,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "The lysine methyltransferase KMT2C (also known as MLL3",
            "probability": 0.0040496495600860875,
            "start_logit": 0.4480235278606415,
            "end_logit": 1.0561468601226807,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3), a subunit",
            "probability": 0.001997651526551255,
            "start_logit": 3.8967103958129883,
            "end_logit": -3.09919810295105,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT",
            "probability": 0.001994963323065873,
            "start_logit": 3.8967103958129883,
            "end_logit": -3.1005446910858154,
            "question_text": "List the components of the COMPASS complex"
        }
    ],
    "5e6e5d1d51b80c9423000003": [
        {
            "text": "fibromyalgia syndrome",
            "probability": 0.8362712762875419,
            "start_logit": 3.302805185317993,
            "end_logit": 3.359997034072876,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "fibromyalgia",
            "probability": 0.08279202154185711,
            "start_logit": 3.302805185317993,
            "end_logit": 1.0473756790161133,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "fibromyalgia syndrome (FMS)",
            "probability": 0.07674977177103179,
            "start_logit": 3.302805185317993,
            "end_logit": 0.9715943932533264,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "syndrome",
            "probability": 0.0018017912110189927,
            "start_logit": -2.8373665809631348,
            "end_logit": 3.359997034072876,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "gia syndrome",
            "probability": 0.0008755561312214324,
            "start_logit": -3.5590438842773438,
            "end_logit": 3.359997034072876,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "myalgia syndrome",
            "probability": 0.000699301376359285,
            "start_logit": -3.7838213443756104,
            "end_logit": 3.359997034072876,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "fi",
            "probability": 0.0003231037523926436,
            "start_logit": 3.302805185317993,
            "end_logit": -4.498737812042236,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "syndrome (FMS)",
            "probability": 0.0001653614899206586,
            "start_logit": -2.8373665809631348,
            "end_logit": 0.9715943932533264,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "gia",
            "probability": 8.668127691649354e-05,
            "start_logit": -3.5590438842773438,
            "end_logit": 1.0473756790161133,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "gia syndrome (FMS)",
            "probability": 8.035518515270278e-05,
            "start_logit": -3.5590438842773438,
            "end_logit": 0.9715943932533264,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "myalgia",
            "probability": 6.923181060673094e-05,
            "start_logit": -3.7838213443756104,
            "end_logit": 1.0473756790161133,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "myalgia syndrome (FMS)",
            "probability": 6.417919944949697e-05,
            "start_logit": -3.7838213443756104,
            "end_logit": 0.9715943932533264,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "FMS)",
            "probability": 1.2167291126902032e-05,
            "start_logit": -5.446749210357666,
            "end_logit": 0.9715943932533264,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "psychological disorders",
            "probability": 3.071277965953825e-06,
            "start_logit": -2.96789813041687,
            "end_logit": -2.8839142322540283,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "personality and psychological disorders",
            "probability": 1.6158537879347193e-06,
            "start_logit": -3.610128402709961,
            "end_logit": -2.8839142322540283,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "psychological",
            "probability": 1.4502578495160707e-06,
            "start_logit": -2.96789813041687,
            "end_logit": -3.6342666149139404,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "behavioral symptoms, personality and psychological disorders",
            "probability": 1.0843214355183694e-06,
            "start_logit": -4.009037494659424,
            "end_logit": -2.8839142322540283,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "personality and psychological",
            "probability": 7.630063659493057e-07,
            "start_logit": -3.610128402709961,
            "end_logit": -3.6342666149139404,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "personality",
            "probability": 7.049412780128781e-07,
            "start_logit": -3.610128402709961,
            "end_logit": -3.713418483734131,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "behavioral symptoms, personality and psychological",
            "probability": 5.120167209517537e-07,
            "start_logit": -4.009037494659424,
            "end_logit": -3.6342666149139404,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        }
    ],
    "5e7f5a18835f4e4777000013": [
        {
            "text": "influenza",
            "probability": 0.20468041223815953,
            "start_logit": -2.786602258682251,
            "end_logit": -3.971310615539551,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "microneedle patch vaccination against influenza",
            "probability": 0.09001921683946079,
            "start_logit": -3.6080288887023926,
            "end_logit": -3.971310615539551,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "vaccination against influenza",
            "probability": 0.07095095896798415,
            "start_logit": -3.8460631370544434,
            "end_logit": -3.971310615539551,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "Microneedle patches provide an alternative to conventional needle-and-syringe immunisation",
            "probability": 0.058914417928681274,
            "start_logit": -3.28662109375,
            "end_logit": -4.716655731201172,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "microneedle patch vaccination",
            "probability": 0.05686414219840188,
            "start_logit": -3.6080288887023926,
            "end_logit": -4.430668830871582,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "single, dissolvable microneedle patch vaccination against influenza",
            "probability": 0.053588499807975934,
            "start_logit": -4.126717567443848,
            "end_logit": -3.971310615539551,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "influenza.",
            "probability": 0.04983495871542065,
            "start_logit": -2.786602258682251,
            "end_logit": -5.3840436935424805,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "vaccination",
            "probability": 0.04481893490657249,
            "start_logit": -3.8460631370544434,
            "end_logit": -4.430668830871582,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "microneedle patch",
            "probability": 0.044620600271523564,
            "start_logit": -3.6080288887023926,
            "end_logit": -4.67313814163208,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "Microneedle patches provide an alternative to conventional needle-and-syringe immunisation,",
            "probability": 0.04215544279038824,
            "start_logit": -3.28662109375,
            "end_logit": -5.051377773284912,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "in",
            "probability": 0.04056132787252302,
            "start_logit": -2.786602258682251,
            "end_logit": -5.589945316314697,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "Microneedle patches",
            "probability": 0.03801456199906439,
            "start_logit": -3.28662109375,
            "end_logit": -5.1547722816467285,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "single, dissolvable microneedle patch vaccination",
            "probability": 0.03385126176685396,
            "start_logit": -4.126717567443848,
            "end_logit": -4.430668830871582,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "microneedle patch v",
            "probability": 0.03370207240977523,
            "start_logit": -3.6080288887023926,
            "end_logit": -4.953774452209473,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "v",
            "probability": 0.026563154408979373,
            "start_logit": -3.8460631370544434,
            "end_logit": -4.953774452209473,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "single, dissolvable microneedle patch",
            "probability": 0.02656267309397572,
            "start_logit": -4.126717567443848,
            "end_logit": -4.67313814163208,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "Micro",
            "probability": 0.024477870019026928,
            "start_logit": -3.28662109375,
            "end_logit": -5.594972133636475,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "microneedle patch vaccination against influenza.",
            "probability": 0.02191760269453211,
            "start_logit": -3.6080288887023926,
            "end_logit": -5.3840436935424805,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "single, dissolvable microneedle patch v",
            "probability": 0.02006286617756859,
            "start_logit": -4.126717567443848,
            "end_logit": -4.953774452209473,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "microneedle patch vaccination against in",
            "probability": 0.017839024893132327,
            "start_logit": -3.6080288887023926,
            "end_logit": -5.589945316314697,
            "question_text": "List the vaccine strains contained in Fluvirin."
        }
    ],
    "5e7f5b43835f4e4777000014": [
        {
            "text": "Yamagata",
            "probability": 0.5150508950722562,
            "start_logit": 3.2800240516662598,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Victoria and Yamagata",
            "probability": 0.40421690235182356,
            "start_logit": 3.037709951400757,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Victoria",
            "probability": 0.03926503095376906,
            "start_logit": 3.037709951400757,
            "end_logit": 0.9888072609901428,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.017704750776653864,
            "start_logit": -0.09040866047143936,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.009799335571727833,
            "start_logit": -0.6819270849227905,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Yamagata)",
            "probability": 0.0033970736971944003,
            "start_logit": 3.2800240516662598,
            "end_logit": -1.7009267807006836,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Victoria and Yamagata)",
            "probability": 0.0026660561511074317,
            "start_logit": 3.037709951400757,
            "end_logit": -1.7009267807006836,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "B-strain lineage viruses (Victoria",
            "probability": 0.0017198132567673038,
            "start_logit": -0.09040866047143936,
            "end_logit": 0.9888072609901428,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.0015736202273478265,
            "start_logit": -2.5108628273010254,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "both B-strain lineage viruses (Victoria",
            "probability": 0.0009518929374590211,
            "start_logit": -0.6819270849227905,
            "end_logit": 0.9888072609901428,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "viruses (Victoria and Yamagata",
            "probability": 0.0007674698064041154,
            "start_logit": -3.2288978099823,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "(Victoria and Yamagata",
            "probability": 0.0005003677388671634,
            "start_logit": -3.656653642654419,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "two A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.00042595867682221865,
            "start_logit": -3.817654609680176,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "B-strain lineage viruses",
            "probability": 0.00039529423356897295,
            "start_logit": -0.09040866047143936,
            "end_logit": -0.48153334856033325,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "V",
            "probability": 0.0003570791310990488,
            "start_logit": 3.037709951400757,
            "end_logit": -3.71132493019104,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "gata",
            "probability": 0.00030717365723002495,
            "start_logit": -4.144583702087402,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "viruses and both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.00025683365136291606,
            "start_logit": -4.323568344116211,
            "end_logit": 3.3204245567321777,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Yamagata).",
            "probability": 0.00023849165229631076,
            "start_logit": 3.2800240516662598,
            "end_logit": -4.357262134552002,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "both B-strain lineage viruses",
            "probability": 0.0002187899108650106,
            "start_logit": -0.6819270849227905,
            "end_logit": -0.48153334856033325,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Victoria and Yamagata).",
            "probability": 0.00018717054537777022,
            "start_logit": 3.037709951400757,
            "end_logit": -4.357262134552002,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        }
    ],
    "5e44baaa48dab47f2600001a": [
        {
            "text": "pan-ErbB inhibitor,",
            "probability": 0.2149099751864022,
            "start_logit": -1.527807354927063,
            "end_logit": -3.508397340774536,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "pan-ErbB",
            "probability": 0.1898885008891994,
            "start_logit": -1.527807354927063,
            "end_logit": -3.6321794986724854,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "pan-ErbB inhibitor",
            "probability": 0.14781262781092017,
            "start_logit": -1.527807354927063,
            "end_logit": -3.8826711177825928,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "pan-ErbB inhibitor, in patients with human epidermal growth factor receptor 2",
            "probability": 0.12494330903199592,
            "start_logit": -1.527807354927063,
            "end_logit": -4.050756454467773,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "pan",
            "probability": 0.06611732377348192,
            "start_logit": -1.527807354927063,
            "end_logit": -4.687185764312744,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "epidermal growth factor receptor 2",
            "probability": 0.04575688141342527,
            "start_logit": -2.532325267791748,
            "end_logit": -4.050756454467773,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "ErbB inhibitor,",
            "probability": 0.039679432158322585,
            "start_logit": -3.217193603515625,
            "end_logit": -3.508397340774536,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "ErbB",
            "probability": 0.03505964710173816,
            "start_logit": -3.217193603515625,
            "end_logit": -3.6321794986724854,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "ErbB inhibitor",
            "probability": 0.027291060511638324,
            "start_logit": -3.217193603515625,
            "end_logit": -3.8826711177825928,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "ErbB inhibitor, in patients with human epidermal growth factor receptor 2",
            "probability": 0.023068633971370437,
            "start_logit": -3.217193603515625,
            "end_logit": -4.050756454467773,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "pan-ErbB inhibitor, in patients with human epidermal growth factor receptor",
            "probability": 0.013688067222842822,
            "start_logit": -1.527807354927063,
            "end_logit": -6.262092113494873,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "pan-Er",
            "probability": 0.013159468178151841,
            "start_logit": -1.527807354927063,
            "end_logit": -6.3014750480651855,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "pan-ErbB inhibitor, in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.",
            "probability": 0.012336419561095569,
            "start_logit": -1.527807354927063,
            "end_logit": -6.366060733795166,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "irreversible pan-ErbB inhibitor,",
            "probability": 0.00852722448482263,
            "start_logit": -4.754762649536133,
            "end_logit": -3.508397340774536,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "irreversible pan-ErbB",
            "probability": 0.007534419343561008,
            "start_logit": -4.754762649536133,
            "end_logit": -3.6321794986724854,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "t",
            "probability": 0.0063103963073771864,
            "start_logit": -2.36163067817688,
            "end_logit": -6.202594757080078,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "tyrosine kinase inhibitors",
            "probability": 0.006177142132821173,
            "start_logit": -2.36163067817688,
            "end_logit": -6.223937511444092,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "an irreversible pan-ErbB inhibitor,",
            "probability": 0.005933755989904632,
            "start_logit": -5.117369174957275,
            "end_logit": -3.508397340774536,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "tyrosine kinase",
            "probability": 0.005929637761800838,
            "start_logit": -2.36163067817688,
            "end_logit": -6.264830112457275,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "tyrosine kinase inhibitors of HER2.",
            "probability": 0.005876077169127793,
            "start_logit": -2.36163067817688,
            "end_logit": -6.273903846740723,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        }
    ],
    "5e35c75d158f994d3a000001": [
        {
            "text": "homologous recombination-mediated transgenesis",
            "probability": 0.35577924793044874,
            "start_logit": 1.8320794105529785,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "homologous recombination",
            "probability": 0.29199592779650546,
            "start_logit": 1.8320794105529785,
            "end_logit": 0.48568275570869446,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "transgenesis",
            "probability": 0.05044319404907368,
            "start_logit": -0.12138320505619049,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR/Cas9 systems to induce targeted mutations and homologous recombination-mediated transgenesis",
            "probability": 0.03747742160359769,
            "start_logit": -0.4184923768043518,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Cas9 systems to induce targeted mutations and homologous recombination-mediated transgenesis",
            "probability": 0.031734881216915846,
            "start_logit": -0.5848146080970764,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR/Cas9 systems to induce targeted mutations and homologous recombination",
            "probability": 0.030758551984748143,
            "start_logit": -0.4184923768043518,
            "end_logit": 0.48568275570869446,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Cas9 systems to induce targeted mutations and homologous recombination",
            "probability": 0.02604552159336943,
            "start_logit": -0.5848146080970764,
            "end_logit": 0.48568275570869446,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR/Cas9 systems to induce targeted mutations",
            "probability": 0.01704793741638366,
            "start_logit": -0.4184923768043518,
            "end_logit": -0.1044560894370079,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "recombination-mediated transgenesis",
            "probability": 0.016121429548307354,
            "start_logit": -1.2620816230773926,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "homologous recombination-mediated transgenesis in the sea anemone Nematostella vectensis",
            "probability": 0.014554642062819506,
            "start_logit": 1.8320794105529785,
            "end_logit": -2.5131471157073975,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Cas9 systems to induce targeted mutations",
            "probability": 0.014435738792938078,
            "start_logit": -0.5848146080970764,
            "end_logit": -0.1044560894370079,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "targeted mutations and homologous recombination-mediated transgenesis",
            "probability": 0.014405316906153307,
            "start_logit": -1.3746336698532104,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "induce targeted mutations and homologous recombination-mediated transgenesis",
            "probability": 0.014256803994634472,
            "start_logit": -1.384996771812439,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "mutations and homologous recombination-mediated transgenesis",
            "probability": 0.013334879577034728,
            "start_logit": -1.4518479108810425,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "recombination",
            "probability": 0.013231215158688097,
            "start_logit": -1.2620816230773926,
            "end_logit": 0.48568275570869446,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "homologous recombination-mediated",
            "probability": 0.013204774397251567,
            "start_logit": 1.8320794105529785,
            "end_logit": -2.610478639602661,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "targeted mutations and homologous recombination",
            "probability": 0.01182276341209538,
            "start_logit": -1.3746336698532104,
            "end_logit": 0.48568275570869446,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "induce targeted mutations and homologous recombination",
            "probability": 0.011700875568324403,
            "start_logit": -1.384996771812439,
            "end_logit": 0.48568275570869446,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "mutations and homologous recombination",
            "probability": 0.010944231730210733,
            "start_logit": -1.4518479108810425,
            "end_logit": 0.48568275570869446,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "CRISPR/Cas9 systems to induce targeted mutations and homologous recombination-mediated transgenesis",
            "probability": 0.010704645260499631,
            "start_logit": -1.6715532541275024,
            "end_logit": 0.6832533478736877,
            "question_text": "List targeted genome editing methodologies"
        }
    ],
    "5e3e8b1c48dab47f26000008": [
        {
            "text": "destabilizing effect",
            "probability": 0.5056680109865817,
            "start_logit": 3.3772382736206055,
            "end_logit": 3.0593631267547607,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases its steady-state levels",
            "probability": 0.25107370681667224,
            "start_logit": 3.0836806297302246,
            "end_logit": 2.65278697013855,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "destabilizing",
            "probability": 0.13309687476686644,
            "start_logit": 3.3772382736206055,
            "end_logit": 1.724560022354126,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner",
            "probability": 0.046527789977161685,
            "start_logit": 3.0836806297302246,
            "end_logit": 0.9670901894569397,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases",
            "probability": 0.02633136303000293,
            "start_logit": 3.0836806297302246,
            "end_logit": 0.39780116081237793,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "elevated D14-3-3\u025b has a destabilizing effect",
            "probability": 0.012782203922876757,
            "start_logit": -0.3005881905555725,
            "end_logit": 3.0593631267547607,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases its steady-state levels ostensibly by occluding access to proteases",
            "probability": 0.007383996241274981,
            "start_logit": 3.0836806297302246,
            "end_logit": -0.8736445903778076,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "stabilizes the mutant protein, elevated D14-3-3\u025b has a destabilizing effect",
            "probability": 0.006091017300214528,
            "start_logit": -1.0418269634246826,
            "end_logit": 3.0593631267547607,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "elevated D14-3-3\u025b has a destabilizing",
            "probability": 0.003364403833749375,
            "start_logit": -0.3005881905555725,
            "end_logit": 1.724560022354126,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "stabilizes the mutant protein, elevated D14-3-3\u025b has a destabilizing",
            "probability": 0.0016032166346211338,
            "start_logit": -1.0418269634246826,
            "end_logit": 1.724560022354126,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "a destabilizing effect",
            "probability": 0.0012005035933704412,
            "start_logit": -2.665900945663452,
            "end_logit": 3.0593631267547607,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "destabilizing effect probably because of altered 14-3-3 dimer composition",
            "probability": 0.001017406215999294,
            "start_logit": 3.3772382736206055,
            "end_logit": -3.1492607593536377,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "levels",
            "probability": 0.0009468254072872856,
            "start_logit": -2.496706485748291,
            "end_logit": 2.65278697013855,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "recruitment of dimers on accumulating wild-type Tau increases its steady-state levels",
            "probability": 0.0008136572968040149,
            "start_logit": -1.987578272819519,
            "end_logit": 1.9920833110809326,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent",
            "probability": 0.0007580028197341322,
            "start_logit": 3.0836806297302246,
            "end_logit": -3.1500277519226074,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "occluding access to proteases in a phosphorylation-dependent manner",
            "probability": 0.00032441841505151197,
            "start_logit": -1.8820903301239014,
            "end_logit": 0.9670901894569397,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "a destabilizing",
            "probability": 0.0003159845451015464,
            "start_logit": -2.665900945663452,
            "end_logit": 1.724560022354126,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "phosphorylation-dependent manner",
            "probability": 0.00027408768444747364,
            "start_logit": -2.0506763458251953,
            "end_logit": 0.9670901894569397,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "elevation itself is not pathogenic, but recruitment of dimers on accumulating wild-type Tau increases its steady-state levels",
            "probability": 0.0002510693129440862,
            "start_logit": -3.16338849067688,
            "end_logit": 1.9920833110809326,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner",
            "probability": 0.00017546119923847822,
            "start_logit": -2.496706485748291,
            "end_logit": 0.9670901894569397,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        }
    ],
    "5e4b52e36d0a27794100001b": [
        {
            "text": "trifluridine/tipiracil",
            "probability": 0.4305758974335096,
            "start_logit": 6.347067356109619,
            "end_logit": 6.13038969039917,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine",
            "probability": 0.31517862663717483,
            "start_logit": 6.347067356109619,
            "end_logit": 5.818405628204346,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiracil",
            "probability": 0.2498837145513433,
            "start_logit": 5.802939414978027,
            "end_logit": 6.13038969039917,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102",
            "probability": 0.0011229935493759443,
            "start_logit": 6.347067356109619,
            "end_logit": 0.1812640130519867,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiracil (TAS-102",
            "probability": 0.0006517266786364694,
            "start_logit": 5.802939414978027,
            "end_logit": 0.1812640130519867,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "triflurid",
            "probability": 0.00038679997204934895,
            "start_logit": 6.347067356109619,
            "end_logit": -0.8845815062522888,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine/tipiraci",
            "probability": 0.0003492061862570509,
            "start_logit": 6.347067356109619,
            "end_logit": -0.9868266582489014,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 0.00020440076878595559,
            "start_logit": 6.347067356109619,
            "end_logit": -1.5224065780639648,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiraci",
            "probability": 0.0002026609930707864,
            "start_logit": 5.802939414978027,
            "end_logit": -0.9868266582489014,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "luridine/tipiracil",
            "probability": 0.0002025415133703838,
            "start_logit": -1.3148666620254517,
            "end_logit": 6.13038969039917,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102, Lonsurf\u00ae)",
            "probability": 0.00020046460089748384,
            "start_logit": 6.347067356109619,
            "end_logit": -1.54185152053833,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "luridine",
            "probability": 0.0001482590093909062,
            "start_logit": -1.3148666620254517,
            "end_logit": 5.818405628204346,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "/tipiracil",
            "probability": 0.0001290051887782166,
            "start_logit": -1.7659589052200317,
            "end_logit": 6.13038969039917,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "cil",
            "probability": 0.00012592489842455634,
            "start_logit": -1.790125846862793,
            "end_logit": 6.13038969039917,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "t",
            "probability": 0.0001225780197803438,
            "start_logit": 6.347067356109619,
            "end_logit": -2.0337414741516113,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 0.00011862350787824154,
            "start_logit": 5.802939414978027,
            "end_logit": -1.5224065780639648,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiracil (TAS-102, Lonsurf\u00ae)",
            "probability": 0.00011633916205458587,
            "start_logit": 5.802939414978027,
            "end_logit": -1.54185152053833,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "fluridine/tipiracil",
            "probability": 0.00011540138766334767,
            "start_logit": -1.8773951530456543,
            "end_logit": 6.13038969039917,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "fluridine",
            "probability": 8.447303040545779e-05,
            "start_logit": -1.8773951530456543,
            "end_logit": 5.818405628204346,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "ridine/tipiracil",
            "probability": 8.036291115308914e-05,
            "start_logit": -2.2392587661743164,
            "end_logit": 6.13038969039917,
            "question_text": "Which drugs are included in the drug LONSURF?"
        }
    ],
    "5d38673da1e1595105000002": [
        {
            "text": "miR-144",
            "probability": 0.6512165774040389,
            "start_logit": 2.747490406036377,
            "end_logit": 3.8110287189483643,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-144 expression, which partially contributed to the suppression of COX-2 in mGCs. Both CP2 and miR-144",
            "probability": 0.11287959389269632,
            "start_logit": 2.3571276664733887,
            "end_logit": 2.448870897293091,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "144",
            "probability": 0.10834823420420178,
            "start_logit": 0.9539985656738281,
            "end_logit": 3.8110287189483643,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-144 in ovulation. miR-144",
            "probability": 0.057865147279584674,
            "start_logit": 1.8085405826568604,
            "end_logit": 2.329251527786255,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "144 alter prostaglandin E2 (PGE2) production by regulating COX-2 expression. In addition, miR-144",
            "probability": 0.02658048996293998,
            "start_logit": 0.7531164884567261,
            "end_logit": 2.6067378520965576,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "144 expression, which partially contributed to the suppression of COX-2 in mGCs. Both CP2 and miR-144",
            "probability": 0.02077589338707851,
            "start_logit": 0.6645992994308472,
            "end_logit": 2.448870897293091,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "144 in ovulation. miR-144",
            "probability": 0.019011830776783804,
            "start_logit": 0.6954867839813232,
            "end_logit": 2.329251527786255,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "CP2 upregulated miR-144",
            "probability": 0.0020349881604959084,
            "start_logit": -2.119676113128662,
            "end_logit": 2.9098429679870605,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-144 in ovulation.",
            "probability": 0.00033129040924382864,
            "start_logit": 1.8085405826568604,
            "end_logit": -2.8336236476898193,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "overexpression of miR-144",
            "probability": 0.00014423976481670885,
            "start_logit": -4.783083915710449,
            "end_logit": 2.9264824390411377,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-144 was one of the differentially expressed microRNAs,",
            "probability": 0.0001247040570559702,
            "start_logit": 2.142979383468628,
            "end_logit": -4.145114421844482,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "144 in ovulation.",
            "probability": 0.00010884681876092394,
            "start_logit": 0.6954867839813232,
            "end_logit": -2.8336236476898193,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-144 expression,",
            "probability": 9.99845735716322e-05,
            "start_logit": 2.3571276664733887,
            "end_logit": -4.580190181732178,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "mi",
            "probability": 9.649319309988396e-05,
            "start_logit": 2.747490406036377,
            "end_logit": -5.006096363067627,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "CP2 and miR-144",
            "probability": 8.961873350650862e-05,
            "start_logit": -4.7813849449157715,
            "end_logit": 2.448870897293091,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-144 in ovulation. miR-144 was one of the differentially expressed microRNAs,",
            "probability": 8.925563767356727e-05,
            "start_logit": 1.8085405826568604,
            "end_logit": -4.145114421844482,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-144/COX-2/PGE2/ovulation pathway in mGCs.",
            "probability": 8.101686072540447e-05,
            "start_logit": 2.747490406036377,
            "end_logit": -5.180911540985107,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-144 in ovulation. mi",
            "probability": 6.284765406454332e-05,
            "start_logit": 1.8085405826568604,
            "end_logit": -4.49590539932251,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "Smad4",
            "probability": 2.9621924894907914e-05,
            "start_logit": -1.196606993675232,
            "end_logit": -2.2429566383361816,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "144 in ovulation. miR-144 was one of the differentially expressed microRNAs,",
            "probability": 2.932530476635417e-05,
            "start_logit": 0.6954867839813232,
            "end_logit": -4.145114421844482,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        }
    ],
    "5e5e50751af46fc13000000b": [
        {
            "text": "antibiotics",
            "probability": 0.9617454533729433,
            "start_logit": 4.364319801330566,
            "end_logit": 3.767930030822754,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "antibacterials",
            "probability": 0.030027886740121565,
            "start_logit": 2.2601256370544434,
            "end_logit": 2.405500888824463,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "anti",
            "probability": 0.0044056673897781675,
            "start_logit": 4.364319801330566,
            "end_logit": -1.6179280281066895,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "antibacterial",
            "probability": 0.0023144844624752576,
            "start_logit": 2.2601256370544434,
            "end_logit": -0.15743865072727203,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "antibiotics.",
            "probability": 0.0007809099611420259,
            "start_logit": 4.364319801330566,
            "end_logit": -3.3481152057647705,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "biotics",
            "probability": 0.0004422564679175037,
            "start_logit": -3.3202953338623047,
            "end_logit": 3.767930030822754,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "classes of antibiotics",
            "probability": 0.0001101020356070788,
            "start_logit": -4.710777759552002,
            "end_logit": 3.767930030822754,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "other classes of antibiotics",
            "probability": 6.407090818142372e-05,
            "start_logit": -5.252194881439209,
            "end_logit": 3.767930030822754,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "s",
            "probability": 5.091663610937132e-05,
            "start_logit": -4.119566440582275,
            "end_logit": 2.405500888824463,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "retapamulin from that of other classes of antibiotics",
            "probability": 2.050657111788161e-05,
            "start_logit": -6.391439914703369,
            "end_logit": 3.767930030822754,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "ials",
            "probability": 1.4588764797759946e-05,
            "start_logit": -5.369504451751709,
            "end_logit": 2.405500888824463,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "antibacterials in current use.",
            "probability": 1.1441421365402295e-05,
            "start_logit": 2.2601256370544434,
            "end_logit": -5.4671406745910645,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "bacterials",
            "probability": 8.491610845756837e-06,
            "start_logit": -5.910677433013916,
            "end_logit": 2.405500888824463,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "ial",
            "probability": 1.124470387921301e-06,
            "start_logit": -5.369504451751709,
            "end_logit": -0.15743865072727203,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "bacterial",
            "probability": 6.545149691679908e-07,
            "start_logit": -5.910677433013916,
            "end_logit": -0.15743865072727203,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "classes of anti",
            "probability": 5.043672898281967e-07,
            "start_logit": -4.710777759552002,
            "end_logit": -1.6179280281066895,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "biotics.",
            "probability": 3.590996764944868e-07,
            "start_logit": -3.3202953338623047,
            "end_logit": -3.3481152057647705,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "other classes of anti",
            "probability": 2.9350293242188035e-07,
            "start_logit": -5.252194881439209,
            "end_logit": -1.6179280281066895,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "pleuromutilin",
            "probability": 1.9376362687206098e-07,
            "start_logit": -4.09480094909668,
            "end_logit": -3.190570592880249,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "retapamulin from that of other classes of anti",
            "probability": 9.393871458749078e-08,
            "start_logit": -6.391439914703369,
            "end_logit": -1.6179280281066895,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        }
    ],
    "5e47546d3f54159529000019": [
        {
            "text": "ulcerative colitis",
            "probability": 0.544308697474197,
            "start_logit": 5.3294148445129395,
            "end_logit": 5.11401891708374,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Ulcerative Colitis",
            "probability": 0.2884407270696682,
            "start_logit": 4.9931817054748535,
            "end_logit": 4.815225124359131,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Ulcerative Colitis Endoscopic Index of Severity, Ulcerative Colitis",
            "probability": 0.1607270346544975,
            "start_logit": 4.9931817054748535,
            "end_logit": 4.230443000793457,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's disease",
            "probability": 0.0021725133722242224,
            "start_logit": 2.2187042236328125,
            "end_logit": 2.7010977268218994,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's disease, such as the Crohn's Disease",
            "probability": 0.0009894731001414737,
            "start_logit": 2.2187042236328125,
            "end_logit": 1.9146302938461304,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis",
            "probability": 0.0006993153368521682,
            "start_logit": -1.3277552127838135,
            "end_logit": 5.11401891708374,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative",
            "probability": 0.0005727866042704811,
            "start_logit": 5.3294148445129395,
            "end_logit": -1.7427396774291992,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's Disease",
            "probability": 0.0005685534406767867,
            "start_logit": 1.664626955986023,
            "end_logit": 1.9146302938461304,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's Disease Endoscopic Index of Severity, Simple Endoscopic Score for Crohn's Disease",
            "probability": 0.0003263486797999729,
            "start_logit": 1.664626955986023,
            "end_logit": 1.3595013618469238,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Colitis",
            "probability": 0.00024265676809900107,
            "start_logit": -2.0874152183532715,
            "end_logit": 4.815225124359131,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Ulcerative",
            "probability": 0.00018035755394897168,
            "start_logit": 4.9931817054748535,
            "end_logit": -2.5620784759521484,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Colitis Endoscopic Index of Severity, Ulcerative Colitis",
            "probability": 0.0001352149648616588,
            "start_logit": -2.0874152183532715,
            "end_logit": 4.230443000793457,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative co",
            "probability": 0.00011027809623713178,
            "start_logit": 5.3294148445129395,
            "end_logit": -3.3902475833892822,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Ulcerative Colitis Endoscopic Index of Severity, Ulcerative",
            "probability": 0.00010833862466384163,
            "start_logit": 4.9931817054748535,
            "end_logit": -3.0717580318450928,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Inflammatory bowel disease",
            "probability": 0.00010590825786159003,
            "start_logit": 1.07804274559021,
            "end_logit": 0.8206924200057983,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ul",
            "probability": 7.515165096258975e-05,
            "start_logit": 5.3294148445129395,
            "end_logit": -3.773744821548462,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "is",
            "probability": 6.918182710855875e-05,
            "start_logit": -3.6411187648773193,
            "end_logit": 5.11401891708374,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's",
            "probability": 5.879714453309396e-05,
            "start_logit": 2.2187042236328125,
            "end_logit": -0.9084489941596985,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Ul",
            "probability": 5.712181266882159e-05,
            "start_logit": 4.9931817054748535,
            "end_logit": -3.7118337154388428,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Modified Baron Index, Endoscopic Activity Index, Ulcerative Colitis",
            "probability": 5.1543566726990184e-05,
            "start_logit": -3.6366357803344727,
            "end_logit": 4.815225124359131,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        }
    ],
    "5e80669e835f4e4777000025": [
        {
            "text": "captopril",
            "probability": 0.9975284968625522,
            "start_logit": 5.2196455001831055,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captop",
            "probability": 0.0006785975650746069,
            "start_logit": 5.2196455001831055,
            "end_logit": -1.9274896383285522,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ril",
            "probability": 0.0003702528058879055,
            "start_logit": -2.6792044639587402,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "inhibitor captopril",
            "probability": 0.0002791807253361746,
            "start_logit": -2.961531162261963,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "cap",
            "probability": 0.00018825385234891455,
            "start_logit": 5.2196455001831055,
            "end_logit": -3.209726572036743,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "NRG Oncology Radiation Therapy Oncology Group 0123 was to test the ability of the angiotensin-converting enzyme inhibitor captopril",
            "probability": 0.00017426171081932326,
            "start_logit": -3.4328322410583496,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captopril to alter the incidence of pulmonary damage after radiation therapy for lung cancer",
            "probability": 0.0001291617401186963,
            "start_logit": 5.2196455001831055,
            "end_logit": -3.5864524841308594,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitor captopril",
            "probability": 0.00010742717286499784,
            "start_logit": -3.9165773391723633,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captopril to alter the incidence of pulmonary damage after radiation therapy for lung cancer;",
            "probability": 9.419117579519392e-05,
            "start_logit": 5.2196455001831055,
            "end_logit": -3.902191400527954,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "Radiation Therapy Oncology Group 0123 was to test the ability of the angiotensin-converting enzyme inhibitor captopril",
            "probability": 8.488270667619925e-05,
            "start_logit": -4.152120113372803,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captopril to alter the incidence of pulmonary damage after radiation therapy",
            "probability": 6.918057504665024e-05,
            "start_logit": 5.2196455001831055,
            "end_logit": -4.2107977867126465,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "the angiotensin-converting enzyme inhibitor captopril",
            "probability": 5.349063133159921e-05,
            "start_logit": -4.613883972167969,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "topril",
            "probability": 4.713889343138033e-05,
            "start_logit": -4.740292072296143,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "test the ability of the angiotensin-converting enzyme inhibitor captopril",
            "probability": 4.4564453862224214e-05,
            "start_logit": -4.796453952789307,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "0123 was to test the ability of the angiotensin-converting enzyme inhibitor captopril",
            "probability": 3.4777719199701674e-05,
            "start_logit": -5.0444135665893555,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "enzyme inhibitor captopril",
            "probability": 2.5169433803795693e-05,
            "start_logit": -5.367760181427002,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captopril to alter the incidence of pulmonary damage",
            "probability": 2.4977219838789237e-05,
            "start_logit": 5.2196455001831055,
            "end_logit": -5.229553699493408,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "Group 0123 was to test the ability of the angiotensin-converting enzyme inhibitor captopril",
            "probability": 2.4564564653152235e-05,
            "start_logit": -5.392085552215576,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "converting enzyme inhibitor captopril",
            "probability": 2.2819696977586752e-05,
            "start_logit": -5.465766429901123,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "to test the ability of the angiotensin-converting enzyme inhibitor captopril",
            "probability": 1.8610494381446557e-05,
            "start_logit": -5.6696648597717285,
            "end_logit": 5.365518093109131,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        }
    ],
    "5e4609b83f54159529000005": [
        {
            "text": "proliferative vitreoretinopathy",
            "probability": 0.4680177662884798,
            "start_logit": 3.89928936958313,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "vitreoretinopathy",
            "probability": 0.29065073788000967,
            "start_logit": 3.422905445098877,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "proliferative vitreoretinopathy of the left eye",
            "probability": 0.07605427402188368,
            "start_logit": 3.89928936958313,
            "end_logit": 1.9684691429138184,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "severe proliferative vitreoretinopathy",
            "probability": 0.0610860739948854,
            "start_logit": 1.8630670309066772,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "vitreoretinopathy of the left eye",
            "probability": 0.047231606267193665,
            "start_logit": 3.422905445098877,
            "end_logit": 1.9684691429138184,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "ophthalmological symptomatology of severe proliferative vitreoretinopathy",
            "probability": 0.029994046848774738,
            "start_logit": 1.1517820358276367,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "severe proliferative vitreoretinopathy of the left eye",
            "probability": 0.00992666805658064,
            "start_logit": 1.8630670309066772,
            "end_logit": 1.9684691429138184,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "ophthalmological symptomatology of severe proliferative vitreoretinopathy of the left eye",
            "probability": 0.004874121502165037,
            "start_logit": 1.1517820358276367,
            "end_logit": 1.9684691429138184,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "proliferative",
            "probability": 0.0032187047346859884,
            "start_logit": 3.89928936958313,
            "end_logit": -1.1939990520477295,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "proliferative vitreoretinopathy of the left eye (LE)",
            "probability": 0.0015831195347407244,
            "start_logit": 3.89928936958313,
            "end_logit": -1.9035807847976685,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "initial ophthalmological symptomatology of severe proliferative vitreoretinopathy",
            "probability": 0.0015429596805217858,
            "start_logit": -1.8155144453048706,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "tinopathy",
            "probability": 0.0011317475457578597,
            "start_logit": -2.1254539489746094,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "vitreoretinopathy of the left eye (LE)",
            "probability": 0.0009831568245232559,
            "start_logit": 3.422905445098877,
            "end_logit": -1.9035807847976685,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "symptomatology of severe proliferative vitreoretinopathy",
            "probability": 0.0009316604449147974,
            "start_logit": -2.3200037479400635,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "left eye",
            "probability": 0.0006196766347420655,
            "start_logit": -0.9107153415679932,
            "end_logit": 1.9684691429138184,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "proliferative v",
            "probability": 0.0005269029667120993,
            "start_logit": 3.89928936958313,
            "end_logit": -3.0037169456481934,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "oretinopathy",
            "probability": 0.00047349731084413653,
            "start_logit": -2.996825933456421,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "severe proliferative",
            "probability": 0.0004201080594652545,
            "start_logit": 1.8630670309066772,
            "end_logit": -1.1939990520477295,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "pathy",
            "probability": 0.0003960650974960481,
            "start_logit": -3.175393581390381,
            "end_logit": 3.7855281829833984,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "proliferative vitreoretinopathy of the left eye (LE).",
            "probability": 0.0003371063056234734,
            "start_logit": 3.89928936958313,
            "end_logit": -3.4503350257873535,
            "question_text": "List characteristic features of the Revesz syndrome."
        }
    ],
    "5d387360a1e1595105000007": [
        {
            "text": "ameliorated EAE and lupus-like disease in murine models. Inhibition of CaMK4 reduced Il17 transcription",
            "probability": 0.1980816798814306,
            "start_logit": 4.810204982757568,
            "end_logit": 4.5335164070129395,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "ameliorated EAE and lupus-like disease",
            "probability": 0.16600540749134898,
            "start_logit": 4.810204982757568,
            "end_logit": 4.3568572998046875,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "decreased the frequency of IL-17-producing T cells and ameliorated EAE and lupus-like disease",
            "probability": 0.11606620389793443,
            "start_logit": 4.452345371246338,
            "end_logit": 4.3568572998046875,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced Il17 transcription",
            "probability": 0.10371292080398664,
            "start_logit": 4.16315221786499,
            "end_logit": 4.5335164070129395,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced activation of the AKT/mTOR pathway, which is known to enhance Th17 differentiation",
            "probability": 0.09638289305595833,
            "start_logit": 4.226099491119385,
            "end_logit": 4.397271156311035,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "ameliorated EAE and lupus-like disease in murine models",
            "probability": 0.06839344973683169,
            "start_logit": 4.810204982757568,
            "end_logit": 3.47011399269104,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "decreased the frequency of IL-17-producing T cells and ameliorated EAE and lupus-like disease in murine models",
            "probability": 0.04781873194613805,
            "start_logit": 4.452345371246338,
            "end_logit": 3.47011399269104,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "enhance Th17 differentiation",
            "probability": 0.04507976171066327,
            "start_logit": 3.4662041664123535,
            "end_logit": 4.397271156311035,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "decreased the frequency of IL-17-producing T cells",
            "probability": 0.029888646405775585,
            "start_logit": 4.452345371246338,
            "end_logit": 3.0001752376556396,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced activation of the AKT/mTOR pathway",
            "probability": 0.023675516522872486,
            "start_logit": 4.226099491119385,
            "end_logit": 2.9933838844299316,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "lupus-like disease in murine models. Inhibition of CaMK4 reduced Il17 transcription",
            "probability": 0.019903453004140842,
            "start_logit": 2.512418746948242,
            "end_logit": 4.5335164070129395,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "lupus-like disease",
            "probability": 0.016680395826686747,
            "start_logit": 2.512418746948242,
            "end_logit": 4.3568572998046875,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced activation of the AKT",
            "probability": 0.012756654304310685,
            "start_logit": 4.226099491119385,
            "end_logit": 2.374995470046997,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced Il17 transcription through decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1) and reduced activation of the AKT",
            "probability": 0.011978408871007854,
            "start_logit": 4.16315221786499,
            "end_logit": 2.374995470046997,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1) and reduced activation of the AKT/mTOR pathway",
            "probability": 0.0104091113803837,
            "start_logit": 3.404339551925659,
            "end_logit": 2.9933838844299316,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibited Th17 differentiation",
            "probability": 0.008294115897990938,
            "start_logit": 2.455291748046875,
            "end_logit": 3.715296506881714,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduction of IL17A and IL17F mRNA",
            "probability": 0.007193410384736357,
            "start_logit": 3.8325014114379883,
            "end_logit": 2.1957058906555176,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "lupus-like disease in murine models",
            "probability": 0.006872244891314211,
            "start_logit": 2.512418746948242,
            "end_logit": 3.47011399269104,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1) and reduced activation of the AKT",
            "probability": 0.005608554954496536,
            "start_logit": 3.404339551925659,
            "end_logit": 2.374995470046997,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "ameliorated EAE and lupus-like disease in murine models. Inhibition of CaMK4 reduced",
            "probability": 0.0051984390319915795,
            "start_logit": 4.810204982757568,
            "end_logit": 0.8931953310966492,
            "question_text": "What are the effects of CAMK4 inhibition?"
        }
    ],
    "5e4949d36d0a277941000006": [
        {
            "text": "Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome",
            "probability": 0.6065738818410222,
            "start_logit": 2.0802416801452637,
            "end_logit": 1.8325397968292236,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Intestinal Dysrhythmia (CAID) syndrome",
            "probability": 0.18312482037202915,
            "start_logit": 0.8825831413269043,
            "end_logit": 1.8325397968292236,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Chronic Atrial and Intestinal Dysrhythmia",
            "probability": 0.1110599083310255,
            "start_logit": 2.0802416801452637,
            "end_logit": 0.13478302955627441,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Intestinal Dysrhythmia",
            "probability": 0.03352901661694599,
            "start_logit": 0.8825831413269043,
            "end_logit": 0.13478302955627441,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "(CAID) syndrome",
            "probability": 0.01820967807661799,
            "start_logit": -1.4256316423416138,
            "end_logit": 1.8325397968292236,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Chronic Atrial and Intestinal Dysrhythmia (CAID",
            "probability": 0.008136119546691937,
            "start_logit": 2.0802416801452637,
            "end_logit": -2.478973388671875,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Atrial and Intestinal Dysrhythmia (CAID) syndrome",
            "probability": 0.0081016391227131,
            "start_logit": -2.235518455505371,
            "end_logit": 1.8325397968292236,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Chronic Atrial and Intestinal Dysrhythmia (CAID)",
            "probability": 0.006371995032817115,
            "start_logit": 2.0802416801452637,
            "end_logit": -2.723374128341675,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome.",
            "probability": 0.005989344394166642,
            "start_logit": 2.0802416801452637,
            "end_logit": -2.7853047847747803,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "syndrome",
            "probability": 0.0031477340768281425,
            "start_logit": -3.1809020042419434,
            "end_logit": 1.8325397968292236,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Intestinal Dysrhythmia (CAID",
            "probability": 0.0024562967102889745,
            "start_logit": 0.8825831413269043,
            "end_logit": -2.478973388671875,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "CAID) syndrome",
            "probability": 0.0020625957905265244,
            "start_logit": -3.6036195755004883,
            "end_logit": 1.8325397968292236,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Intestinal Dysrhythmia (CAID)",
            "probability": 0.0019237070383817197,
            "start_logit": 0.8825831413269043,
            "end_logit": -2.723374128341675,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Intestinal Dysrhythmia (CAID) syndrome.",
            "probability": 0.0018081847062044242,
            "start_logit": 0.8825831413269043,
            "end_logit": -2.7853047847747803,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Atrial and Intestinal Dysrhythmia",
            "probability": 0.0014833597773261655,
            "start_logit": -2.235518455505371,
            "end_logit": 0.13478302955627441,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Chronic Atrial",
            "probability": 0.0014762439206831835,
            "start_logit": 2.0802416801452637,
            "end_logit": -4.18578577041626,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Dysrhythmia (CAID) syndrome",
            "probability": 0.0013534904920377304,
            "start_logit": -4.024898052215576,
            "end_logit": 1.8325397968292236,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Chronic",
            "probability": 0.001351392973186639,
            "start_logit": 2.0802416801452637,
            "end_logit": -4.274150848388672,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome. These",
            "probability": 0.0010965848096809298,
            "start_logit": 2.0802416801452637,
            "end_logit": -4.483086109161377,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "disorder termed Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome",
            "probability": 0.0007440063708260329,
            "start_logit": -4.623290538787842,
            "end_logit": 1.8325397968292236,
            "question_text": "List cohesinopathies"
        }
    ],
    "5e3c841148dab47f26000002": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.8831713955185428,
            "start_logit": 4.2996392250061035,
            "end_logit": 4.5843377113342285,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease (AD) is the most common cause of progressive dementia",
            "probability": 0.05910975849186308,
            "start_logit": 4.2996392250061035,
            "end_logit": 1.8802144527435303,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease (AD)",
            "probability": 0.027201419719642336,
            "start_logit": 4.2996392250061035,
            "end_logit": 1.1040875911712646,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "dementia",
            "probability": 0.014543946024432035,
            "start_logit": 2.8974180221557617,
            "end_logit": 1.8802144527435303,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's",
            "probability": 0.008722801546221154,
            "start_logit": 4.2996392250061035,
            "end_logit": -0.033241111785173416,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "heimer's disease",
            "probability": 0.0027047111877757306,
            "start_logit": -1.4888849258422852,
            "end_logit": 4.5843377113342285,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "disease",
            "probability": 0.0017009460116751997,
            "start_logit": -1.9526954889297485,
            "end_logit": 4.5843377113342285,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer",
            "probability": 0.0005204811914005518,
            "start_logit": 4.2996392250061035,
            "end_logit": -2.8521831035614014,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease (AD) is the most common cause of progressive dem",
            "probability": 0.0005106476329256976,
            "start_logit": 4.2996392250061035,
            "end_logit": -2.8712570667266846,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease (AD) is the most common cause of progressive dementia in the elderly",
            "probability": 0.00034452193638818,
            "start_logit": 4.2996392250061035,
            "end_logit": -3.2647790908813477,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease (AD",
            "probability": 0.00025424631402455795,
            "start_logit": 4.2996392250061035,
            "end_logit": -3.5686333179473877,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Al",
            "probability": 0.0002493066327489967,
            "start_logit": 4.2996392250061035,
            "end_logit": -3.5882532596588135,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "heimer's disease (AD) is the most common cause of progressive dementia",
            "probability": 0.00018102355433035188,
            "start_logit": -1.4888849258422852,
            "end_logit": 1.8802144527435303,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease (",
            "probability": 0.00015419829481207005,
            "start_logit": 4.2996392250061035,
            "end_logit": -4.068697452545166,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "neurofibrillary tangles",
            "probability": 0.00014540669335983146,
            "start_logit": 0.20590457320213318,
            "end_logit": -0.03366760537028313,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "dem",
            "probability": 0.0001256447632381663,
            "start_logit": 2.8974180221557617,
            "end_logit": -2.8712570667266846,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "disease (AD) is the most common cause of progressive dementia",
            "probability": 0.00011384257740683114,
            "start_logit": -1.9526954889297485,
            "end_logit": 1.8802144527435303,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "dementia in the elderly",
            "probability": 8.476956385724802e-05,
            "start_logit": 2.8974180221557617,
            "end_logit": -3.2647790908813477,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "heimer's disease (AD)",
            "probability": 8.330431059296611e-05,
            "start_logit": -1.4888849258422852,
            "end_logit": 1.1040875911712646,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease (AD) is the most common cause of progressive dement",
            "probability": 7.76280347620833e-05,
            "start_logit": 4.2996392250061035,
            "end_logit": -4.755008220672607,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        }
    ],
    "5e4703d13f54159529000016": [
        {
            "text": "Melanin",
            "probability": 0.9834541359782489,
            "start_logit": 4.086109161376953,
            "end_logit": 3.8618812561035156,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Melanin,",
            "probability": 0.007543701774009503,
            "start_logit": 4.086109161376953,
            "end_logit": -1.008476734161377,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Melanin, a naturally occurring, ubiquitous pigment,",
            "probability": 0.0034946467853845527,
            "start_logit": 4.086109161376953,
            "end_logit": -1.7779574394226074,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Melanin, a naturally occurring, ubiquitous pigment, has been shown to confer radioresistance",
            "probability": 0.0016783845014145073,
            "start_logit": 4.086109161376953,
            "end_logit": -2.5113580226898193,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "melanin",
            "probability": 0.0008729726314160292,
            "start_logit": 0.5775526165962219,
            "end_logit": 0.3435157239437103,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Melanin, a naturally occurring, ubiquitous pigment",
            "probability": 0.0008526820084974915,
            "start_logit": 4.086109161376953,
            "end_logit": -3.188558340072632,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Melanin, a naturally occurring, ubiquitous pigment, has been shown to confer radioresistance,",
            "probability": 0.0007732431739678583,
            "start_logit": 4.086109161376953,
            "end_logit": -3.286351442337036,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Melani",
            "probability": 0.0003022621585938572,
            "start_logit": 4.086109161376953,
            "end_logit": -4.225650310516357,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Me",
            "probability": 0.0002539553727699387,
            "start_logit": 4.086109161376953,
            "end_logit": -4.399786472320557,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "n",
            "probability": 0.00023016547164420224,
            "start_logit": -4.273918628692627,
            "end_logit": 3.8618812561035156,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "lanin",
            "probability": 0.00020012824101574633,
            "start_logit": -4.413758754730225,
            "end_logit": 3.8618812561035156,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Melanin, a naturally occurring, ubiquitous pigment, has been shown to confer radioresistance, acting as a potential",
            "probability": 0.00018646630791236614,
            "start_logit": 4.086109161376953,
            "end_logit": -4.7086944580078125,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Melanin, a naturally occurring, ubiquitous pigment, has been shown to confer radioresistance, acting",
            "probability": 0.00014218826003036168,
            "start_logit": 4.086109161376953,
            "end_logit": -4.979793071746826,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "melanin in CN cells subjected to high RBE and high LET ionizing radiation",
            "probability": 4.868463282762141e-06,
            "start_logit": 0.5775526165962219,
            "end_logit": -4.84561014175415,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "investigation provides the first direct evidence of the radioprotective properties of melanin",
            "probability": 2.4195949510780987e-06,
            "start_logit": -5.310751438140869,
            "end_logit": 0.3435157239437103,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "morphological investigation provides the first direct evidence of the radioprotective properties of melanin",
            "probability": 1.926105960260356e-06,
            "start_logit": -5.538851261138916,
            "end_logit": 0.3435157239437103,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "n,",
            "probability": 1.7655115914795484e-06,
            "start_logit": -4.273918628692627,
            "end_logit": -1.008476734161377,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "This morphological investigation provides the first direct evidence of the radioprotective properties of melanin",
            "probability": 1.7146897656935147e-06,
            "start_logit": -5.6551194190979,
            "end_logit": 0.3435157239437103,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "lanin,",
            "probability": 1.535107445837492e-06,
            "start_logit": -4.413758754730225,
            "end_logit": -1.008476734161377,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "pigment,",
            "probability": 8.378620981487415e-07,
            "start_logit": -4.249780178070068,
            "end_logit": -1.7779574394226074,
            "question_text": "List radioprotection agents."
        }
    ],
    "5e52900d6d0a277941000041": [
        {
            "text": "PAR2",
            "probability": 0.6118697664545982,
            "start_logit": 2.7397751808166504,
            "end_logit": 1.8864786624908447,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Vav3. A point mutation in PAR2",
            "probability": 0.10785566929287353,
            "start_logit": 1.0040496587753296,
            "end_logit": 1.8864786624908447,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR",
            "probability": 0.07980658622725428,
            "start_logit": 2.7397751808166504,
            "end_logit": -0.15043476223945618,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Akt/PKB as also Etk/Bmx and Vav3. A point mutation in PAR2",
            "probability": 0.05479868782083159,
            "start_logit": 0.3269219696521759,
            "end_logit": 1.8864786624908447,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Etk/Bmx and Vav3. A point mutation in PAR2",
            "probability": 0.024500104619076854,
            "start_logit": -0.47806689143180847,
            "end_logit": 1.8864786624908447,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR2, H349A,",
            "probability": 0.021802790849470115,
            "start_logit": 2.7397751808166504,
            "end_logit": -1.448002815246582,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Vav3. A point mutation in PAR",
            "probability": 0.01406768767379297,
            "start_logit": 1.0040496587753296,
            "end_logit": -0.15043476223945618,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Bmx and Vav3. A point mutation in PAR2",
            "probability": 0.01382240374385653,
            "start_logit": -1.050453543663025,
            "end_logit": 1.8864786624908447,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR2, H349A, but not R352A,",
            "probability": 0.013037563256529702,
            "start_logit": 2.7397751808166504,
            "end_logit": -1.9622061252593994,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Vav3",
            "probability": 0.012414137311008485,
            "start_logit": 1.0040496587753296,
            "end_logit": -0.27547934651374817,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Akt/PKB as also Etk/Bmx and Vav3. A point mutation in PAR",
            "probability": 0.007147429803655925,
            "start_logit": 0.3269219696521759,
            "end_logit": -0.15043476223945618,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR2,",
            "probability": 0.00672936700896674,
            "start_logit": 2.7397751808166504,
            "end_logit": -2.6235597133636475,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Akt/PKB as also Etk/Bmx and Vav3",
            "probability": 0.0063073034503513155,
            "start_logit": 0.3269219696521759,
            "end_logit": -0.27547934651374817,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PKB as also Etk/Bmx and Vav3. A point mutation in PAR2",
            "probability": 0.005673992800863233,
            "start_logit": -1.9408512115478516,
            "end_logit": 1.8864786624908447,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Akt/PKB as also Etk/Bmx",
            "probability": 0.004158200763087833,
            "start_logit": 0.3269219696521759,
            "end_logit": -0.6921051144599915,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Vav3. A point mutation in PAR2, H349A,",
            "probability": 0.003843227314773081,
            "start_logit": 1.0040496587753296,
            "end_logit": -1.448002815246582,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Akt/PKB",
            "probability": 0.0033716573475062322,
            "start_logit": 0.3269219696521759,
            "end_logit": -0.9017831683158875,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Etk/Bmx and Vav3. A point mutation in PAR",
            "probability": 0.003195565166078838,
            "start_logit": -0.47806689143180847,
            "end_logit": -0.15043476223945618,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "Etk/Bmx and Vav3",
            "probability": 0.0028199506328165686,
            "start_logit": -0.47806689143180847,
            "end_logit": -0.27547934651374817,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "H349A, but not R352A, abrogated PH-protein association and is sufficient to markedly reduce PAR2",
            "probability": 0.0027779084626080833,
            "start_logit": -2.5211918354034424,
            "end_logit": 1.75262451171875,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        }
    ],
    "5e52c5166d0a27794100004d": [
        {
            "text": "multiple sclerosis",
            "probability": 0.23718955870668354,
            "start_logit": -1.277825951576233,
            "end_logit": -1.489792823791504,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "analysis of multiple sclerosis",
            "probability": 0.0956625934611066,
            "start_logit": -2.1858582496643066,
            "end_logit": -1.489792823791504,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "transcriptomic analysis of multiple sclerosis",
            "probability": 0.08781394345143843,
            "start_logit": -2.271465301513672,
            "end_logit": -1.489792823791504,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "perform systematic transcriptomic analysis of multiple sclerosis",
            "probability": 0.06540585001850904,
            "start_logit": -2.5660738945007324,
            "end_logit": -1.489792823791504,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "systematic transcriptomic analysis of multiple sclerosis",
            "probability": 0.058711423377894256,
            "start_logit": -2.674051284790039,
            "end_logit": -1.489792823791504,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "MS stages",
            "probability": 0.04369406309046278,
            "start_logit": -2.3990771770477295,
            "end_logit": -2.0601890087127686,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "multiple sclerosis (MS)",
            "probability": 0.04282445758477781,
            "start_logit": -1.277825951576233,
            "end_logit": -3.201543092727661,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "analysis",
            "probability": 0.041840714011912784,
            "start_logit": -2.1858582496643066,
            "end_logit": -2.3167502880096436,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "multiple sclerosis (MS) risk genes",
            "probability": 0.04111688877580081,
            "start_logit": -1.277825951576233,
            "end_logit": -3.2422335147857666,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "multiple sclerosis (MS) risk genes in peripheral blood mononuclear cells",
            "probability": 0.04076319620782207,
            "start_logit": -1.277825951576233,
            "end_logit": -3.250872850418091,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "transcriptomic analysis",
            "probability": 0.038407887150830065,
            "start_logit": -2.271465301513672,
            "end_logit": -2.3167502880096436,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "multiple sclerosis (MS) risk genes in peripheral blood mononuclear cells (PBMCs)",
            "probability": 0.03542098168237319,
            "start_logit": -1.277825951576233,
            "end_logit": -3.391348123550415,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "perform systematic transcriptomic analysis",
            "probability": 0.028607080012346974,
            "start_logit": -2.5660738945007324,
            "end_logit": -2.3167502880096436,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "transcriptomic",
            "probability": 0.026182769105368885,
            "start_logit": -2.271465301513672,
            "end_logit": -2.699911594390869,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "systematic transcriptomic analysis",
            "probability": 0.025679085062496772,
            "start_logit": -2.674051284790039,
            "end_logit": -2.3167502880096436,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "perform systematic transcriptomic",
            "probability": 0.01950153018833546,
            "start_logit": -2.5660738945007324,
            "end_logit": -2.699911594390869,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "multiple sclerosis (MS) risk genes in peripheral blood mononuclear cells (PBMCs) of subjects with distinct",
            "probability": 0.018853389072091387,
            "start_logit": -1.277825951576233,
            "end_logit": -4.0219597816467285,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "distinct MS stages",
            "probability": 0.017547247615466034,
            "start_logit": -3.311392307281494,
            "end_logit": -2.0601890087127686,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "systematic transcriptomic",
            "probability": 0.017505507459655963,
            "start_logit": -2.674051284790039,
            "end_logit": -2.699911594390869,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "analysis of multiple sclerosis (MS)",
            "probability": 0.01727183396462707,
            "start_logit": -2.1858582496643066,
            "end_logit": -3.201543092727661,
            "question_text": "List the stages/types of Multiple Sclerosis."
        }
    ],
    "5e6e8897c6a8763d23000003": [
        {
            "text": "A-1210477",
            "probability": 0.9371699545707635,
            "start_logit": 5.087059020996094,
            "end_logit": 6.248918056488037,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "1210477",
            "probability": 0.04413093486589092,
            "start_logit": 2.031355381011963,
            "end_logit": 6.248918056488037,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "ABT-263",
            "probability": 0.005407732462907787,
            "start_logit": 3.3056583404541016,
            "end_logit": 2.87528395652771,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "-1210477",
            "probability": 0.004508513698948026,
            "start_logit": -0.24983808398246765,
            "end_logit": 6.248918056488037,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-1210477,",
            "probability": 0.004358363473508837,
            "start_logit": 5.087059020996094,
            "end_logit": 0.8781500458717346,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-1210477, a selective MCL-1 inhibitor",
            "probability": 0.0008511473714143826,
            "start_logit": 5.087059020996094,
            "end_logit": -0.7551165819168091,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "7",
            "probability": 0.0007820059986561097,
            "start_logit": -2.0016984939575195,
            "end_logit": 6.248918056488037,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-1210",
            "probability": 0.0004795298677944763,
            "start_logit": 5.087059020996094,
            "end_logit": -1.3288956880569458,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "477",
            "probability": 0.0004629014370392847,
            "start_logit": -2.5260467529296875,
            "end_logit": 6.248918056488037,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A",
            "probability": 0.0003838360914030588,
            "start_logit": 5.087059020996094,
            "end_logit": -1.5514862537384033,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-1210477, a selective MCL-1",
            "probability": 0.00028713875137923475,
            "start_logit": 5.087059020996094,
            "end_logit": -1.8417363166809082,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-121047",
            "probability": 0.00024175339473782187,
            "start_logit": 5.087059020996094,
            "end_logit": -2.0137836933135986,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-1210477, a selective",
            "probability": 0.00022475635024363414,
            "start_logit": 5.087059020996094,
            "end_logit": -2.0866849422454834,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "1210477,",
            "probability": 0.00020523348367414344,
            "start_logit": 2.031355381011963,
            "end_logit": 0.8781500458717346,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-121",
            "probability": 0.00012572364667255958,
            "start_logit": 5.087059020996094,
            "end_logit": -2.6676156520843506,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "BCL-w and A-1210477",
            "probability": 0.00010931055115622357,
            "start_logit": -3.9693679809570312,
            "end_logit": 6.248918056488037,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-1210477, a selective MCL-1 inhibitor.",
            "probability": 8.905036073305506e-05,
            "start_logit": 5.087059020996094,
            "end_logit": -3.0124998092651367,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "0477",
            "probability": 8.766524811832825e-05,
            "start_logit": -4.190035343170166,
            "end_logit": 6.248918056488037,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-",
            "probability": 5.436820697408556e-05,
            "start_logit": 5.087059020996094,
            "end_logit": -3.505922317504883,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "1210477, a selective MCL-1 inhibitor",
            "probability": 4.008016798443592e-05,
            "start_logit": 2.031355381011963,
            "end_logit": -0.7551165819168091,
            "question_text": "List Mcl-1 inhibitors."
        }
    ],
    "5e7659db835f4e4777000001": [
        {
            "text": "Rotarix",
            "probability": 0.6567338667739876,
            "start_logit": 5.702669620513916,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTeq and Rotarix",
            "probability": 0.2663549271588372,
            "start_logit": 4.800220489501953,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTeq",
            "probability": 0.0684376413977303,
            "start_logit": 4.800220489501953,
            "end_logit": 4.2922844886779785,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rotarix,",
            "probability": 0.005594337317796918,
            "start_logit": 5.702669620513916,
            "end_logit": 0.8856672644615173,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTeq and Rotarix,",
            "probability": 0.002268924117014613,
            "start_logit": 4.800220489501953,
            "end_logit": 0.8856672644615173,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "q and Rotarix",
            "probability": 0.00012311431078955182,
            "start_logit": -2.87925124168396,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rot",
            "probability": 9.90131176312261e-05,
            "start_logit": 5.702669620513916,
            "end_logit": -3.148590564727783,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "x",
            "probability": 8.668445910197307e-05,
            "start_logit": -3.2300899028778076,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTe",
            "probability": 7.40206071328875e-05,
            "start_logit": 4.800220489501953,
            "end_logit": -2.537050247192383,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": ", RotaTeq and Rotarix",
            "probability": 4.0551881869803465e-05,
            "start_logit": -3.9897823333740234,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTeq and Rot",
            "probability": 4.0157258622861064e-05,
            "start_logit": 4.800220489501953,
            "end_logit": -3.148590564727783,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "q",
            "probability": 3.163317886633102e-05,
            "start_logit": -2.87925124168396,
            "end_logit": 4.2922844886779785,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus vaccines, RotaTeq and Rotarix",
            "probability": 2.2774297369292553e-05,
            "start_logit": -4.566731929779053,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccines, RotaTeq and Rotarix",
            "probability": 2.213788390272841e-05,
            "start_logit": -4.59507417678833,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rotari",
            "probability": 1.51776818615477e-05,
            "start_logit": 5.702669620513916,
            "end_logit": -5.024016857147217,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Two rotavirus vaccines, RotaTeq and Rotarix",
            "probability": 1.4137228626563101e-05,
            "start_logit": -5.043552875518799,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rotarix, are licensed for global use; however, the protection they confer to unvaccinated individuals through indirect effects remains unknown.",
            "probability": 1.3528371676764671e-05,
            "start_logit": 5.702669620513916,
            "end_logit": -5.139053821563721,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": ", RotaTeq",
            "probability": 1.0419462403087936e-05,
            "start_logit": -3.9897823333740234,
            "end_logit": 4.2922844886779785,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rotarix, are licensed for global use;",
            "probability": 1.0117643849766763e-05,
            "start_logit": 5.702669620513916,
            "end_logit": -5.429562091827393,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "arix",
            "probability": 6.835850928968648e-06,
            "start_logit": -5.770183563232422,
            "end_logit": 5.651191234588623,
            "question_text": "Name two rotavirus vaccines."
        }
    ],
    "5e80e449835f4e477700002c": [
        {
            "text": "pneumocytes and surface enterocytes of the small intestine",
            "probability": 0.2662755260526107,
            "start_logit": 5.2091498374938965,
            "end_logit": 4.694772243499756,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pneumocytes",
            "probability": 0.1669040412085903,
            "start_logit": 5.2091498374938965,
            "end_logit": 4.227659702301025,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine",
            "probability": 0.14280280359994357,
            "start_logit": 4.586082935333252,
            "end_logit": 4.694772243499756,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "enterocytes of the small intestine",
            "probability": 0.12964584361118564,
            "start_logit": 4.489424705505371,
            "end_logit": 4.694772243499756,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pneumocytes and surface enterocytes",
            "probability": 0.07732960415181951,
            "start_logit": 5.2091498374938965,
            "end_logit": 3.458317518234253,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "enterocytes",
            "probability": 0.037650706826134875,
            "start_logit": 4.489424705505371,
            "end_logit": 3.458317518234253,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine. Despite the fact that SARS-CoV can infect the lung and intestine",
            "probability": 0.031195334732411574,
            "start_logit": 4.586082935333252,
            "end_logit": 3.1735761165618896,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "enterocytes of the small intestine. Despite the fact that SARS-CoV can infect the lung and intestine",
            "probability": 0.02832119108422334,
            "start_logit": 4.489424705505371,
            "end_logit": 3.1735761165618896,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "surface enterocytes of the small intestine",
            "probability": 0.021359921184689323,
            "start_logit": 2.6861345767974854,
            "end_logit": 4.694772243499756,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pneumocytes and surface enterocytes of the small intestine. Despite the fact that SARS-CoV can infect the lung",
            "probability": 0.020208904895015575,
            "start_logit": 5.2091498374938965,
            "end_logit": 2.116364002227783,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "lung and intestine",
            "probability": 0.01220649788012585,
            "start_logit": 3.647782802581787,
            "end_logit": 3.1735761165618896,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "the small intestine",
            "probability": 0.010917945809755813,
            "start_logit": 2.015026092529297,
            "end_logit": 4.694772243499756,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine. Despite the fact that SARS-CoV can infect the lung",
            "probability": 0.010837977937644388,
            "start_logit": 4.586082935333252,
            "end_logit": 2.116364002227783,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "enterocytes of the small intestine. Despite the fact that SARS-CoV can infect the lung",
            "probability": 0.009839434222185535,
            "start_logit": 4.489424705505371,
            "end_logit": 2.116364002227783,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "intestine",
            "probability": 0.007903955271533921,
            "start_logit": 3.2131776809692383,
            "end_logit": 3.1735761165618896,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pneumocytes and surface enterocytes of the small intestine.",
            "probability": 0.0074791727692401725,
            "start_logit": 5.2091498374938965,
            "end_logit": 1.1223628520965576,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "surface enterocytes",
            "probability": 0.006203177116622184,
            "start_logit": 2.6861345767974854,
            "end_logit": 3.458317518234253,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "surface enterocytes of the small intestine. Despite the fact that SARS-CoV can infect the lung and intestine",
            "probability": 0.004666084099308088,
            "start_logit": 2.6861345767974854,
            "end_logit": 3.1735761165618896,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "lung",
            "probability": 0.0042408185664779986,
            "start_logit": 3.647782802581787,
            "end_logit": 2.116364002227783,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine.",
            "probability": 0.004011058980481841,
            "start_logit": 4.586082935333252,
            "end_logit": 1.1223628520965576,
            "question_text": "Which tissues express the ACE2 protein?"
        }
    ],
    "5e7768f9835f4e477700000b": [
        {
            "text": "Exubera\u00ae",
            "probability": 0.9044255337626483,
            "start_logit": 5.70290470123291,
            "end_logit": 6.166903972625732,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza\u00ae",
            "probability": 0.05422735046040304,
            "start_logit": 4.405664443969727,
            "end_logit": 4.65002965927124,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Exubera",
            "probability": 0.030773406233003862,
            "start_logit": 5.70290470123291,
            "end_logit": 2.7862548828125,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Exubera\u00ae,",
            "probability": 0.007175179551802525,
            "start_logit": 5.70290470123291,
            "end_logit": 1.330231785774231,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza",
            "probability": 0.002395274516559683,
            "start_logit": 4.405664443969727,
            "end_logit": 1.5303421020507812,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "\u00ae",
            "probability": 0.0005303925598525498,
            "start_logit": -1.7385331392288208,
            "end_logit": 6.166903972625732,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "ubera\u00ae",
            "probability": 0.00011509944186212098,
            "start_logit": -3.2663540840148926,
            "end_logit": 6.166903972625732,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza\u00ae",
            "probability": 0.0001145931452389702,
            "start_logit": -1.7538882493972778,
            "end_logit": 4.65002965927124,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Ex",
            "probability": 7.025024359474652e-05,
            "start_logit": 5.70290470123291,
            "end_logit": -3.2960875034332275,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "subcutaneous (SC) route for diabetes management. Despite discontinuation of the first inhalable insulin, Exubera\u00ae",
            "probability": 5.296667431467439e-05,
            "start_logit": -4.042487621307373,
            "end_logit": 6.166903972625732,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "first inhalable insulin, Exubera\u00ae",
            "probability": 3.76641466807779e-05,
            "start_logit": -4.383441925048828,
            "end_logit": 6.166903972625732,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "ra\u00ae",
            "probability": 3.0337578456515412e-05,
            "start_logit": -4.5997633934021,
            "end_logit": 6.166903972625732,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "the first inhalable insulin, Exubera\u00ae",
            "probability": 9.554016181159486e-06,
            "start_logit": -5.755188941955566,
            "end_logit": 6.166903972625732,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Exubera\u00ae, due to suboptimal market acceptance, development of orally inhaled insulin",
            "probability": 9.045245852405429e-06,
            "start_logit": 5.70290470123291,
            "end_logit": -5.345911979675293,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "za\u00ae",
            "probability": 8.60825125155449e-06,
            "start_logit": -4.342555046081543,
            "end_logit": 4.65002965927124,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "A",
            "probability": 6.175717630858712e-06,
            "start_logit": 4.405664443969727,
            "end_logit": -4.430285930633545,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza\u00ae and several others awaiting approval.",
            "probability": 5.063416678715703e-06,
            "start_logit": 4.405664443969727,
            "end_logit": -4.628869533538818,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza",
            "probability": 5.061690055533055e-06,
            "start_logit": -1.7538882493972778,
            "end_logit": 1.5303421020507812,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "orally inhaled insulin delivery systems has been galvanized by the recent approval of Afrezza\u00ae",
            "probability": 4.23552572047446e-06,
            "start_logit": -5.051768779754639,
            "end_logit": 4.65002965927124,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "\u00ae,",
            "probability": 4.207822211796317e-06,
            "start_logit": -1.7385331392288208,
            "end_logit": 1.330231785774231,
            "question_text": "Name two inhalable insulin products."
        }
    ]
}
